[{"conversation_id":"380647728197292032","author_id":"116716199","possibly_sensitive":false,"text":"The EPAR for #Tafinlar (#dabrafenib) for the treatment of #melanoma is available on our website: http://t.co/HnM4SGmIxu","source":"Twitter Web Client","id":"380647728197292032","entities":{"hashtags":[{"start":13,"end":22,"tag":"Tafinlar"},{"start":24,"end":35,"tag":"dabrafenib"},{"start":58,"end":67,"tag":"melanoma"}],"urls":[{"start":97,"end":119,"url":"http://t.co/HnM4SGmIxu","expanded_url":"http://bit.ly/19glED1","display_url":"bit.ly/19glED1"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-19T11:01:05.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"380647309958471680","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: New FDA Guidance Details How to Convey Patient Counseling Information Through Labeling http://t.co/A5gWTlVX5S","source":"TweetDeck","id":"380647309958471680","entities":{"hashtags":{},"urls":[{"start":100,"end":122,"url":"http://t.co/A5gWTlVX5S","expanded_url":"http://www.raps.org/focus-online/news/news-article-view/article/4088/new-fda-guidance-details-how-to-convey-patient-counseling-information-through-l.aspx#.UjrY3TJZrmZ.twitter","display_url":"raps.org/focus-online/n…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":17,"end":19,"probability":0.6139,"type":"Organization","normalized_text":"FDA"}]},"lang":"en","created_at":"2013-09-19T10:59:25.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380647155083399168"}],"attachments":{"media_keys":{}}},{"conversation_id":"380640028244049920","author_id":"116716199","possibly_sensitive":false,"text":"RT @sailinsomnia: New #FDA Guidance Details How to Convey Patient Counseling Information Through Labeling http://t.co/k8yXAsVYHN","source":"TweetDeck","id":"380640028244049920","entities":{"hashtags":[{"start":22,"end":26,"tag":"FDA"}],"urls":[{"start":106,"end":128,"url":"http://t.co/k8yXAsVYHN","expanded_url":"http://www.raps.org/focus-online/news/news-article-view/article/4088/new-fda-guidance-details-how-to-convey-patient-counseling-information-through-l.aspx#.UjrR8JJExoM.twitter","display_url":"raps.org/focus-online/n…"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-19T10:30:29.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380639849914433536"}],"attachments":{"media_keys":{}}},{"conversation_id":"380636390570352640","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAAD_EU: Cold? #Flu? Get well without #antibiotics. Watch the Sneezing panda video: http://t.co/U5DWyqRDWg #EAAD","source":"TweetDeck","id":"380636390570352640","entities":{"hashtags":[{"start":19,"end":23,"tag":"Flu"},{"start":42,"end":54,"tag":"antibiotics"},{"start":111,"end":116,"tag":"EAAD"}],"urls":[{"start":88,"end":110,"url":"http://t.co/U5DWyqRDWg","expanded_url":"http://bit.ly/SB0Dcf","display_url":"bit.ly/SB0Dcf"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":{}},"lang":"en","created_at":"2013-09-19T10:16:02.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380636217601036289"}],"attachments":{"media_keys":{}}},{"conversation_id":"380635472013557760","author_id":"116716199","possibly_sensitive":false,"text":"RT @uicc: Have you read the Refreshed #WorldCancerDeclaration? Don't miss your chance to give feedback: http://t.co/99QwOxFkdW","source":"TweetDeck","id":"380635472013557760","entities":{"hashtags":[{"start":38,"end":61,"tag":"WorldCancerDeclaration"}],"urls":[{"start":104,"end":126,"url":"http://t.co/99QwOxFkdW","expanded_url":"http://bit.ly/143HeG5","display_url":"bit.ly/143HeG5"}],"mentions":[{"start":3,"end":8,"username":"uicc","id":"53023973"}],"annotations":{}},"lang":"en","created_at":"2013-09-19T10:12:23.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380635208271134720"}],"attachments":{"media_keys":{}}},{"conversation_id":"380628942732161024","author_id":"116716199","possibly_sensitive":false,"text":"RT @IMI_JU: IMI's 10th Call for proposals - indicative text now available: http://t.co/4H6E3ilKmn","source":"TweetDeck","id":"380628942732161024","entities":{"hashtags":{},"urls":[{"start":75,"end":97,"url":"http://t.co/4H6E3ilKmn","expanded_url":"http://ow.ly/p0Km6","display_url":"ow.ly/p0Km6"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"lang":"en","created_at":"2013-09-19T09:46:26.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380628289540612096"}],"attachments":{"media_keys":{}}},{"conversation_id":"380628767892578304","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: We're making big decisions on #future  #hospital #pharmacy and we want #patients #doctors &amp; #nurses to input! http://t.co/hR…","source":"TweetDeck","id":"380628767892578304","entities":{"hashtags":[{"start":45,"end":52,"tag":"future"},{"start":54,"end":63,"tag":"hospital"},{"start":64,"end":73,"tag":"pharmacy"},{"start":86,"end":95,"tag":"patients"},{"start":96,"end":104,"tag":"doctors"},{"start":111,"end":118,"tag":"nurses"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"annotations":{}},"lang":"en","created_at":"2013-09-19T09:45:44.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380625095716139008"}],"attachments":{"media_keys":{}}},{"conversation_id":"380628667560648704","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: The European Antibiotic Awareness Day is on Twitter! Follow us @EAAD_EU and learn more on #antibiotic resistance in Europe #EA…","source":"TweetDeck","id":"380628667560648704","entities":{"hashtags":[{"start":103,"end":114,"tag":"antibiotic"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":76,"end":84,"username":"EAAD_EU","id":"1725283578"}],"annotations":[{"start":17,"end":49,"probability":0.5051,"type":"Other","normalized_text":"European Antibiotic Awareness Day"},{"start":57,"end":63,"probability":0.5958,"type":"Product","normalized_text":"Twitter"},{"start":129,"end":134,"probability":0.9856,"type":"Place","normalized_text":"Europe"}]},"lang":"en","created_at":"2013-09-19T09:45:20.000Z","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380624651107315713"}],"attachments":{"media_keys":{}}},{"conversation_id":"380622852837634048","author_id":"116716199","possibly_sensitive":false,"text":"Our website and other online tools will be unavailable from tomorrow evening until Monday morning: http://t.co/3fJYOIo6SD","source":"bitly bitlink","id":"380622852837634048","entities":{"hashtags":{},"urls":[{"start":99,"end":121,"url":"http://t.co/3fJYOIo6SD","expanded_url":"http://bit.ly/155UOjL","display_url":"bit.ly/155UOjL"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-19T09:22:14.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"380618411463962624","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO_Europe: Member States report over 90000 measles cases &amp; 70000 rubella cases over past 3 years in European Region http://t.co/L24aq5…","source":"TweetDeck","id":"380618411463962624","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"lang":"en","created_at":"2013-09-19T09:04:35.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380618077198503936"}],"attachments":{"media_keys":{}}},{"conversation_id":"380618193041371136","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO_Europe: The European Region has experienced outbreaks of vaccine preventable diseases over past the 4 years http://t.co/L24aq5SSVO …","source":"TweetDeck","id":"380618193041371136","entities":{"hashtags":{},"urls":[{"start":116,"end":138,"url":"http://t.co/L24aq5SSVO","expanded_url":"http://bit.ly/14lqqzq","display_url":"bit.ly/14lqqzq"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"lang":"en","created_at":"2013-09-19T09:03:43.000Z","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380617868376698880"}],"attachments":{"media_keys":{}}},{"conversation_id":"380617902598410240","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO_Europe: 4 principle objectives outlined in the Polio Eradication &amp; Endgame Strategic Plan 2013-2018 http://t.co/QTsRX53yxb #RC63Izm…","source":"TweetDeck","id":"380617902598410240","entities":{"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/QTsRX53yxb","expanded_url":"http://bit.ly/16helaR","display_url":"bit.ly/16helaR"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":55,"end":71,"probability":0.3044,"type":"Organization","normalized_text":"Polio Eradication"}]},"lang":"en","created_at":"2013-09-19T09:02:34.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380616667371278337"}],"attachments":{"media_keys":{}}},{"conversation_id":"380617734385844224","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO_Europe: Immunization helped drive remarkable reduction in child mortality in European Region over recent decades http://t.co/L24aq5…","source":"TweetDeck","id":"380617734385844224","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":85,"end":99,"probability":0.4535,"type":"Place","normalized_text":"European Region"}]},"lang":"en","created_at":"2013-09-19T09:01:54.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380616045796417536"}],"attachments":{"media_keys":{}}},{"conversation_id":"380616630759600128","author_id":"116716199","possibly_sensitive":false,"text":"We've published the assessment report for #Tafinlar (#dabrafenib) for the treatment of #melanoma: http://t.co/yfpgCi1C39","source":"bitly bitlink","id":"380616630759600128","entities":{"hashtags":[{"start":42,"end":51,"tag":"Tafinlar"},{"start":53,"end":64,"tag":"dabrafenib"},{"start":87,"end":96,"tag":"melanoma"}],"urls":[{"start":98,"end":120,"url":"http://t.co/yfpgCi1C39","expanded_url":"http://bit.ly/19glED1","display_url":"bit.ly/19glED1"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-19T08:57:30.000Z","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"380614853398134784","author_id":"116716199","possibly_sensitive":false,"text":"RT @AlzDisInt: It's nearly here...The World Alzheimer Report 2013 will be available from 8pm GMT tonight! http://t.co/VzC5RGGNYx http://t.c…","source":"TweetDeck","id":"380614853398134784","entities":{"hashtags":{},"urls":[{"start":106,"end":128,"url":"http://t.co/VzC5RGGNYx","expanded_url":"http://tinyurl.com/ksqrwd6","display_url":"tinyurl.com/ksqrwd6"}],"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"}],"annotations":[{"start":34,"end":64,"probability":0.564,"type":"Other","normalized_text":"The World Alzheimer Report 2013"}]},"lang":"en","created_at":"2013-09-19T08:50:27.000Z","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380613415925854208"}],"attachments":{"media_keys":{}}},{"conversation_id":"380367352510308353","author_id":"116716199","possibly_sensitive":false,"text":"RT @USPharmacopeia: Fact: An estimated 25% of the total medicine supply is counterfeit in developing countries - @WHO #globalhealth #cgi2013","source":"TweetDeck","id":"380367352510308353","entities":{"hashtags":[{"start":118,"end":131,"tag":"globalhealth"},{"start":132,"end":140,"tag":"cgi2013"}],"urls":{},"mentions":[{"start":3,"end":18,"username":"USPharmacopeia","id":"47953929"},{"start":113,"end":117,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-09-18T16:26:58.000Z","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380367190915956736"}],"attachments":{"media_keys":{}}},{"conversation_id":"380367330314047488","author_id":"116716199","possibly_sensitive":false,"text":"RT @USPharmacopeia: Counterfeit meds threaten lives around the world. Chat w/ us as we share some alarming facts about this #globalhealth i…","source":"TweetDeck","id":"380367330314047488","entities":{"hashtags":[{"start":124,"end":137,"tag":"globalhealth"}],"urls":{},"mentions":[{"start":3,"end":18,"username":"USPharmacopeia","id":"47953929"}],"annotations":{}},"lang":"en","created_at":"2013-09-18T16:26:53.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380366923986268160"}],"attachments":{"media_keys":{}}},{"conversation_id":"380366575037317120","author_id":"116716199","possibly_sensitive":false,"text":"RT @Aifa_ufficiale: Second edition of the masters in medicines regulatory sciences. After the success of the first... http://t.co/7nkWHAbEq4","source":"TweetDeck","id":"380366575037317120","entities":{"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/7nkWHAbEq4","expanded_url":"http://fb.me/2lptVMT9F","display_url":"fb.me/2lptVMT9F"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"lang":"en","created_at":"2013-09-18T16:23:53.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"380366000119877633","author_id":"116716199","possibly_sensitive":false,"text":"RT @Aifa_ufficiale: AIFA masters in medicines regulatory science activated for academic year 2013/14. See the call: http://t.co/JuBoj4huqW","source":"TweetDeck","id":"380366000119877633","entities":{"hashtags":{},"urls":[{"start":116,"end":138,"url":"http://t.co/JuBoj4huqW","expanded_url":"http://www.agenziafarmaco.gov.it/sites/default/files/26132_0.pdf","display_url":"agenziafarmaco.gov.it/sites/default/…"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"lang":"en","created_at":"2013-09-18T16:21:35.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"380365326858608640","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: Brain atrophy linked with cognitive decline in #diabetes http://t.co/bffttvknKF","source":"TweetDeck","id":"380365326858608640","entities":{"hashtags":[{"start":58,"end":67,"tag":"diabetes"}],"urls":[{"start":68,"end":90,"url":"http://t.co/bffttvknKF","expanded_url":"http://bit.ly/164PCgK","display_url":"bit.ly/164PCgK"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-09-18T16:18:55.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380355038431809536"}],"attachments":{"media_keys":{}}},{"conversation_id":"380348905919373312","author_id":"116716199","possibly_sensitive":false,"text":"RT @innovationunion: New pancreatic stem cell research could transform treatment: Stem cell research is of huge importance because it... ht…","source":"TweetDeck","id":"380348905919373312","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"lang":"en","created_at":"2013-09-18T15:13:40.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380348124532707328"}],"attachments":{"media_keys":{}}},{"conversation_id":"380348648741416960","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: ECDC article about the new @CDCgov report on #antibiotic resistance threats in US, 2013: http://t.co/8GenTJ1Jcz","source":"TweetDeck","id":"380348648741416960","entities":{"hashtags":[{"start":58,"end":69,"tag":"antibiotic"}],"urls":[{"start":102,"end":124,"url":"http://t.co/8GenTJ1Jcz","expanded_url":"http://bit.ly/14iGlOK","display_url":"bit.ly/14iGlOK"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":40,"end":47,"username":"CDCgov","id":"146569971"}],"annotations":[{"start":92,"end":93,"probability":0.9769,"type":"Place","normalized_text":"US"}]},"lang":"en","created_at":"2013-09-18T15:12:39.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380342476256444418"}],"attachments":{"media_keys":{}}},{"conversation_id":"380348410106511360","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: WHO policy briefs to combat antimicrobial resistance http://t.co/49nrF3O0dg","source":"TweetDeck","id":"380348410106511360","entities":{"hashtags":{},"urls":[{"start":62,"end":84,"url":"http://t.co/49nrF3O0dg","expanded_url":"http://goo.gl/gO2sPg","display_url":"goo.gl/gO2sPg","status":500,"unwound_url":"https://www.who.int/world-health-day/2011/policybriefs/en/"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-09-18T15:11:42.000Z","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380341324429262849"}],"attachments":{"media_keys":{}}},{"conversation_id":"380331799584731136","author_id":"116716199","possibly_sensitive":false,"text":"RT @sailinsomnia: Please be aware of the changes to #MedicinesNames: sulPHate to sulFate http://t.co/tNzmuILs78","source":"TweetDeck","id":"380331799584731136","entities":{"hashtags":[{"start":52,"end":67,"tag":"MedicinesNames"}],"urls":[{"start":89,"end":111,"url":"http://t.co/tNzmuILs78","expanded_url":"http://www.mhra.gov.uk/Howweregulate/Medicines/Medicinesregulatorynews/CON273729","display_url":"mhra.gov.uk/Howweregulate/…"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-18T14:05:41.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380324814864388096"}],"attachments":{"media_keys":{}}},{"conversation_id":"380330825730236416","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: #RareDiseases - Pitt Hopkins Awareness Day Today http://t.co/mKdBl0Ui45","source":"TweetDeck","id":"380330825730236416","entities":{"hashtags":[{"start":11,"end":24,"tag":"RareDiseases"}],"urls":[{"start":60,"end":82,"url":"http://t.co/mKdBl0Ui45","expanded_url":"http://bit.ly/1a3NraO","display_url":"bit.ly/1a3NraO"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":27,"end":38,"probability":0.8271,"type":"Person","normalized_text":"Pitt Hopkins"}]},"lang":"en","created_at":"2013-09-18T14:01:49.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380330645668372483"}],"attachments":{"media_keys":{}}},{"conversation_id":"380321750363688960","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: The European Antibiotic Awareness Day is on Facebook! Follow us and get information on #antibiotic resistance http://t.co/t1lS…","source":"TweetDeck","id":"380321750363688960","entities":{"hashtags":[{"start":100,"end":111,"tag":"antibiotic"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":17,"end":49,"probability":0.4657,"type":"Other","normalized_text":"European Antibiotic Awareness Day"},{"start":57,"end":64,"probability":0.4808,"type":"Product","normalized_text":"Facebook"}]},"lang":"en","created_at":"2013-09-18T13:25:45.000Z","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380320147870711809"}],"attachments":{"media_keys":{}}},{"conversation_id":"380321165715460096","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: Antimicrobial resistance can also result in greater risk of death and higher costs (for treatment) http://t.co/CnsmuK7FPu","source":"TweetDeck","id":"380321165715460096","entities":{"hashtags":{},"urls":[{"start":108,"end":130,"url":"http://t.co/CnsmuK7FPu","expanded_url":"http://goo.gl/9gK5tN","display_url":"goo.gl/9gK5tN"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-09-18T13:23:26.000Z","public_metrics":{"retweet_count":81,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380304605927575552"}],"attachments":{"media_keys":{}}},{"conversation_id":"380321105938239488","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: Antimicrobial resistance is when microorganisms fail to respond to conventional treatment, hence prolonged illness http://t.co/Cns…","source":"TweetDeck","id":"380321105938239488","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-09-18T13:23:12.000Z","public_metrics":{"retweet_count":90,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380303624674373632"}],"attachments":{"media_keys":{}}},{"conversation_id":"380321055036170240","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: We are rapidly running out of treatment options for gonorrhoea, returning it to a major public health problem http://t.co/Jd1czGA1…","source":"TweetDeck","id":"380321055036170240","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-09-18T13:23:00.000Z","public_metrics":{"retweet_count":97,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380303179423834112"}],"attachments":{"media_keys":{}}},{"conversation_id":"380320913969127424","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: The advisory group to review &amp; help shape a global strategy to tackle growing challenge of antimicrobial resistance http://t.co/Jd…","source":"TweetDeck","id":"380320913969127424","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-09-18T13:22:26.000Z","public_metrics":{"retweet_count":33,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380300817518964737"}],"attachments":{"media_keys":{}}},{"conversation_id":"380320794792194048","author_id":"116716199","possibly_sensitive":false,"text":"RT @eurordis: Submit a poster to European Conference on #RareDiseases and Orphan Products 2014 http://t.co/GkZBG7uddP in partnership with @…","source":"TweetDeck","id":"380320794792194048","entities":{"hashtags":[{"start":56,"end":69,"tag":"RareDiseases"}],"urls":[{"start":95,"end":117,"url":"http://t.co/GkZBG7uddP","expanded_url":"http://ow.ly/oYxOh","display_url":"ow.ly/oYxOh"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":{}},"lang":"en","created_at":"2013-09-18T13:21:58.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380292778863108096"}],"attachments":{"media_keys":{}}},{"conversation_id":"380266376428265472","author_id":"116716199","possibly_sensitive":false,"text":"RT @EU_Health: Antimicrobial resistance and healthcare-associated infections - @ECDC_EU topic publications #AMR http://t.co/tZgEDJ57fn","source":"TweetDeck","id":"380266376428265472","entities":{"hashtags":[{"start":107,"end":111,"tag":"AMR"}],"urls":[{"start":112,"end":134,"url":"http://t.co/tZgEDJ57fn","expanded_url":"http://bit.ly/1f50A4k","display_url":"bit.ly/1f50A4k"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":79,"end":87,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","created_at":"2013-09-18T09:45:43.000Z","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380265552247132160"}],"attachments":{"media_keys":{}}},{"conversation_id":"380266315061399552","author_id":"116716199","possibly_sensitive":false,"text":"RT @AlzDisInt: 2 days to go until our 2013 report. Last year we looked at the stigma of dementia, please take a second to see why... http:/…","source":"TweetDeck","id":"380266315061399552","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"}],"annotations":{}},"lang":"en","created_at":"2013-09-18T09:45:29.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380264112921395201"}],"attachments":{"media_keys":{}}},{"conversation_id":"380266084601192448","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: Richard Bergström : Clinical trial data is not a public good http://t.co/Whb9akgku7 #ClinicalTrials #ctdata","source":"TweetDeck","id":"380266084601192448","entities":{"hashtags":[{"start":95,"end":110,"tag":"ClinicalTrials"},{"start":111,"end":118,"tag":"ctdata"}],"urls":[{"start":72,"end":94,"url":"http://t.co/Whb9akgku7","expanded_url":"http://bit.ly/18xzNPC","display_url":"bit.ly/18xzNPC"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"ro","created_at":"2013-09-18T09:44:34.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"380249112446509056","author_id":"116716199","possibly_sensitive":false,"text":"RT @eurordis: Today is 1st ever Pitt Hopkins syndrome awareness day. http://t.co/0WU1aoETkJ 18th chromosome, neurodevelopmental disorder #R…","source":"TweetDeck","id":"380249112446509056","entities":{"hashtags":{},"urls":[{"start":69,"end":91,"url":"http://t.co/0WU1aoETkJ","expanded_url":"http://youtu.be/GNF1aaPcXEY","display_url":"youtu.be/GNF1aaPcXEY"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":[{"start":32,"end":43,"probability":0.9693,"type":"Person","normalized_text":"Pitt Hopkins"}]},"lang":"en","created_at":"2013-09-18T08:37:07.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380247227199152128"}],"attachments":{"media_keys":{}}},{"conversation_id":"380243419781935104","author_id":"116716199","possibly_sensitive":false,"text":"RT @LV_MPA: Warning regarding slimming products containing dinitrophenol http://t.co/uf00uCwT5D","source":"TweetDeck","id":"380243419781935104","entities":{"hashtags":{},"urls":[{"start":73,"end":95,"url":"http://t.co/uf00uCwT5D","expanded_url":"http://bit.ly/1eOzTpM","display_url":"bit.ly/1eOzTpM"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"lang":"en","created_at":"2013-09-18T08:14:30.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"380241191079391232"}],"attachments":{"media_keys":{}}},{"conversation_id":"380005387321507841","author_id":"116716199","possibly_sensitive":false,"text":"RT @HAIEurope: Join us for our #globalhealth conference 'Big #Pharma: Good Pharma - Bad Pharma?' this Sat., 21 Sept in #Berlin. Reg: http:/…","source":"TweetDeck","id":"380005387321507841","entities":{"hashtags":[{"start":31,"end":44,"tag":"globalhealth"},{"start":61,"end":68,"tag":"Pharma"},{"start":119,"end":126,"tag":"Berlin"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":{}},"lang":"en","created_at":"2013-09-17T16:28:39.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379993279120437248"}],"attachments":{"media_keys":{}}},{"conversation_id":"380005299794751488","author_id":"116716199","possibly_sensitive":false,"text":"RT @AEMPSGOB: Withdrawal of several products with sibutramine http://t.co/jOI9ziTadI","source":"TweetDeck","id":"380005299794751488","entities":{"hashtags":{},"urls":[{"start":62,"end":84,"url":"http://t.co/jOI9ziTadI","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/medIlegales/2013/ICM_MI_08-2013-productos-adelgazantes.htm","display_url":"aemps.gob.es/informa/notasI…"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"lang":"en","created_at":"2013-09-17T16:28:18.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379980187972407296","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: How the bacteria in your gut may be shaping your waistline #obesity \nhttp://t.co/efXQIZwf8h","source":"TweetDeck","id":"379980187972407296","entities":{"hashtags":[{"start":70,"end":78,"tag":"obesity"}],"urls":[{"start":80,"end":102,"url":"http://t.co/efXQIZwf8h","expanded_url":"http://econ.st/186WK8C","display_url":"econ.st/186WK8C"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-09-17T14:48:31.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379979936506736640"}],"attachments":{"media_keys":{}}},{"conversation_id":"379975536606736384","author_id":"116716199","possibly_sensitive":false,"text":"RT @TOPRANEWS: October's Regulatory Rapporteur looks at the impact of new pharmacovigilance legislation on authorities and industry. http:/…","source":"TweetDeck","id":"379975536606736384","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":[{"start":25,"end":45,"probability":0.2607,"type":"Person","normalized_text":"Regulatory Rapporteur"}]},"lang":"en","created_at":"2013-09-17T14:30:02.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379975487763644416"}],"attachments":{"media_keys":{}}},{"conversation_id":"379973464301789184","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: Why personalised medicine is bad for us all: http://t.co/Fu3rhJiShF","source":"TweetDeck","id":"379973464301789184","entities":{"hashtags":{},"urls":[{"start":58,"end":80,"url":"http://t.co/Fu3rhJiShF","expanded_url":"http://www.newscientist.com/article/mg21929340.200-why-personalised-medicine-is-bad-for-us-all.html#.UjhkPn-8BS1","display_url":"newscientist.com/article/mg2192…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","created_at":"2013-09-17T14:21:48.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379972275585294336"}],"attachments":{"media_keys":{}}},{"conversation_id":"379968348689534976","author_id":"116716199","possibly_sensitive":false,"text":"RT @nice_intl: \"Why personalised medicine is bad for us all\" http://t.co/CposltFR5I","source":"TweetDeck","id":"379968348689534976","entities":{"hashtags":{},"urls":[{"start":61,"end":83,"url":"http://t.co/CposltFR5I","expanded_url":"http://www.newscientist.com/article/mg21929340.200-why-personalised-medicine-is-bad-for-us-all.html#.UjhfPGSY5tI","display_url":"newscientist.com/article/mg2192…"}],"mentions":[{"start":3,"end":13,"username":"nice_intl","id":"794424916133056512"}],"annotations":{}},"lang":"en","created_at":"2013-09-17T14:01:28.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379968016114409473"}],"attachments":{"media_keys":{}}},{"conversation_id":"379949476783595520","author_id":"116716199","possibly_sensitive":false,"text":"RT @sailinsomnia: Establishing Drug Substance/Drug Product Specs Throughout Development http://t.co/g6wfqgq1ri","source":"TweetDeck","id":"379949476783595520","entities":{"hashtags":{},"urls":[{"start":88,"end":110,"url":"http://t.co/g6wfqgq1ri","expanded_url":"http://www.raps.org/focus-online/features/features-article-view/article/4071/establishing-drug-substancedrug-product-specs-throughout-development.aspx#.UjhLMWpMsnY.twitter","display_url":"raps.org/focus-online/f…"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-17T12:46:29.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379945279220232193"}],"attachments":{"media_keys":{}}},{"conversation_id":"379943077315899393","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: Living near livestock farms and manure-treated fields associated with higher rates of antibiotic-resistant infection http://t.co…","source":"TweetDeck","id":"379943077315899393","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-09-17T12:21:03.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379942975599423488"}],"attachments":{"media_keys":{}}},{"conversation_id":"379939578230358016","author_id":"116716199","possibly_sensitive":false,"text":"RT @eurordis: EURORDIS Awards 2014 nomination process is open to everyone. Submit a nomination  http://t.co/rw74TjmGtk #RareDisease","source":"TweetDeck","id":"379939578230358016","entities":{"hashtags":[{"start":119,"end":131,"tag":"RareDisease"}],"urls":[{"start":96,"end":118,"url":"http://t.co/rw74TjmGtk","expanded_url":"http://ow.ly/oWud8","display_url":"ow.ly/oWud8"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":{}},"lang":"en","created_at":"2013-09-17T12:07:09.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379939277976899584"}],"attachments":{"media_keys":{}}},{"conversation_id":"379939420876845056","author_id":"116716199","possibly_sensitive":false,"text":"RT @EUombudsman: International Right to Know Day Seminar 27/9 - \"EU transparency: Where are we now?\" http://t.co/sQ9VhBVr7Y #11rtkdEO #RTKD…","source":"TweetDeck","id":"379939420876845056","entities":{"hashtags":[{"start":124,"end":133,"tag":"11rtkdEO"}],"urls":[{"start":101,"end":123,"url":"http://t.co/sQ9VhBVr7Y","expanded_url":"http://bit.ly/17mw2Gv","display_url":"bit.ly/17mw2Gv"}],"mentions":[{"start":3,"end":15,"username":"EUombudsman","id":"873777758"}],"annotations":{}},"lang":"en","created_at":"2013-09-17T12:06:31.000Z","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379938955493244928"}],"attachments":{"media_keys":{}}},{"conversation_id":"379915625017397248","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: European Medicines Agency reveals new structure: http://t.co/dNgpiBzCh0","source":"TweetDeck","id":"379915625017397248","entities":{"hashtags":{},"urls":[{"start":62,"end":84,"url":"http://t.co/dNgpiBzCh0","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/09/news_detail_001886.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":13,"end":37,"probability":0.7973,"type":"Organization","normalized_text":"European Medicines Agency"}]},"lang":"en","created_at":"2013-09-17T10:31:58.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379913198234648576"}],"attachments":{"media_keys":{}}},{"conversation_id":"379912320048037889","author_id":"116716199","possibly_sensitive":false,"text":"Yesterday we published details on our new organisational structure: http://t.co/MIS1VfUoTd","source":"Twitter Web Client","id":"379912320048037889","entities":{"hashtags":{},"urls":[{"start":68,"end":90,"url":"http://t.co/MIS1VfUoTd","expanded_url":"http://bit.ly/17CRM4l","display_url":"bit.ly/17CRM4l"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-17T10:18:50.000Z","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379882129871888385","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: Available epi data show that there is no evidence of a link between measles-mumps-rubella vaccine and #autism spectrum disorders","source":"TweetDeck","id":"379882129871888385","entities":{"hashtags":[{"start":111,"end":118,"tag":"autism"}],"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-09-17T08:18:52.000Z","public_metrics":{"retweet_count":175,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379882060149579776"}],"attachments":{"media_keys":{}}},{"conversation_id":"379880862088581120","author_id":"116716199","possibly_sensitive":false,"text":"Yesterday we published the agenda of this week's #herbal-committee meeting for the first time. Minutes to follow: http://t.co/y5YarTkCHo","source":"Twitter Web Client","id":"379880862088581120","entities":{"hashtags":[{"start":49,"end":56,"tag":"herbal"}],"urls":[{"start":114,"end":136,"url":"http://t.co/y5YarTkCHo","expanded_url":"http://bit.ly/19XAK18","display_url":"bit.ly/19XAK18"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-17T08:13:50.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379880597272793089","author_id":"116716199","possibly_sensitive":false,"text":"On Friday, we published the highlights from our #veterinary committee (#CVMP) meeting: http://t.co/YdgDztMmGy","source":"Twitter Web Client","id":"379880597272793089","entities":{"hashtags":[{"start":48,"end":59,"tag":"veterinary"},{"start":71,"end":76,"tag":"CVMP"}],"urls":[{"start":87,"end":109,"url":"http://t.co/YdgDztMmGy","expanded_url":"http://bit.ly/1eUx2cj","display_url":"bit.ly/1eUx2cj"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-17T08:12:46.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379640011635044353","author_id":"116716199","possibly_sensitive":false,"text":"We've started publishing the agendas and minutes of our #herbal-committee meetings: http://t.co/L4vDQf7xlG","source":"bitly bitlink","id":"379640011635044353","entities":{"hashtags":[{"start":56,"end":63,"tag":"herbal"}],"urls":[{"start":84,"end":106,"url":"http://t.co/L4vDQf7xlG","expanded_url":"http://bit.ly/19XAK18","display_url":"bit.ly/19XAK18"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-16T16:16:46.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379632901148934144","author_id":"116716199","possibly_sensitive":false,"text":"RT @US_FDA: FDA prohibits manufacture of FDA-regulated drugs from Ranbaxy’s Mohali, India, plant and issues import alert http://t.co/yqySon…","source":"TweetDeck","id":"379632901148934144","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":12,"end":14,"probability":0.8611,"type":"Organization","normalized_text":"FDA"},{"start":76,"end":88,"probability":0.6123,"type":"Place","normalized_text":"Mohali, India"}]},"lang":"en","created_at":"2013-09-16T15:48:31.000Z","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379632805119930369"}],"attachments":{"media_keys":{}}},{"conversation_id":"379619097648312320","author_id":"116716199","possibly_sensitive":false,"text":"RT @DrugInfoAssn: #Researchers study “super responders” to figure out which cancer drugs can help which #patients http://t.co/Ym17VnFOPf","source":"TweetDeck","id":"379619097648312320","entities":{"hashtags":[{"start":18,"end":30,"tag":"Researchers"},{"start":104,"end":113,"tag":"patients"}],"urls":[{"start":114,"end":136,"url":"http://t.co/Ym17VnFOPf","expanded_url":"http://medcitynews.com/2013/09/researchers-study-super-responders-to-figure-out-which-cancer-drugs-can-help-which-patients/","display_url":"medcitynews.com/2013/09/resear…"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":{}},"lang":"en","created_at":"2013-09-16T14:53:40.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379618785335865344"}],"attachments":{"media_keys":{}}},{"conversation_id":"379593464201371648","author_id":"116716199","possibly_sensitive":false,"text":"RT @MHRAmedicines: Class 2 Drug Alert (Action Within 48 Hours): Bydureon 2mg powder and solvent for prolonged-release suspension ... http:/…","source":"TweetDeck","id":"379593464201371648","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{}},"lang":"en","created_at":"2013-09-16T13:11:49.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379592775911477249"}],"attachments":{"media_keys":{}}},{"conversation_id":"379593402641555457","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: #Resarch - Potential new drug target for cystic fibrosis http://t.co/P5Ow6co0qy","source":"TweetDeck","id":"379593402641555457","entities":{"hashtags":[{"start":11,"end":19,"tag":"Resarch"}],"urls":[{"start":68,"end":90,"url":"http://t.co/P5Ow6co0qy","expanded_url":"http://bit.ly/16cePQu","display_url":"bit.ly/16cePQu"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-09-16T13:11:34.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379591131949830144"}],"attachments":{"media_keys":{}}},{"conversation_id":"379583098134228992","author_id":"116716199","possibly_sensitive":false,"text":"RT @EU_eHealth: 'Biomedical Facebook': New web portal for drug discovery\nhttps://t.co/2Ezh8BT4JC #eHealth #Granatum_project","source":"TweetDeck","id":"379583098134228992","entities":{"hashtags":[{"start":97,"end":105,"tag":"eHealth"},{"start":106,"end":123,"tag":"Granatum_project"}],"urls":[{"start":73,"end":96,"url":"https://t.co/2Ezh8BT4JC","expanded_url":"https://ec.europa.eu/digital-agenda/en/news/biomedical-facebook-new-web-portal-drug-discovery","display_url":"ec.europa.eu/digital-agenda…"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"annotations":[{"start":28,"end":35,"probability":0.3616,"type":"Product","normalized_text":"Facebook"}]},"lang":"en","created_at":"2013-09-16T12:30:37.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379582928503599104"}],"attachments":{"media_keys":{}}},{"conversation_id":"379577670557638656","author_id":"116716199","possibly_sensitive":false,"text":"We published the highlights from our #veterinary committee (#CVMP) meeting on Friday: http://t.co/YdgDztMmGy","source":"Twitter Web Client","id":"379577670557638656","entities":{"hashtags":[{"start":37,"end":48,"tag":"veterinary"},{"start":60,"end":65,"tag":"CVMP"}],"urls":[{"start":86,"end":108,"url":"http://t.co/YdgDztMmGy","expanded_url":"http://bit.ly/1eUx2cj","display_url":"bit.ly/1eUx2cj"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-16T12:09:03.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379575613776224256","author_id":"116716199","possibly_sensitive":false,"text":"RT @euparkinsons: Fact: Early #pharmacological intervention shown 2 reduce economic impact 2 #PwParkinson's &amp; society #PDConsensusDoc http:…","source":"TweetDeck","id":"379575613776224256","entities":{"hashtags":[{"start":30,"end":46,"tag":"pharmacological"},{"start":93,"end":105,"tag":"PwParkinson"},{"start":122,"end":137,"tag":"PDConsensusDoc"}],"urls":{},"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"lang":"en","created_at":"2013-09-16T12:00:53.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379575492610772992"}],"attachments":{"media_keys":{}}},{"conversation_id":"379566112587120640","author_id":"116716199","possibly_sensitive":false,"text":"RT @Legemiddelinfo: Read review of Buccolam, a new drug for seizures in children and adolescents with epilepsy: http://t.co/uX8n9bhyv8","source":"TweetDeck","id":"379566112587120640","entities":{"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/uX8n9bhyv8","expanded_url":"http://bit.ly/164j2Mf","display_url":"bit.ly/164j2Mf"}],"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"annotations":[{"start":35,"end":42,"probability":0.3271,"type":"Other","normalized_text":"Buccolam"}]},"lang":"en","created_at":"2013-09-16T11:23:07.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379561526077583360","author_id":"116716199","possibly_sensitive":false,"text":"We've published the assessment report for #Stivarga (#regorafenib) for metastatic #colorectal #cancer: http://t.co/1mMDQJZkyN","source":"Twitter Web Client","id":"379561526077583360","entities":{"hashtags":[{"start":42,"end":51,"tag":"Stivarga"},{"start":53,"end":65,"tag":"regorafenib"},{"start":82,"end":93,"tag":"colorectal"},{"start":94,"end":101,"tag":"cancer"}],"urls":[{"start":103,"end":125,"url":"http://t.co/1mMDQJZkyN","expanded_url":"http://bit.ly/1e9u6K5","display_url":"bit.ly/1e9u6K5"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-16T11:04:54.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379561089203048448","author_id":"116716199","possibly_sensitive":false,"text":"Comment on our reflection paper on data requirements for intravenous #iron-based #nano-#colloidal products: http://t.co/7qO4CzfJFg","source":"Twitter Web Client","id":"379561089203048448","entities":{"hashtags":[{"start":69,"end":74,"tag":"iron"},{"start":81,"end":86,"tag":"nano"},{"start":87,"end":97,"tag":"colloidal"}],"urls":[{"start":108,"end":130,"url":"http://t.co/7qO4CzfJFg","expanded_url":"http://bit.ly/1aN4nXt","display_url":"bit.ly/1aN4nXt"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-16T11:03:10.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379560830552924160","author_id":"116716199","possibly_sensitive":false,"text":"Two weeks left to comment on our concept paper on the development of product-specific guidance on #bioequivalence: http://t.co/2lqZfQ5tzI","source":"Twitter Web Client","id":"379560830552924160","entities":{"hashtags":[{"start":98,"end":113,"tag":"bioequivalence"}],"urls":[{"start":115,"end":137,"url":"http://t.co/2lqZfQ5tzI","expanded_url":"http://bit.ly/1687kt7","display_url":"bit.ly/1687kt7"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-16T11:02:08.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379560641893122048","author_id":"116716199","possibly_sensitive":false,"text":"Two weeks left to comment on our concept paper on statistical methodology for the comparative assessment of quality: http://t.co/cPzrMeq9Ln","source":"Twitter Web Client","id":"379560641893122048","entities":{"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/cPzrMeq9Ln","expanded_url":"http://bit.ly/17HuhKI","display_url":"bit.ly/17HuhKI"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-16T11:01:23.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379560467351359488","author_id":"116716199","possibly_sensitive":false,"text":"Two weeks left to comment on our draft policy on publication and access to clinical-trial data: http://t.co/4kxT5eqwZi  #ctdata","source":"Twitter Web Client","id":"379560467351359488","entities":{"hashtags":[{"start":120,"end":127,"tag":"ctdata"}],"urls":[{"start":96,"end":118,"url":"http://t.co/4kxT5eqwZi","expanded_url":"http://bit.ly/1642OCB","display_url":"bit.ly/1642OCB"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-16T11:00:41.000Z","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379544803840491520","author_id":"116716199","possibly_sensitive":false,"text":"The EPAR for #Stivarga (#regorafenib) for metastatic #colorectal #cancer is available on our website: http://t.co/1mMDQJZkyN","source":"Twitter Web Client","id":"379544803840491520","entities":{"hashtags":[{"start":13,"end":22,"tag":"Stivarga"},{"start":24,"end":36,"tag":"regorafenib"},{"start":53,"end":64,"tag":"colorectal"},{"start":65,"end":72,"tag":"cancer"}],"urls":[{"start":102,"end":124,"url":"http://t.co/1mMDQJZkyN","expanded_url":"http://bit.ly/1e9u6K5","display_url":"bit.ly/1e9u6K5"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-16T09:58:27.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379526822683111425","author_id":"116716199","possibly_sensitive":false,"text":"@jagasquet Thanks very much - we're correcting it on our website and will republish our tweet now.","source":"TweetDeck","id":"379544598324183040","entities":{"hashtags":{},"urls":{},"mentions":[{"start":0,"end":10,"username":"jagasquet","id":"633978297"}],"annotations":{}},"lang":"en","created_at":"2013-09-16T09:57:38.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"379542747796873216"}],"in_reply_to_user_id":"633978297","attachments":{"media_keys":{}}},{"conversation_id":"379533142170017792","author_id":"116716199","possibly_sensitive":false,"text":"We've just announced details of our new organisational structure: http://t.co/e3qjALiuwK","source":"bitly bitlink","id":"379533142170017792","entities":{"hashtags":{},"urls":[{"start":66,"end":88,"url":"http://t.co/e3qjALiuwK","expanded_url":"http://bit.ly/17CRM4l","display_url":"bit.ly/17CRM4l"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-16T09:12:07.000Z","public_metrics":{"retweet_count":9,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379527369641717760","author_id":"116716199","possibly_sensitive":false,"text":"We've published a paper on data requirements for intravenous #iron-based #nano-#colloidal products for consultation: http://t.co/h0InI7TgDN","source":"bitly bitlink","id":"379527369641717760","entities":{"hashtags":[{"start":61,"end":66,"tag":"iron"},{"start":73,"end":78,"tag":"nano"},{"start":79,"end":89,"tag":"colloidal"}],"urls":[{"start":117,"end":139,"url":"http://t.co/h0InI7TgDN","expanded_url":"http://bit.ly/1aN4nXt","display_url":"bit.ly/1aN4nXt"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-16T08:49:10.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379526721206104064","author_id":"116716199","possibly_sensitive":false,"text":"Last week our #Paediatric Committee elected Dirk Mentzer as its new Chair and Henk van den Berg as Vice-Chair: http://t.co/jdB3pYd4oU","source":"Twitter Web Client","id":"379526721206104064","entities":{"hashtags":[{"start":14,"end":25,"tag":"Paediatric"}],"urls":[{"start":111,"end":133,"url":"http://t.co/jdB3pYd4oU","expanded_url":"http://bit.ly/1e95qkX","display_url":"bit.ly/1e95qkX"}],"mentions":{},"annotations":[{"start":44,"end":55,"probability":0.9514,"type":"Person","normalized_text":"Dirk Mentzer"},{"start":78,"end":94,"probability":0.296,"type":"Person","normalized_text":"Henk van den Berg"}]},"lang":"en","created_at":"2013-09-16T08:46:36.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379526136264667136","author_id":"116716199","possibly_sensitive":false,"text":"Two more weeks to comment on our concept paper on the development of product-specific guidance on #bioequivalence: http://t.co/jSlBn5DeWw","source":"bitly bitlink","id":"379526136264667136","entities":{"hashtags":[{"start":98,"end":113,"tag":"bioequivalence"}],"urls":[{"start":115,"end":137,"url":"http://t.co/jSlBn5DeWw","expanded_url":"http://bit.ly/1687kt7","display_url":"bit.ly/1687kt7"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-16T08:44:16.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379525775114121216","author_id":"116716199","possibly_sensitive":false,"text":"Two more weeks to comment on our concept paper on statistical methodology for the comparative assessment of quality: http://t.co/2GiPwDNgNp","source":"bitly bitlink","id":"379525775114121216","entities":{"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/2GiPwDNgNp","expanded_url":"http://bit.ly/17HuhKI","display_url":"bit.ly/17HuhKI"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-16T08:42:50.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379525075822989312","author_id":"116716199","possibly_sensitive":false,"text":"Two more weeks to comment on our draft policy on publication and access to clinical-trial data: http://t.co/iqErVQ8UdB #ctdata","source":"bitly bitlink","id":"379525075822989312","entities":{"hashtags":[{"start":119,"end":126,"tag":"ctdata"}],"urls":[{"start":96,"end":118,"url":"http://t.co/iqErVQ8UdB","expanded_url":"http://bit.ly/1642OCB","display_url":"bit.ly/1642OCB"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-16T08:40:03.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"379524109786697728","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: Natural defences against disease: http://t.co/8VhlkugHBP","source":"TweetDeck","id":"379524109786697728","entities":{"hashtags":{},"urls":[{"start":47,"end":69,"url":"http://t.co/8VhlkugHBP","expanded_url":"http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&DOC=8&CAT=NEWS&QUERY=014125e2b0e3:e65b:21b75e1e&RCN=36054","display_url":"cordis.europa.eu/fetch?CALLER=E…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","created_at":"2013-09-16T08:36:13.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"379522356252667904"}],"attachments":{"media_keys":{}}},{"conversation_id":"379524094666227712","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: Natural defenses against disease: http://t.co/hnj3vvfYRw","source":"TweetDeck","id":"379524094666227712","entities":{"hashtags":{},"urls":[{"start":47,"end":69,"url":"http://t.co/hnj3vvfYRw","expanded_url":"http://cordis.europa.eu/fetch?CALLER=PL_NEWS&ACTION=D&DOC=4&CAT=NEWS&QUERY=0140cdf6aa0c:c668:202f86ac&RCN=36054","display_url":"cordis.europa.eu/fetch?CALLER=P…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","created_at":"2013-09-16T08:36:10.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"378820569581780992","author_id":"116716199","possibly_sensitive":false,"text":"RT @HealthCanada: Health Ministers and Industry join forces to reduce impact of #drugshortages in Canada. http://t.co/cfKLjyhqJJ #health","source":"Twitter for iPhone","id":"378820569581780992","entities":{"hashtags":[{"start":80,"end":94,"tag":"drugshortages"},{"start":129,"end":136,"tag":"health"}],"urls":[{"start":106,"end":128,"url":"http://t.co/cfKLjyhqJJ","expanded_url":"http://bit.ly/14MEbt7","display_url":"bit.ly/14MEbt7"}],"mentions":[{"start":3,"end":16,"username":"HealthCanada","id":"928334374256472064"}],"annotations":[{"start":98,"end":103,"probability":0.9938,"type":"Place","normalized_text":"Canada"}]},"lang":"en","created_at":"2013-09-14T10:00:36.000Z","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378554910448447488"}],"attachments":{"media_keys":{}}},{"conversation_id":"378819724521783296","author_id":"116716199","possibly_sensitive":false,"text":"RT @sailinsomnia: #ConflictsOfInterest Often Under-reported in #ClinicalTrials http://t.co/Bu6ffRJVKM #pharmaceuticals","source":"Twitter for iPhone","id":"378819724521783296","entities":{"hashtags":[{"start":18,"end":38,"tag":"ConflictsOfInterest"},{"start":63,"end":78,"tag":"ClinicalTrials"},{"start":102,"end":118,"tag":"pharmaceuticals"}],"urls":[{"start":79,"end":101,"url":"http://t.co/Bu6ffRJVKM","expanded_url":"http://www.medpagetoday.com/MeetingCoverage/PRC/41482","display_url":"medpagetoday.com/MeetingCoverag…"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-14T09:57:15.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378545515438161920"}],"attachments":{"media_keys":{}}},{"conversation_id":"378541508741591040","author_id":"116716199","possibly_sensitive":false,"text":"RT @FDAanimalhealth: Do you know what happens when a problem with an FDA regulated product is reported? http://t.co/yZRjupSm14","source":"TweetDeck","id":"378541508741591040","entities":{"hashtags":{},"urls":[{"start":104,"end":126,"url":"http://t.co/yZRjupSm14","expanded_url":"http://1.usa.gov/pOpSme","display_url":"1.usa.gov/pOpSme"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":[{"start":69,"end":71,"probability":0.7922,"type":"Organization","normalized_text":"FDA"}]},"lang":"en","created_at":"2013-09-13T15:31:43.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378541453896450048"}],"attachments":{"media_keys":{}}},{"conversation_id":"378541497488273408","author_id":"116716199","possibly_sensitive":false,"text":"RT @DrugInfoAssn: Conflicts of Interest Often Under-reported in Clinical Trials http://t.co/NHjJO2YoXS","source":"TweetDeck","id":"378541497488273408","entities":{"hashtags":{},"urls":[{"start":80,"end":102,"url":"http://t.co/NHjJO2YoXS","expanded_url":"http://fb.me/ITTkCS5a","display_url":"fb.me/ITTkCS5a"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":{}},"lang":"en","created_at":"2013-09-13T15:31:40.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378541259507658752"}],"attachments":{"media_keys":{}}},{"conversation_id":"378539576941629441","author_id":"116716199","possibly_sensitive":false,"text":"RT @sailinsomnia: New Recalls by Johnson &amp; Johnson Raise Concern About #QualityControl Improvements http://t.co/g43UNc8Eic #JNJ #Pharmaceut…","source":"TweetDeck","id":"378539576941629441","entities":{"hashtags":[{"start":75,"end":90,"tag":"QualityControl"},{"start":127,"end":131,"tag":"JNJ"}],"urls":[{"start":104,"end":126,"url":"http://t.co/g43UNc8Eic","expanded_url":"http://nyti.ms/19N2Ewz","display_url":"nyti.ms/19N2Ewz"}],"mentions":{},"annotations":[{"start":33,"end":39,"probability":0.774,"type":"Person","normalized_text":"Johnson"},{"start":43,"end":49,"probability":0.6748,"type":"Person","normalized_text":"Johnson"}]},"lang":"en","created_at":"2013-09-13T15:24:02.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378539373697855488"}],"attachments":{"media_keys":{}}},{"conversation_id":"378533365609414656","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: EMA | Paediatric Committee has elected a new Chair,  Dirk Mentzer, and Vice-Chair, Henk van den Berg: http://t.co/5u7RW7UeiI","source":"TweetDeck","id":"378533365609414656","entities":{"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/5u7RW7UeiI","expanded_url":"http://bit.ly/1e95qkX","display_url":"bit.ly/1e95qkX"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":19,"end":38,"probability":0.7418,"type":"Organization","normalized_text":"Paediatric Committee"},{"start":66,"end":77,"probability":0.8857,"type":"Person","normalized_text":"Dirk Mentzer"}]},"lang":"en","created_at":"2013-09-13T14:59:21.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378527324313907200"}],"attachments":{"media_keys":{}}},{"conversation_id":"378522079400062976","author_id":"116716199","possibly_sensitive":false,"text":"RT @LV_MPA: Examination of bromocriptine when used to inhibit or stop milk production http://t.co/xsxyTSO7h7","source":"TweetDeck","id":"378522079400062976","entities":{"hashtags":{},"urls":[{"start":86,"end":108,"url":"http://t.co/xsxyTSO7h7","expanded_url":"http://bit.ly/161q1zz","display_url":"bit.ly/161q1zz"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"lang":"en","created_at":"2013-09-13T14:14:30.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"378521865268252672","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: #Westnile fever weekly update: number of cases &amp; affected areas continues to increase. See infographic http://t.co/OlhCx8y0hP","source":"TweetDeck","id":"378521865268252672","entities":{"hashtags":[{"start":13,"end":22,"tag":"Westnile"}],"urls":[{"start":120,"end":142,"url":"http://t.co/OlhCx8y0hP","expanded_url":"https://twitter.com/ECDC_EU/status/378506878491172864/photo/1","display_url":"pic.twitter.com/OlhCx8y0hP"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","created_at":"2013-09-13T14:13:39.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378506878491172864"}],"attachments":{"media_keys":["3_378506878495367168"]}},{"conversation_id":"378497457052991488","author_id":"116716199","possibly_sensitive":false,"text":"Our #Paediatric Committee has elected a new Chair,  Dirk Mentzer, and Vice-Chair, Henk van den Berg: http://t.co/GVmkJDQ1eE","source":"bitly bitlink","id":"378497457052991488","entities":{"hashtags":[{"start":4,"end":15,"tag":"Paediatric"}],"urls":[{"start":101,"end":123,"url":"http://t.co/GVmkJDQ1eE","expanded_url":"http://bit.ly/1e95qkX","display_url":"bit.ly/1e95qkX"}],"mentions":{},"annotations":[{"start":52,"end":63,"probability":0.9008,"type":"Person","normalized_text":"Dirk Mentzer"},{"start":82,"end":98,"probability":0.313,"type":"Person","normalized_text":"Henk van den Berg"}]},"lang":"en","created_at":"2013-09-13T12:36:40.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"378480303611711488","author_id":"116716199","possibly_sensitive":false,"text":"Our human medicines committee, #CHMP, is meeting next week. We're publishing the highlights on Friday: http://t.co/J0zDIBL3ZI","source":"Twitter Web Client","id":"378480303611711488","entities":{"hashtags":[{"start":31,"end":36,"tag":"CHMP"}],"urls":[{"start":103,"end":125,"url":"http://t.co/J0zDIBL3ZI","expanded_url":"http://bit.ly/1aGJNIb","display_url":"bit.ly/1aGJNIb"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-13T11:28:30.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"378480142386872321","author_id":"116716199","possibly_sensitive":false,"text":"Just a few days left: comment on our draft Community #herbal monograph on #Curcuma xanthorrhiza (#Javaneseturmeric): http://t.co/4g7RAIt9qa","source":"Twitter Web Client","id":"378480142386872321","entities":{"hashtags":[{"start":53,"end":60,"tag":"herbal"},{"start":74,"end":82,"tag":"Curcuma"},{"start":97,"end":114,"tag":"Javaneseturmeric"}],"urls":[{"start":117,"end":139,"url":"http://t.co/4g7RAIt9qa","expanded_url":"http://bit.ly/1a5aypw","display_url":"bit.ly/1a5aypw"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-13T11:27:52.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"378479988611092480","author_id":"116716199","possibly_sensitive":false,"text":"Just a few days left to comment on our draft Community #herbal monograph on #Rubus idaeus (#raspberry leaf): http://t.co/QxhxYsNDUE","source":"Twitter Web Client","id":"378479988611092480","entities":{"hashtags":[{"start":55,"end":62,"tag":"herbal"},{"start":76,"end":82,"tag":"Rubus"},{"start":91,"end":101,"tag":"raspberry"}],"urls":[{"start":109,"end":131,"url":"http://t.co/QxhxYsNDUE","expanded_url":"http://bit.ly/1dsTkTo","display_url":"bit.ly/1dsTkTo"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-13T11:27:15.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"378479689087860737","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFSA_EU: 15 September: last day to comment on #EFSA’s draft #BPA exposure assessment. Stakeholders are invited to comment here:http://t…","source":"TweetDeck","id":"378479689087860737","entities":{"hashtags":[{"start":50,"end":55,"tag":"EFSA"},{"start":64,"end":68,"tag":"BPA"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"lang":"en","created_at":"2013-09-13T11:26:04.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378470537342640128"}],"attachments":{"media_keys":{}}},{"conversation_id":"378461698262585344","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: READ : Out just now .. Efpia's Weekly Newsletter http://t.co/kGl7JzXzkX","source":"TweetDeck","id":"378461698262585344","entities":{"hashtags":{},"urls":[{"start":60,"end":82,"url":"http://t.co/kGl7JzXzkX","expanded_url":"http://bit.ly/1aw1y9J","display_url":"bit.ly/1aw1y9J"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-09-13T10:14:35.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378456177866076161"}],"attachments":{"media_keys":{}}},{"conversation_id":"378461583414132736","author_id":"116716199","possibly_sensitive":false,"text":"RT @EU_Health: 2 weeks left! Submit your #media materials on #healthcare &amp; #patients' rights to #EUHealthPrize by 30.09 http://t.co/JC0QY7I…","source":"TweetDeck","id":"378461583414132736","entities":{"hashtags":[{"start":41,"end":47,"tag":"media"},{"start":61,"end":72,"tag":"healthcare"},{"start":79,"end":88,"tag":"patients"},{"start":100,"end":114,"tag":"EUHealthPrize"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"lang":"en","created_at":"2013-09-13T10:14:07.000Z","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378452561386147840"}],"attachments":{"media_keys":{}}},{"conversation_id":"378461532591767552","author_id":"116716199","possibly_sensitive":false,"text":"RT @Aifa_ufficiale: Important information on new oral anticoagulants Eliquis, Pradaxa and Xarelto: http://t.co/WdwMB1hfgE","source":"TweetDeck","id":"378461532591767552","entities":{"hashtags":{},"urls":[{"start":99,"end":121,"url":"http://t.co/WdwMB1hfgE","expanded_url":"http://fb.me/z2fJQEEZ","display_url":"fb.me/z2fJQEEZ"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"lang":"ca","created_at":"2013-09-13T10:13:55.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"378461271433424897","author_id":"116716199","possibly_sensitive":false,"text":"RT @UNAIDS: @UNAIDS talks about the new vaccine research that is boosting hope for human #HIV #vaccine http://t.co/xLvZCcRQ99 @UNAIDScience…","source":"TweetDeck","id":"378461271433424897","entities":{"hashtags":[{"start":89,"end":93,"tag":"HIV"},{"start":94,"end":102,"tag":"vaccine"}],"urls":[{"start":103,"end":125,"url":"http://t.co/xLvZCcRQ99","expanded_url":"http://bit.ly/14QFz8U","display_url":"bit.ly/14QFz8U"}],"mentions":[{"start":3,"end":10,"username":"UNAIDS","id":"19177501"},{"start":12,"end":19,"username":"UNAIDS","id":"19177501"}],"annotations":{}},"lang":"en","created_at":"2013-09-13T10:12:53.000Z","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378446926167171072"}],"attachments":{"media_keys":{}}},{"conversation_id":"378461206400729089","author_id":"116716199","possibly_sensitive":false,"text":"RT @LV_MPA: Just one week left until our information meeting in Uppsala: http://t.co/VJDnZR7PnH","source":"TweetDeck","id":"378461206400729089","entities":{"hashtags":{},"urls":[{"start":73,"end":95,"url":"http://t.co/VJDnZR7PnH","expanded_url":"http://www.lakemedelsverket.se/malgrupp/Foretag/Valkommen-till-innovationskontoret/Aktuellt/Lakemedelsverket-bjuder-in-till-mote-i-Uppsala/","display_url":"lakemedelsverket.se/malgrupp/Foret…"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":[{"start":64,"end":70,"probability":0.5403,"type":"Place","normalized_text":"Uppsala"}]},"lang":"en","created_at":"2013-09-13T10:12:37.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"378440534966435840","author_id":"116716199","possibly_sensitive":false,"text":"RT @euparkinsons: #Levodopa, vitamins, ageing &amp; the neuropathy of #Parkinson’s disease: http://t.co/SkR2d1L5i4","source":"TweetDeck","id":"378440534966435840","entities":{"hashtags":[{"start":18,"end":27,"tag":"Levodopa"},{"start":70,"end":80,"tag":"Parkinson"}],"urls":[{"start":92,"end":114,"url":"http://t.co/SkR2d1L5i4","expanded_url":"http://bit.ly/15mrELn","display_url":"bit.ly/15mrELn"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"lang":"en","created_at":"2013-09-13T08:50:29.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378437965367635969"}],"attachments":{"media_keys":{}}},{"conversation_id":"378428932967923712","author_id":"116716199","possibly_sensitive":false,"text":"Our Committee for Medicinal Products for Human Use (#CHMP) meets next week. Highlights will be published on Friday: http://t.co/pWRDdvVLVD","source":"bitly bitlink","id":"378428932967923712","entities":{"hashtags":[{"start":52,"end":57,"tag":"CHMP"}],"urls":[{"start":116,"end":138,"url":"http://t.co/pWRDdvVLVD","expanded_url":"http://bit.ly/1aGJNIb","display_url":"bit.ly/1aGJNIb"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-13T08:04:23.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"378428579782328320","author_id":"116716199","possibly_sensitive":false,"text":"RT @AlzDisInt: 1 week until ADI launch the World Alzheimer Report 2013. The theme this year is long term care. More info here http://t.co/c…","source":"TweetDeck","id":"378428579782328320","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"}],"annotations":[{"start":43,"end":69,"probability":0.5137,"type":"Other","normalized_text":"World Alzheimer Report 2013"}]},"lang":"en","created_at":"2013-09-13T08:02:58.000Z","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378428540644904960"}],"attachments":{"media_keys":{}}},{"conversation_id":"378428469291405312","author_id":"116716199","possibly_sensitive":false,"text":"Last few days to comment on our draft Community #herbal monograph on #Curcuma xanthorrhiza (#Javaneseturmeric): http://t.co/4g7RAIt9qa","source":"Twitter Web Client","id":"378428469291405312","entities":{"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":77,"tag":"Curcuma"},{"start":92,"end":109,"tag":"Javaneseturmeric"}],"urls":[{"start":112,"end":134,"url":"http://t.co/4g7RAIt9qa","expanded_url":"http://bit.ly/1a5aypw","display_url":"bit.ly/1a5aypw"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-13T08:02:32.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"378428404212572160","author_id":"116716199","possibly_sensitive":false,"text":"Last few days to comment on our draft Community #herbal monograph on #Rubus idaeus (#raspberry leaf): http://t.co/QxhxYsNDUE","source":"Twitter Web Client","id":"378428404212572160","entities":{"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":75,"tag":"Rubus"},{"start":84,"end":94,"tag":"raspberry"}],"urls":[{"start":102,"end":124,"url":"http://t.co/QxhxYsNDUE","expanded_url":"http://bit.ly/1dsTkTo","display_url":"bit.ly/1dsTkTo"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-13T08:02:17.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"378194994399809536","author_id":"116716199","possibly_sensitive":false,"text":"RT @IMI_JU: EMA ready to join consortium on proposal for IMI 9th Call topic 'WEBAE' on pharmacovigilance. More info: http://t.co/2sBGgu8kz8…","source":"TweetDeck","id":"378194994399809536","entities":{"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/2sBGgu8kz8","expanded_url":"http://ow.ly/oOx3A","display_url":"ow.ly/oOx3A"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"lang":"en","created_at":"2013-09-12T16:34:47.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378190274025234432"}],"attachments":{"media_keys":{}}},{"conversation_id":"378194896903217152","author_id":"116716199","possibly_sensitive":false,"text":"RT @UNAIDS: .@UNAIDS looks at new #vaccine in monkeys - could it be answer to #HIV cure? http://t.co/0ktCUzxRkc @UNAIDSciencenow","source":"TweetDeck","id":"378194896903217152","entities":{"hashtags":[{"start":34,"end":42,"tag":"vaccine"},{"start":78,"end":82,"tag":"HIV"}],"urls":[{"start":89,"end":111,"url":"http://t.co/0ktCUzxRkc","expanded_url":"http://bit.ly/1d8a1kd","display_url":"bit.ly/1d8a1kd"}],"mentions":[{"start":3,"end":10,"username":"UNAIDS","id":"19177501"},{"start":13,"end":20,"username":"UNAIDS","id":"19177501"},{"start":112,"end":128,"username":"UNAIDSciencenow","id":"21288875"}],"annotations":{}},"lang":"en","created_at":"2013-09-12T16:34:24.000Z","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378186007277228032"}],"attachments":{"media_keys":{}}},{"conversation_id":"378193950781079553","author_id":"116716199","possibly_sensitive":false,"text":"You can still provide comments on our #conflictsofinterests policy for experts until 18 Sept: http://t.co/9wg6aJ7wj3  #coiworkshop","source":"Twitter Web Client","id":"378193950781079553","entities":{"hashtags":[{"start":38,"end":59,"tag":"conflictsofinterests"},{"start":118,"end":130,"tag":"coiworkshop"}],"urls":[{"start":94,"end":116,"url":"http://t.co/9wg6aJ7wj3","expanded_url":"http://bit.ly/1aEgPbM","display_url":"bit.ly/1aEgPbM"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-12T16:30:39.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"378162458231603200","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: \"Counterfeit medicines on the rise in Europe – Experts call for better consumer information and protection\" - http://t.co/V3dTRL…","source":"TweetDeck","id":"378162458231603200","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":49,"end":54,"probability":0.986,"type":"Place","normalized_text":"Europe"}]},"lang":"en","created_at":"2013-09-12T14:25:30.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378160952199221248"}],"attachments":{"media_keys":{}}},{"conversation_id":"378152012724314112","author_id":"116716199","possibly_sensitive":false,"text":"RT @EUombudsman: &lt;30 seats left! International Right to Know Day Seminar 27/9 - \"EU transparency: Where are we now?\" http://t.co/sQ9VhBVr7Y…","source":"TweetDeck","id":"378152012724314112","entities":{"hashtags":{},"urls":[{"start":120,"end":142,"url":"http://t.co/sQ9VhBVr7Y","expanded_url":"http://bit.ly/17mw2Gv","display_url":"bit.ly/17mw2Gv"}],"mentions":[{"start":3,"end":15,"username":"EUombudsman","id":"873777758"}],"annotations":{}},"lang":"en","created_at":"2013-09-12T13:44:00.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378150292203655168"}],"attachments":{"media_keys":{}}},{"conversation_id":"378135649855229952","author_id":"116716199","possibly_sensitive":false,"text":"RT @US_FDA: #FDAVoice: Thinking Globally to Strengthen  Science and Public Health Locally http://t.co/JJihG55pP9","source":"TweetDeck","id":"378135649855229952","entities":{"hashtags":[{"start":12,"end":21,"tag":"FDAVoice"}],"urls":[{"start":90,"end":112,"url":"http://t.co/JJihG55pP9","expanded_url":"http://blogs.fda.gov/fdavoice/index.php/2013/09/thinking-globally-to-strengthen-science-and-public-health-locally/?source=govdelivery&utm_medium=email&utm_source=govdelivery","display_url":"blogs.fda.gov/fdavoice/index…"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":{}},"lang":"en","created_at":"2013-09-12T12:38:59.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378135513623826432"}],"attachments":{"media_keys":{}}},{"conversation_id":"378114100359737344","author_id":"116716199","possibly_sensitive":false,"text":"Our #tender for high-level business #consultancy is open for applications until 17 October: http://t.co/suUSdhvjp7  #procurement","source":"Twitter Web Client","id":"378114100359737344","entities":{"hashtags":[{"start":4,"end":11,"tag":"tender"},{"start":36,"end":48,"tag":"consultancy"},{"start":116,"end":128,"tag":"procurement"}],"urls":[{"start":92,"end":114,"url":"http://t.co/suUSdhvjp7","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-12T11:13:21.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"378113225793241088","author_id":"116716199","possibly_sensitive":false,"text":"RT @EU_ECHA: Are you a journalist interested in health? Enter DG Sanco's EU Health Prize for Journalists 2013! http://t.co/49ctoblQ3m","source":"TweetDeck","id":"378113225793241088","entities":{"hashtags":{},"urls":[{"start":111,"end":133,"url":"http://t.co/49ctoblQ3m","expanded_url":"http://bit.ly/18WABIQ","display_url":"bit.ly/18WABIQ"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":[{"start":62,"end":69,"probability":0.6598,"type":"Organization","normalized_text":"DG Sanco"}]},"lang":"en","created_at":"2013-09-12T11:09:52.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378094124345196544"}],"attachments":{"media_keys":{}}},{"conversation_id":"378094833493356544","author_id":"116716199","possibly_sensitive":false,"text":"RT @HAIEurope: #EFPIA response to #clinicaltrial policy argues transparency supersedes pub health interest http://t.co/zgp0BvYVS2 #ctdata","source":"TweetDeck","id":"378094833493356544","entities":{"hashtags":[{"start":15,"end":21,"tag":"EFPIA"},{"start":34,"end":48,"tag":"clinicaltrial"},{"start":130,"end":137,"tag":"ctdata"}],"urls":[{"start":107,"end":129,"url":"http://t.co/zgp0BvYVS2","expanded_url":"http://bit.ly/16mBr45","display_url":"bit.ly/16mBr45"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":{}},"lang":"en","created_at":"2013-09-12T09:56:47.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"378094479200493568","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: There is no vaccine, no specific treatment for #dengue. Need to control the mosquitoes that carry dengue #virus http://t.co/tlaNDu…","source":"TweetDeck","id":"378094479200493568","entities":{"hashtags":[{"start":56,"end":63,"tag":"dengue"},{"start":114,"end":120,"tag":"virus"}],"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-09-12T09:55:23.000Z","public_metrics":{"retweet_count":124,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378090319134216193"}],"attachments":{"media_keys":{}}},{"conversation_id":"378084840194973696","author_id":"116716199","possibly_sensitive":false,"text":"We've opened an invitation to #tender for high-level business #consultancy: http://t.co/KG3On2gVL3 #procurement","source":"bitly bitlink","id":"378084840194973696","entities":{"hashtags":[{"start":30,"end":37,"tag":"tender"},{"start":62,"end":74,"tag":"consultancy"},{"start":99,"end":111,"tag":"procurement"}],"urls":[{"start":76,"end":98,"url":"http://t.co/KG3On2gVL3","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-12T09:17:05.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"374840221033975808","author_id":"116716199","possibly_sensitive":false,"text":"@K_N_Atuah Sorry to hear you're having problems. Please forward details to us at http://t.co/81mvfkEvbJ and we will look into it.","source":"TweetDeck","id":"378081772858523648","entities":{"hashtags":{},"urls":[{"start":81,"end":103,"url":"http://t.co/81mvfkEvbJ","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"mentions":[{"start":0,"end":10,"username":"K_N_Atuah","id":"206819876"}],"annotations":{}},"lang":"en","created_at":"2013-09-12T09:04:53.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"377815337099464704"}],"in_reply_to_user_id":"206819876","attachments":{"media_keys":{}}},{"conversation_id":"378076679081840640","author_id":"116716199","possibly_sensitive":false,"text":"On Friday we heard views from stakeholders on our #conflictsofinterests policy for scientific experts: http://t.co/9GIgbbb65a #coiworkshop","source":"bitly bitlink","id":"378076679081840640","entities":{"hashtags":[{"start":50,"end":71,"tag":"conflictsofinterests"},{"start":126,"end":138,"tag":"coiworkshop"}],"urls":[{"start":103,"end":125,"url":"http://t.co/9GIgbbb65a","expanded_url":"http://bit.ly/1aEgPbM","display_url":"bit.ly/1aEgPbM"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-12T08:44:39.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"378075907959054336","author_id":"116716199","possibly_sensitive":false,"text":"RT @HAIEurope: still places on our #glohealthschool publc Conference 'Big Pharma: Good Pharma–Bad Pharma?' in Berlin 21 Sep. tickets:http:/…","source":"TweetDeck","id":"378075907959054336","entities":{"hashtags":[{"start":35,"end":51,"tag":"glohealthschool"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":[{"start":110,"end":115,"probability":0.8476,"type":"Place","normalized_text":"Berlin"}]},"lang":"en","created_at":"2013-09-12T08:41:35.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"378067342577524736"}],"attachments":{"media_keys":{}}},{"conversation_id":"377792046603726848","author_id":"116716199","possibly_sensitive":false,"text":"RT @IFAHEurope: Find out more about #animalhealth products and their #ResponsibleUse: http://t.co/MZXgl1hjtc","source":"TweetDeck","id":"377792046603726848","entities":{"hashtags":[{"start":36,"end":49,"tag":"animalhealth"},{"start":69,"end":84,"tag":"ResponsibleUse"}],"urls":[{"start":86,"end":108,"url":"http://t.co/MZXgl1hjtc","expanded_url":"http://bit.ly/19Hmb1o","display_url":"bit.ly/19Hmb1o"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-11T13:53:37.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377791929842290688"}],"attachments":{"media_keys":{}}},{"conversation_id":"377789149446950912","author_id":"116716199","possibly_sensitive":false,"text":"RT @Legemiddelinfo: Bleeding risk using Eliquis, Pradaxa and Xarelto. Read our advice: http://t.co/J2WuyJJujh","source":"TweetDeck","id":"377789149446950912","entities":{"hashtags":{},"urls":[{"start":87,"end":109,"url":"http://t.co/J2WuyJJujh","expanded_url":"http://bit.ly/1eDAl7y","display_url":"bit.ly/1eDAl7y"}],"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"annotations":[{"start":61,"end":67,"probability":0.3185,"type":"Person","normalized_text":"Xarelto"}]},"lang":"en","created_at":"2013-09-11T13:42:06.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377788913391513600","author_id":"116716199","possibly_sensitive":false,"text":"RT @NICEcomms: Looking for authoritative evidence and examples of best practice? September issue of Eyes of Evidence is out now. \nhttps://t…","source":"TweetDeck","id":"377788913391513600","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{}},"lang":"en","created_at":"2013-09-11T13:41:10.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377784921038663681"}],"attachments":{"media_keys":{}}},{"conversation_id":"377788790255128576","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: LOOK: #HIV as you have never seen it before - inside the 3D model of the virus http://t.co/M8ivE9BKvz","source":"TweetDeck","id":"377788790255128576","entities":{"hashtags":[{"start":17,"end":21,"tag":"HIV"}],"urls":[{"start":90,"end":112,"url":"http://t.co/M8ivE9BKvz","expanded_url":"http://bit.ly/fVcoDC","display_url":"bit.ly/fVcoDC"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-09-11T13:40:41.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377783568329478144"}],"attachments":{"media_keys":{}}},{"conversation_id":"377788586256760833","author_id":"116716199","possibly_sensitive":false,"text":"RT @FDA_Drug_Info: Final guidance: INDs-Determining Whether Human Research Studies Can Be Conducted Without an IND. http://t.co/IEuvB6C4nN","source":"TweetDeck","id":"377788586256760833","entities":{"hashtags":{},"urls":[{"start":116,"end":138,"url":"http://t.co/IEuvB6C4nN","expanded_url":"http://1.usa.gov/1aq4Hb0","display_url":"1.usa.gov/1aq4Hb0"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"lang":"en","created_at":"2013-09-11T13:39:52.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377778643180613632"}],"attachments":{"media_keys":{}}},{"conversation_id":"377781013088575488","author_id":"116716199","possibly_sensitive":false,"text":"RT @EATGx: ECRAN short movie on Clinical Trials: EATG, leaded by Brian West and Nikos Dedes is participating to the Europ... http://t.co/Db…","source":"TweetDeck","id":"377781013088575488","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":9,"username":"EATGx","id":"273916420"}],"annotations":[{"start":32,"end":46,"probability":0.3234,"type":"Organization","normalized_text":"Clinical Trials"},{"start":65,"end":74,"probability":0.9544,"type":"Person","normalized_text":"Brian West"},{"start":80,"end":90,"probability":0.9744,"type":"Person","normalized_text":"Nikos Dedes"}]},"lang":"en","created_at":"2013-09-11T13:09:47.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377772771922952192"}],"attachments":{"media_keys":{}}},{"conversation_id":"377768490780078081","author_id":"116716199","possibly_sensitive":false,"text":"@MHESME has written to us to express support for our public consultation on publishing clinical-trial data: http://t.co/lm4MVHHSjB #ctdata","source":"bitly bitlink","id":"377768490780078081","entities":{"hashtags":[{"start":131,"end":138,"tag":"ctdata"}],"urls":[{"start":108,"end":130,"url":"http://t.co/lm4MVHHSjB","expanded_url":"http://bit.ly/1eDfNw4","display_url":"bit.ly/1eDfNw4"}],"mentions":[{"start":0,"end":7,"username":"MHESME","id":"256954308"}],"annotations":{}},"lang":"en","created_at":"2013-09-11T12:20:01.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"in_reply_to_user_id":"256954308","attachments":{"media_keys":{}}},{"conversation_id":"377756700386029568","author_id":"116716199","possibly_sensitive":false,"text":"RT @eurordis: EURORDIS partners w/ @GeneticAlliance @rarediseases @US_FDA @EMA_news for #orphandrug designation and grant workshop http://t…","source":"TweetDeck","id":"377756700386029568","entities":{"hashtags":[{"start":88,"end":99,"tag":"orphandrug"}],"urls":{},"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":35,"end":51,"username":"GeneticAlliance","id":"15755223"},{"start":52,"end":65,"username":"RareDiseases","id":"86129983"},{"start":66,"end":73,"username":"US_FDA","id":"208120290"},{"start":74,"end":83,"username":"EMA_News","id":"116716199"}],"annotations":{}},"lang":"en","created_at":"2013-09-11T11:33:10.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377756057629896704"}],"attachments":{"media_keys":{}}},{"conversation_id":"377756530193735680","author_id":"116716199","possibly_sensitive":false,"text":"RT @EU_Consumer: #EU surveillance studies collect data to build a better picture of the complex reasons for #honeybee losses http://t.co/Wc…","source":"TweetDeck","id":"377756530193735680","entities":{"hashtags":[{"start":17,"end":20,"tag":"EU"},{"start":108,"end":117,"tag":"honeybee"}],"urls":{},"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"}],"annotations":{}},"lang":"en","created_at":"2013-09-11T11:32:29.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377740518609805312"}],"attachments":{"media_keys":{}}},{"conversation_id":"377756501722812416","author_id":"116716199","possibly_sensitive":false,"text":"RT @EU_Consumer: #EU earmarked additional €1.84 million to co-finance studies on #honeybee losses http://t.co/WcB83A9PQ8","source":"TweetDeck","id":"377756501722812416","entities":{"hashtags":[{"start":17,"end":20,"tag":"EU"},{"start":81,"end":90,"tag":"honeybee"}],"urls":[{"start":98,"end":120,"url":"http://t.co/WcB83A9PQ8","expanded_url":"http://ec.europa.eu/food/animal/liveanimals/bees/index_en.htm","display_url":"ec.europa.eu/food/animal/li…"}],"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"}],"annotations":{}},"lang":"en","created_at":"2013-09-11T11:32:23.000Z","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377740311557967872"}],"attachments":{"media_keys":{}}},{"conversation_id":"377756468537483264","author_id":"116716199","possibly_sensitive":false,"text":"RT @EU_Consumer: #EU continues co-financing voluntary surveillance studies on #honeybee losses http://t.co/WcB83A9PQ8","source":"TweetDeck","id":"377756468537483264","entities":{"hashtags":[{"start":17,"end":20,"tag":"EU"},{"start":78,"end":87,"tag":"honeybee"}],"urls":[{"start":95,"end":117,"url":"http://t.co/WcB83A9PQ8","expanded_url":"http://ec.europa.eu/food/animal/liveanimals/bees/index_en.htm","display_url":"ec.europa.eu/food/animal/li…"}],"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"}],"annotations":{}},"lang":"en","created_at":"2013-09-11T11:32:15.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377740116485087232"}],"attachments":{"media_keys":{}}},{"conversation_id":"377756208947793920","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: Initiation of a review of data on medicinal products containing bromocriptine http://t.co/VykxB6tbbz","source":"TweetDeck","id":"377756208947793920","entities":{"hashtags":{},"urls":[{"start":91,"end":113,"url":"http://t.co/VykxB6tbbz","expanded_url":"http://fb.me/Ig2gDPjg","display_url":"fb.me/Ig2gDPjg"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","created_at":"2013-09-11T11:31:13.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377756098541154304","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: PRAC recommendation concerning Numeta products http://t.co/0FoETHReY4","source":"TweetDeck","id":"377756098541154304","entities":{"hashtags":{},"urls":[{"start":60,"end":82,"url":"http://t.co/0FoETHReY4","expanded_url":"http://fb.me/2m1UMFruB","display_url":"fb.me/2m1UMFruB"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":44,"end":49,"probability":0.6373,"type":"Organization","normalized_text":"Numeta"}]},"lang":"en","created_at":"2013-09-11T11:30:46.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377755958401060864","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: PRAC recommended restrictions on the use of short-acting beta-agonists in obstetrics http://t.co/QdgSSRLHR8","source":"TweetDeck","id":"377755958401060864","entities":{"hashtags":{},"urls":[{"start":98,"end":120,"url":"http://t.co/QdgSSRLHR8","expanded_url":"http://fb.me/1UIeWMkhI","display_url":"fb.me/1UIeWMkhI"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","created_at":"2013-09-11T11:30:13.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377755499611303936","author_id":"116716199","possibly_sensitive":false,"text":"RT @URPLWMiPB: Initiation of a review of data on medicinal products containing bromocriptine http://t.co/7U9QqldwVW","source":"TweetDeck","id":"377755499611303936","entities":{"hashtags":{},"urls":[{"start":93,"end":115,"url":"http://t.co/7U9QqldwVW","expanded_url":"http://urpl.gov.pl/aktualnosci/rozpoczecie-przegladu-danych-o-produktach-leczniczych-zawierajacych-bromokryptyne","display_url":"urpl.gov.pl/aktualnosci/ro…"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"lang":"en","created_at":"2013-09-11T11:28:24.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377733268424368128","author_id":"116716199","possibly_sensitive":false,"text":"RT @LV_MPA: PRAC recommends limited use of short-acting beta-agonists in obstetric care http://t.co/kJj4gbsZ8p","source":"TweetDeck","id":"377733268424368128","entities":{"hashtags":{},"urls":[{"start":88,"end":110,"url":"http://t.co/kJj4gbsZ8p","expanded_url":"http://bit.ly/17YTzNL","display_url":"bit.ly/17YTzNL"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"lang":"en","created_at":"2013-09-11T10:00:03.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377723651321499648","author_id":"116716199","possibly_sensitive":false,"text":"RT @eurordis: EURORDIS eNEWS is back from summer break. International updates on #raredisease activities http://t.co/ActtUre9U6","source":"TweetDeck","id":"377723651321499648","entities":{"hashtags":[{"start":81,"end":93,"tag":"raredisease"}],"urls":[{"start":105,"end":127,"url":"http://t.co/ActtUre9U6","expanded_url":"http://ow.ly/oLq8v","display_url":"ow.ly/oLq8v"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":{}},"lang":"en","created_at":"2013-09-11T09:21:50.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377723228678283264"}],"attachments":{"media_keys":{}}},{"conversation_id":"377723349990137856","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: \"Simple test created for drug-resistant malaria\" - http://t.co/CXe6p7rsId","source":"TweetDeck","id":"377723349990137856","entities":{"hashtags":{},"urls":[{"start":62,"end":84,"url":"http://t.co/CXe6p7rsId","expanded_url":"http://bit.ly/13KnjRl","display_url":"bit.ly/13KnjRl"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-09-11T09:20:39.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377716512452120576"}],"attachments":{"media_keys":{}}},{"conversation_id":"377722460906733568","author_id":"116716199","possibly_sensitive":false,"text":"RT @URPLWMiPB: PRAC recommended restrictions on the use of short-acting beta-agonists in obstetrics http://t.co/OwW3gCeIYm","source":"TweetDeck","id":"377722460906733568","entities":{"hashtags":{},"urls":[{"start":100,"end":122,"url":"http://t.co/OwW3gCeIYm","expanded_url":"http://urpl.gov.pl/aktualnosci/rekomendacja-prac-dotyczacych-krotko-dzialajacych-beta-agonistow-w-poloznictwie","display_url":"urpl.gov.pl/aktualnosci/re…"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"lang":"en","created_at":"2013-09-11T09:17:07.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377722335115370496","author_id":"116716199","possibly_sensitive":false,"text":"RT @URPLWMiPB: PRAC recommendation concerning Numeta products http://t.co/0VH1gNYIyU","source":"TweetDeck","id":"377722335115370496","entities":{"hashtags":{},"urls":[{"start":62,"end":84,"url":"http://t.co/0VH1gNYIyU","expanded_url":"http://urpl.gov.pl/aktualnosci/rekomendacja-prac-dotyczacych-produktow-numeta","display_url":"urpl.gov.pl/aktualnosci/re…"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":[{"start":46,"end":51,"probability":0.6373,"type":"Organization","normalized_text":"Numeta"}]},"lang":"en","created_at":"2013-09-11T09:16:37.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377722150511476736","author_id":"116716199","possibly_sensitive":false,"text":"RT @URPLWMiPB: Communication on compliance of the obligation to submit periodic reports (PSURs) http://t.co/i5ZZZooPAy","source":"TweetDeck","id":"377722150511476736","entities":{"hashtags":{},"urls":[{"start":96,"end":118,"url":"http://t.co/i5ZZZooPAy","expanded_url":"http://urpl.gov.pl/aktualnosci/komunikat-prezesa-urzedu-rejestracji-produktow-leczniczych-wyrobow-medycznych-i-produktow-biobojczych-z-dnia-4-wrzesnia-2013-r-w-sprawie-wywiazywania-","display_url":"urpl.gov.pl/aktualnosci/ko…"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"lang":"en","created_at":"2013-09-11T09:15:53.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377705982832291841","author_id":"116716199","possibly_sensitive":false,"text":"Register now for our joint workshop with EDQM on characterisation of new clotting-factor concentrates: http://t.co/PhhktBvaoD","source":"Twitter Web Client","id":"377705982832291841","entities":{"hashtags":{},"urls":[{"start":103,"end":125,"url":"http://t.co/PhhktBvaoD","expanded_url":"http://bit.ly/1an15Xl","display_url":"bit.ly/1an15Xl"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-11T08:11:38.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377469425605414913","author_id":"116716199","possibly_sensitive":false,"text":"RT @FDA_Drug_Info: #FDA proposes new labeling changes to promote safer use of ER/LA #opioid analgesics. http://t.co/7DUaYZFUiJ","source":"TweetDeck","id":"377469425605414913","entities":{"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":84,"end":91,"tag":"opioid"}],"urls":[{"start":104,"end":126,"url":"http://t.co/7DUaYZFUiJ","expanded_url":"http://1.usa.gov/14ClU1B","display_url":"1.usa.gov/14ClU1B"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"lang":"en","created_at":"2013-09-10T16:31:38.000Z","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377469232704790528"}],"attachments":{"media_keys":{}}},{"conversation_id":"377469374053249025","author_id":"116716199","possibly_sensitive":false,"text":"RT @US_FDA: FDA announces safety labeling changes and postmarket study requirements for extended-release and long-acting o... http://t.co/f…","source":"TweetDeck","id":"377469374053249025","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":12,"end":14,"probability":0.9583,"type":"Organization","normalized_text":"FDA"}]},"lang":"en","created_at":"2013-09-10T16:31:26.000Z","public_metrics":{"retweet_count":25,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377467632246480896"}],"attachments":{"media_keys":{}}},{"conversation_id":"377459718857715712","author_id":"116716199","possibly_sensitive":false,"text":"RT @FDACBER: IRB Responsibilities for Reviewing Investigators, Adequacy of Research Sites, and Whether an IND/IDE is Needed  http://t.co/h1…","source":"TweetDeck","id":"377459718857715712","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":{}},"lang":"en","created_at":"2013-09-10T15:53:04.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377442985622777856"}],"attachments":{"media_keys":{}}},{"conversation_id":"377441745258434560","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: \"Stem Cell Treatments Overtake Science\" - http://t.co/jxIE1O7lUH","source":"TweetDeck","id":"377441745258434560","entities":{"hashtags":{},"urls":[{"start":53,"end":75,"url":"http://t.co/jxIE1O7lUH","expanded_url":"http://nyti.ms/13GrehN","display_url":"nyti.ms/13GrehN"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-09-10T14:41:39.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377438074210238465"}],"attachments":{"media_keys":{}}},{"conversation_id":"377441125751332864","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: #ESCAIDE 2013: full conference programme now online: http://t.co/rAENPZvnTk","source":"TweetDeck","id":"377441125751332864","entities":{"hashtags":[{"start":13,"end":21,"tag":"ESCAIDE"}],"urls":[{"start":66,"end":88,"url":"http://t.co/rAENPZvnTk","expanded_url":"http://bit.ly/Rpp3aj","display_url":"bit.ly/Rpp3aj"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","created_at":"2013-09-10T14:39:11.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377436402465513473"}],"attachments":{"media_keys":{}}},{"conversation_id":"377441002161995776","author_id":"116716199","possibly_sensitive":false,"text":"RT @FDA_Drug_Info: New #GDUFA Draft Guidance for Industry: Questions and Answers (Revision 1).  http://t.co/8VY9v2TiOH","source":"TweetDeck","id":"377441002161995776","entities":{"hashtags":[{"start":23,"end":29,"tag":"GDUFA"}],"urls":[{"start":96,"end":118,"url":"http://t.co/8VY9v2TiOH","expanded_url":"http://1.usa.gov/14BWdOF","display_url":"1.usa.gov/14BWdOF"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"lang":"en","created_at":"2013-09-10T14:38:42.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377431807190237184"}],"attachments":{"media_keys":{}}},{"conversation_id":"377424776773775360","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO_Europe_VPI: Update on #measles #rubella #polio in European Region in new issue of WHO EpiBrief http://t.co/FWzoxSv4fB","source":"TweetDeck","id":"377424776773775360","entities":{"hashtags":[{"start":30,"end":38,"tag":"measles"},{"start":39,"end":47,"tag":"rubella"},{"start":48,"end":54,"tag":"polio"}],"urls":[{"start":103,"end":125,"url":"http://t.co/FWzoxSv4fB","expanded_url":"http://bit.ly/17dBknE","display_url":"bit.ly/17dBknE"}],"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"annotations":{}},"lang":"en","created_at":"2013-09-10T13:34:13.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377424686914609152"}],"attachments":{"media_keys":{}}},{"conversation_id":"377416816995618816","author_id":"116716199","possibly_sensitive":false,"text":"Registration is open for our joint workshop with EDQM on characterisation of new clotting-factor concentrates: http://t.co/LZGbxYMH3e","source":"bitly bitlink","id":"377416816995618816","entities":{"hashtags":{},"urls":[{"start":111,"end":133,"url":"http://t.co/LZGbxYMH3e","expanded_url":"http://bit.ly/1an15Xl","display_url":"bit.ly/1an15Xl"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-10T13:02:35.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377391896618074113","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: Today's guest blogger Dr. Paul-Peter Tak wrote on @IMI_JU 2 . More about IMI2 in this VIDEO with IMI's Michel Goldman http://t.c…","source":"TweetDeck","id":"377391896618074113","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":61,"end":68,"username":"imi_ju","id":"1473203261469790214"}],"annotations":[{"start":33,"end":40,"probability":0.9926,"type":"Person","normalized_text":"Dr. Paul"},{"start":42,"end":50,"probability":0.9442,"type":"Person","normalized_text":"Peter Tak"},{"start":114,"end":127,"probability":0.8499,"type":"Person","normalized_text":"Michel Goldman"}]},"lang":"en","created_at":"2013-09-10T11:23:34.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377385673910525952"}],"attachments":{"media_keys":{}}},{"conversation_id":"377391237315440640","author_id":"116716199","possibly_sensitive":false,"text":"RT @AlzDisInt: 10 days to go until the launch of the World Alzheimer Report 2013! Check out our previous reports here - http://t.co/cwCMdGD…","source":"TweetDeck","id":"377391237315440640","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"}],"annotations":[{"start":53,"end":79,"probability":0.6844,"type":"Other","normalized_text":"World Alzheimer Report 2013"}]},"lang":"en","created_at":"2013-09-10T11:20:57.000Z","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377360940045320193"}],"attachments":{"media_keys":{}}},{"conversation_id":"377391178515484673","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: GUEST BLOG Dr. Paul-Peter Tak on @IMI_JU 2 -- a research agenda aiming to impact everyday healthcare &amp; patients http://t.co/vkxK…","source":"TweetDeck","id":"377391178515484673","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":44,"end":51,"username":"imi_ju","id":"1473203261469790214"}],"annotations":[{"start":22,"end":29,"probability":0.9847,"type":"Person","normalized_text":"Dr. Paul"},{"start":31,"end":39,"probability":0.9058,"type":"Person","normalized_text":"Peter Tak"}]},"lang":"en","created_at":"2013-09-10T11:20:43.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377356398239027200"}],"attachments":{"media_keys":{}}},{"conversation_id":"377349046018379776","author_id":"116716199","possibly_sensitive":false,"text":"The EPAR for #Somatropin Biopartners for treatment of growth-hormone deficiency is available on our website: http://t.co/lejNQgOue0","source":"Twitter Web Client","id":"377349046018379776","entities":{"hashtags":[{"start":13,"end":24,"tag":"Somatropin"}],"urls":[{"start":109,"end":131,"url":"http://t.co/lejNQgOue0","expanded_url":"http://bit.ly/18PoxZM","display_url":"bit.ly/18PoxZM"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-10T08:33:18.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377096060826812417","author_id":"116716199","possibly_sensitive":false,"text":"We've just published the assessment report for #Somatropin Biopartners for treatment of growth-hormone deficiency: http://t.co/aBx9KKEQGG","source":"bitly bitlink","id":"377096060826812417","entities":{"hashtags":[{"start":47,"end":58,"tag":"Somatropin"}],"urls":[{"start":115,"end":137,"url":"http://t.co/aBx9KKEQGG","expanded_url":"http://bit.ly/18PoxZM","display_url":"bit.ly/18PoxZM"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-09T15:48:01.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377095020295487488","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: Mosquitoes, sandflies, ticks, snails - we will highlight vector-borne disease prevention on World Health Day 2014 http://t.co/LB1k…","source":"TweetDeck","id":"377095020295487488","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":101,"end":116,"probability":0.7555,"type":"Other","normalized_text":"World Health Day"}]},"lang":"en","created_at":"2013-09-09T15:43:53.000Z","public_metrics":{"retweet_count":67,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377086355580260352"}],"attachments":{"media_keys":{}}},{"conversation_id":"377094867559919616","author_id":"116716199","possibly_sensitive":false,"text":"RT @HAIEurope: The EMA must continue to strengthen its policy on conflicts of interest #coiworkshop","source":"TweetDeck","id":"377094867559919616","entities":{"hashtags":[{"start":87,"end":99,"tag":"coiworkshop"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":[{"start":19,"end":21,"probability":0.3982,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","created_at":"2013-09-09T15:43:17.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377084840975167489"}],"attachments":{"media_keys":{}}},{"conversation_id":"377094649464500224","author_id":"116716199","possibly_sensitive":false,"text":"RT @igznl: The Dutch Healthcare Inspectorate is looking for an experienced psychiatrist. Click on: http://t.co/B3lUqJyyiD","source":"TweetDeck","id":"377094649464500224","entities":{"hashtags":{},"urls":[{"start":99,"end":121,"url":"http://t.co/B3lUqJyyiD","expanded_url":"http://www.werkenvoornederland.nl/vacatures/detail/toezichthoudend-psychiater","display_url":"werkenvoornederland.nl/vacatures/deta…"}],"mentions":[{"start":3,"end":9,"username":"Igznl","id":"1601603352"}],"annotations":{}},"lang":"en","created_at":"2013-09-09T15:42:25.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377093955558838272","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: Video from event on clinical-trial data sharing - Building a data-sharing health infrastructure http://t.co/ggzRwK1dGcb #ctdata","source":"TweetDeck","id":"377093955558838272","entities":{"hashtags":[{"start":131,"end":138,"tag":"ctdata"}],"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-09-09T15:39:39.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377062492968845312","author_id":"116716199","possibly_sensitive":false,"text":"RT @URPLWMiPB: Updated newsletter on medicinal products from the Polish medicines agency http://t.co/IywYjuh4DC","source":"TweetDeck","id":"377062492968845312","entities":{"hashtags":{},"urls":[{"start":89,"end":111,"url":"http://t.co/IywYjuh4DC","expanded_url":"http://bip.urpl.gov.pl/system/article_attachments/attachments/4720/original/Biuletyn_2013-08_EAN.pdf?1378731020","display_url":"bip.urpl.gov.pl/system/article…"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"lang":"en","created_at":"2013-09-09T13:34:38.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377060237314109440","author_id":"116716199","possibly_sensitive":false,"text":"RT @EUombudsman: [Case summary] #Access to clinical studies carried out on a multiple #sclerosis drug http://t.co/j97ABNLZ2h .@EMA_news","source":"TweetDeck","id":"377060237314109440","entities":{"hashtags":[{"start":32,"end":39,"tag":"Access"},{"start":86,"end":96,"tag":"sclerosis"}],"urls":[{"start":102,"end":124,"url":"http://t.co/j97ABNLZ2h","expanded_url":"http://bit.ly/18IAi5u","display_url":"bit.ly/18IAi5u"}],"mentions":[{"start":3,"end":15,"username":"EUombudsman","id":"873777758"},{"start":126,"end":135,"username":"EMA_News","id":"116716199"}],"annotations":{}},"lang":"en","created_at":"2013-09-09T13:25:40.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377047418316918784"}],"attachments":{"media_keys":{}}},{"conversation_id":"377030045627203584","author_id":"116716199","possibly_sensitive":false,"text":"On Friday we published the highlights from our #pharmacovigilance committee's September meeting: http://t.co/YRJIa4LpvG","source":"Twitter Web Client","id":"377030045627203584","entities":{"hashtags":[{"start":47,"end":65,"tag":"pharmacovigilance"}],"urls":[{"start":97,"end":119,"url":"http://t.co/YRJIa4LpvG","expanded_url":"http://bit.ly/18z2J5R","display_url":"bit.ly/18z2J5R"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-09T11:25:42.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377024251481837568","author_id":"116716199","possibly_sensitive":false,"text":"RT @LV_MPA: PRAC recommends suspension &amp; reformulation of Numeta G13E and risk-minimisation measures for Numeta G16E http://t.co/uu9IRNr50F","source":"TweetDeck","id":"377024251481837568","entities":{"hashtags":{},"urls":[{"start":121,"end":143,"url":"http://t.co/uu9IRNr50F","expanded_url":"http://bit.ly/17PxwsO","display_url":"bit.ly/17PxwsO"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"lang":"en","created_at":"2013-09-09T11:02:40.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"377023945217945600","author_id":"116716199","possibly_sensitive":false,"text":"RT @HepatitisEurope: Better tests for liver toxicity would mean more medicines and safer medicines -- for patients » good read http://t.co/…","source":"TweetDeck","id":"377023945217945600","entities":{"hashtags":{},"urls":{},"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-09T11:01:27.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"377019936993837057"}],"attachments":{"media_keys":{}}},{"conversation_id":"376998444977897472","author_id":"116716199","possibly_sensitive":false,"text":"RT @URPLWMiPB: Message to healthcare professionals on the restriction of the use of diclofenac http://t.co/lgw2QLS2fH","source":"TweetDeck","id":"376998444977897472","entities":{"hashtags":{},"urls":[{"start":95,"end":117,"url":"http://t.co/lgw2QLS2fH","expanded_url":"http://urpl.gov.pl/pl-komunikaty-bezp/komunikat-do-fachowych-pracownikow-opieki-zdrowotnej-w-sprawie-ograniczen-w-stosowaniu-diklofenaku-w-zwiazku-z-zagrozeniami-sercowo-naczyniowymi-1","display_url":"urpl.gov.pl/pl-komunikaty-…"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"lang":"en","created_at":"2013-09-09T09:20:08.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"376994517284831232","author_id":"116716199","possibly_sensitive":false,"text":"RT @HAIEurope: EMA's clinical-trial transparency policy must ensure clearer, more specific wording says EFPIA http://t.co/aL0vJYwG9t #ctdata","source":"TweetDeck","id":"376994517284831232","entities":{"hashtags":[{"start":133,"end":140,"tag":"ctdata"}],"urls":[{"start":110,"end":132,"url":"http://t.co/aL0vJYwG9t","expanded_url":"http://bit.ly/15Lc7XW","display_url":"bit.ly/15Lc7XW"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":{}},"lang":"en","created_at":"2013-09-09T09:04:31.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"376994235347927040","author_id":"116716199","possibly_sensitive":false,"text":"RT @HAIEurope: #AbbVie in Brussels debate asked: are you aware you're working with human beings? Watch here http://t.co/g98smwrzQB #ctdata","source":"TweetDeck","id":"376994235347927040","entities":{"hashtags":[{"start":15,"end":22,"tag":"AbbVie"},{"start":131,"end":138,"tag":"ctdata"}],"urls":[{"start":108,"end":130,"url":"http://t.co/g98smwrzQB","expanded_url":"http://bit.ly/17QOkSy","display_url":"bit.ly/17QOkSy"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":[{"start":26,"end":33,"probability":0.9749,"type":"Place","normalized_text":"Brussels"}]},"lang":"en","created_at":"2013-09-09T09:03:24.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"376992335659536385","author_id":"116716199","possibly_sensitive":false,"text":"RT @URPLWMiPB: Important warning regarding the risk of cancer progression associated with Zelboraf http://t.co/2ip2USaWJw","source":"TweetDeck","id":"376992335659536385","entities":{"hashtags":{},"urls":[{"start":99,"end":121,"url":"http://t.co/2ip2USaWJw","expanded_url":"http://urpl.gov.pl/pl-komunikaty-bezp/wazne-ostrzezenie-dotyczace-ryzyka-progresji-nowotworu-zlosliwego-oraz-wysypki-polekowej-z-eozynofilia-i-objawami-ukladowymi-zespol-dress-zwiazanych-z","display_url":"urpl.gov.pl/pl-komunikaty-…"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"lang":"en","created_at":"2013-09-09T08:55:51.000Z","public_metrics":{"retweet_count":1,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"376988987086225408","author_id":"116716199","possibly_sensitive":false,"text":"Register now for the workshop on designation of #orphan medicines and grants: http://t.co/2du4zSt0vJ","source":"Twitter Web Client","id":"376988987086225408","entities":{"hashtags":[{"start":48,"end":55,"tag":"orphan"}],"urls":[{"start":78,"end":100,"url":"http://t.co/2du4zSt0vJ","expanded_url":"http://bit.ly/19pHuoj","display_url":"bit.ly/19pHuoj"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-09T08:42:33.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"376988856047763456","author_id":"116716199","possibly_sensitive":false,"text":"The EPAR for #Aubagio (#teriflunomide) for the treatment of #multiplesclerosis is available on our website: http://t.co/3MMKWeo9Vh","source":"Twitter Web Client","id":"376988856047763456","entities":{"hashtags":[{"start":13,"end":21,"tag":"Aubagio"},{"start":23,"end":37,"tag":"teriflunomide"},{"start":60,"end":78,"tag":"multiplesclerosis"}],"urls":[{"start":108,"end":130,"url":"http://t.co/3MMKWeo9Vh","expanded_url":"http://bit.ly/18HYvaY","display_url":"bit.ly/18HYvaY"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-09T08:42:02.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"376022929274077184","author_id":"116716199","possibly_sensitive":false,"text":"Registration is open for a workshop on designation of #orphan medicines and grants: http://t.co/IJpoMiKcuZ","source":"bitly bitlink","id":"376022929274077184","entities":{"hashtags":[{"start":54,"end":61,"tag":"orphan"}],"urls":[{"start":84,"end":106,"url":"http://t.co/IJpoMiKcuZ","expanded_url":"http://bit.ly/19pHuoj","display_url":"bit.ly/19pHuoj"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-06T16:43:47.000Z","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"376017369090756608","author_id":"116716199","possibly_sensitive":false,"text":"RT @US_FDA: FDA approves Abraxane for late-stage pancreatic cancer http://t.co/NckbM7QWis","source":"TweetDeck","id":"376017369090756608","entities":{"hashtags":{},"urls":[{"start":67,"end":89,"url":"http://t.co/NckbM7QWis","expanded_url":"http://1.usa.gov/1dMVVHM","display_url":"1.usa.gov/1dMVVHM"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":12,"end":14,"probability":0.9098,"type":"Organization","normalized_text":"FDA"}]},"lang":"en","created_at":"2013-09-06T16:21:41.000Z","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"376017147933114368"}],"attachments":{"media_keys":{}}},{"conversation_id":"376010390771351552","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: VIDEO from Aug27 event \"Roadmap for sharing clinical trial data\" Richard Bergstrom presents EFPIA @PhRMA Commitments http://t.co…","source":"TweetDeck","id":"376010390771351552","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":109,"end":115,"username":"PhRMA","id":"116748080"}],"annotations":[{"start":76,"end":92,"probability":0.9837,"type":"Person","normalized_text":"Richard Bergstrom"}]},"lang":"en","created_at":"2013-09-06T15:53:57.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"376005285300551681"}],"attachments":{"media_keys":{}}},{"conversation_id":"376010097681793024","author_id":"116716199","possibly_sensitive":false,"text":"RT @elinhafdavies: One of the great work opportunities I had at @EMA_News to seek the views of young patients  http://t.co/tpYfpickop","source":"TweetDeck","id":"376010097681793024","entities":{"hashtags":{},"urls":[{"start":111,"end":133,"url":"http://t.co/tpYfpickop","expanded_url":"http://www.eu-patient.eu/Press/News/EMA-gathers-the-views-of-young-patients/","display_url":"eu-patient.eu/Press/News/EMA…"}],"mentions":[{"start":3,"end":17,"username":"elinhafdavies","id":"398949811"},{"start":64,"end":73,"username":"EMA_News","id":"116716199"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T15:52:47.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"376006945142210560"}],"attachments":{"media_keys":{}}},{"conversation_id":"376009606834966528","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: How Down syndrome may help unravel Alzheimer's puzzle - NBC http://t.co/kseTE07yOw http://t.co/CefJTkNjbv via @todayshow","source":"TweetDeck","id":"376009606834966528","entities":{"hashtags":{},"urls":[{"start":73,"end":95,"url":"http://t.co/kseTE07yOw","expanded_url":"http://News.com","display_url":"News.com"},{"start":96,"end":118,"url":"http://t.co/CefJTkNjbv","expanded_url":"http://www.nbcnews.com/health/how-down-syndrome-may-help-unravel-alzheimers-puzzle-8C11084898?ocid=twitter","display_url":"nbcnews.com/health/how-dow…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"},{"start":123,"end":133,"username":"TODAYshow","id":"7744592"}],"annotations":[{"start":69,"end":71,"probability":0.8124,"type":"Organization","normalized_text":"NBC"}]},"lang":"en","created_at":"2013-09-06T15:50:50.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"376009191510786049","author_id":"116716199","possibly_sensitive":false,"text":"RT @US_FDA: #FDAVoice: The path toward a risk-based regulatory framework for health IT -  http://t.co/iD57KlkyNr","source":"TweetDeck","id":"376009191510786049","entities":{"hashtags":[{"start":12,"end":21,"tag":"FDAVoice"}],"urls":[{"start":90,"end":112,"url":"http://t.co/iD57KlkyNr","expanded_url":"http://blogs.fda.gov/fdavoice/index.php/2013/09/the-path-toward-a-risk-based-regulatory-framework-for-health-it/?source=govdelivery&utm_medium=email&utm_source=govdelivery#sthash.Vjt4oka7.dpuf","display_url":"blogs.fda.gov/fdavoice/index…"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T15:49:11.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375999346203840512"}],"attachments":{"media_keys":{}}},{"conversation_id":"375998574498029571","author_id":"116716199","possibly_sensitive":false,"text":"Guido Rasi thanks the participants for their interest and input, promising to look at the issues raised: http://t.co/qxCGPU3xUo #coiworkshop","source":"Twitter Web Client","id":"375998574498029571","entities":{"hashtags":[{"start":128,"end":140,"tag":"coiworkshop"}],"urls":[{"start":105,"end":127,"url":"http://t.co/qxCGPU3xUo","expanded_url":"http://bit.ly/1f6tUr9","display_url":"bit.ly/1f6tUr9"}],"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.9871,"type":"Person","normalized_text":"Guido Rasi"}]},"lang":"en","created_at":"2013-09-06T15:07:00.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375997814951526400","author_id":"116716199","possibly_sensitive":false,"text":"Noël Wathion is now summing up the #coiworkshop, including future steps: report and revision of policy: http://t.co/qxCGPU3xUo","source":"Twitter Web Client","id":"375997814951526400","entities":{"hashtags":[{"start":35,"end":47,"tag":"coiworkshop"}],"urls":[{"start":104,"end":126,"url":"http://t.co/qxCGPU3xUo","expanded_url":"http://bit.ly/1f6tUr9","display_url":"bit.ly/1f6tUr9"}],"mentions":{},"annotations":[{"start":0,"end":11,"probability":0.8057,"type":"Person","normalized_text":"Noël Wathion"}]},"lang":"en","created_at":"2013-09-06T15:03:59.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375996325349040128","author_id":"116716199","possibly_sensitive":false,"text":"We've published the assessment report for #Aubagio (#teriflunomide) for the treatment of #multiplesclerosis: http://t.co/bX84oiq936","source":"bitly bitlink","id":"375996325349040128","entities":{"hashtags":[{"start":42,"end":50,"tag":"Aubagio"},{"start":52,"end":66,"tag":"teriflunomide"},{"start":89,"end":107,"tag":"multiplesclerosis"}],"urls":[{"start":109,"end":131,"url":"http://t.co/bX84oiq936","expanded_url":"http://bit.ly/18HYvaY","display_url":"bit.ly/18HYvaY"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-06T14:58:04.000Z","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375988288844468224","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: West Nile fever season entering its peak. Read news item: http://t.co/UZO13ooPXj See infographic: http://t.co/YRurb9bMiF","source":"TweetDeck","id":"375988288844468224","entities":{"hashtags":{},"urls":[{"start":71,"end":93,"url":"http://t.co/UZO13ooPXj","expanded_url":"http://bit.ly/18HSECt","display_url":"bit.ly/18HSECt"},{"start":111,"end":133,"url":"http://t.co/YRurb9bMiF","expanded_url":"https://twitter.com/ECDC_EU/status/375983991603478528/photo/1","display_url":"pic.twitter.com/YRurb9bMiF"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":13,"end":21,"probability":0.5911,"type":"Organization","normalized_text":"West Nile"}]},"lang":"en","created_at":"2013-09-06T14:26:08.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375987735607390208"}],"attachments":{"media_keys":["3_375983991611867136"]}},{"conversation_id":"375984090052571136","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: #WestNile fever season entering its peak. Read news item: http://t.co/LQfU5tCgBp See infographic: http://t.co/DvdCSVsyAe","source":"TweetDeck","id":"375984090052571136","entities":{"hashtags":[{"start":13,"end":22,"tag":"WestNile"}],"urls":[{"start":71,"end":93,"url":"http://t.co/LQfU5tCgBp","expanded_url":"http://bit.ly/18HSECt","display_url":"bit.ly/18HSECt"},{"start":111,"end":133,"url":"http://t.co/DvdCSVsyAe","expanded_url":"https://twitter.com/ECDC_EU/status/375983991603478528/photo/1","display_url":"pic.twitter.com/DvdCSVsyAe"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T14:09:27.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375983991603478528"}],"attachments":{"media_keys":["3_375983991611867136"]}},{"conversation_id":"375980764963540992","author_id":"116716199","possibly_sensitive":false,"text":"RT @cancereu: N Dedes: if raw data are transparent &amp; available then it will be easier to get comments #coiworkshop","source":"TweetDeck","id":"375980764963540992","entities":{"hashtags":[{"start":106,"end":118,"tag":"coiworkshop"}],"urls":{},"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T13:56:14.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375980248115859457"}],"attachments":{"media_keys":{}}},{"conversation_id":"375979877465591808","author_id":"116716199","possibly_sensitive":false,"text":"RT @cancereu: Nikos Dedes: need for transparency not only on financial issues but also on raw data #coiworkshop","source":"TweetDeck","id":"375979877465591808","entities":{"hashtags":[{"start":99,"end":111,"tag":"coiworkshop"}],"urls":{},"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":[{"start":14,"end":24,"probability":0.9259,"type":"Person","normalized_text":"Nikos Dedes"}]},"lang":"en","created_at":"2013-09-06T13:52:42.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375979834213539841"}],"attachments":{"media_keys":{}}},{"conversation_id":"375979592659787777","author_id":"116716199","possibly_sensitive":false,"text":"RT @EU_Health: Call now open for new members of the European Commission's expert group on #RareDiseases http://t.co/1wxaZl22zF","source":"TweetDeck","id":"375979592659787777","entities":{"hashtags":[{"start":90,"end":103,"tag":"RareDiseases"}],"urls":[{"start":104,"end":126,"url":"http://t.co/1wxaZl22zF","expanded_url":"http://ec.europa.eu/dgs/health_consumer/dyna/enews/enews.cfm?al_id=1404","display_url":"ec.europa.eu/dgs/health_con…"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":52,"end":70,"probability":0.4964,"type":"Organization","normalized_text":"European Commission"}]},"lang":"en","created_at":"2013-09-06T13:51:34.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375979110519947265"}],"attachments":{"media_keys":{}}},{"conversation_id":"375971724539727872","author_id":"116716199","possibly_sensitive":false,"text":"RT @AEMPSGOB: Beta-adrenergic agonists of short action in obstetrics: recommendation for restrictions of use http://t.co/0UMyozvtqi","source":"TweetDeck","id":"375971724539727872","entities":{"hashtags":{},"urls":[{"start":109,"end":131,"url":"http://t.co/0UMyozvtqi","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2013/NI-MUH_FV_23-2013-saba.htm","display_url":"aemps.gob.es/informa/notasI…"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T13:20:19.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375969281713782784","author_id":"116716199","possibly_sensitive":false,"text":"Our workshop on conflicts of interests is starting again now with questions from the floor: http://t.co/qxCGPU3xUo #coiworkshop","source":"Twitter Web Client","id":"375969281713782784","entities":{"hashtags":[{"start":115,"end":127,"tag":"coiworkshop"}],"urls":[{"start":92,"end":114,"url":"http://t.co/qxCGPU3xUo","expanded_url":"http://bit.ly/1f6tUr9","display_url":"bit.ly/1f6tUr9"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-06T13:10:36.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375954872983490560","author_id":"116716199","possibly_sensitive":false,"text":"@EUombudsman Go to http://t.co/IO7nFwBCvs and click on 'multimedia' for broadcast and instructions for what to do if you're having problems.","source":"TweetDeck","id":"375958739796623360","entities":{"hashtags":{},"urls":[{"start":19,"end":41,"url":"http://t.co/IO7nFwBCvs","expanded_url":"http://bit.ly/1f6tUr9","display_url":"bit.ly/1f6tUr9"}],"mentions":[{"start":0,"end":12,"username":"EUombudsman","id":"873777758"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T12:28:43.000Z","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"375955342217056256"}],"in_reply_to_user_id":"873777758","attachments":{"media_keys":{}}},{"conversation_id":"375954872983490560","author_id":"116716199","possibly_sensitive":false,"text":"Lunch break now - workshop starting again at 2.00pm London time: http://t.co/FlQL32MWTh #coiworkshop","source":"Twitter Web Client","id":"375954872983490560","entities":{"hashtags":[{"start":88,"end":100,"tag":"coiworkshop"}],"urls":[{"start":65,"end":87,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":{},"annotations":[{"start":52,"end":57,"probability":0.7654,"type":"Place","normalized_text":"London"}]},"lang":"en","created_at":"2013-09-06T12:13:21.000Z","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375952147709710336","author_id":"116716199","possibly_sensitive":false,"text":"RT @cancereu: where to find expert pts?not any more only in patient orgs, many patients prefer to work independently &gt;internet is the culpr…","source":"TweetDeck","id":"375952147709710336","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T12:02:31.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375951790421721090"}],"attachments":{"media_keys":{}}},{"conversation_id":"375950240060547072","author_id":"116716199","possibly_sensitive":false,"text":"RT @cancereu: re Bergstrom comment&gt;to have educated patient at EMA training should start at national level #cancereu #coiworkshop","source":"TweetDeck","id":"375950240060547072","entities":{"hashtags":[{"start":110,"end":119,"tag":"cancereu"},{"start":120,"end":132,"tag":"coiworkshop"}],"urls":{},"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":[{"start":17,"end":25,"probability":0.4392,"type":"Person","normalized_text":"Bergstrom"},{"start":63,"end":65,"probability":0.55,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","created_at":"2013-09-06T11:54:56.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375949412457275392","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: Get it while it's FRESH -- this week's EFPIA newsletter! http://t.co/HlOZgcBHax","source":"TweetDeck","id":"375949412457275392","entities":{"hashtags":{},"urls":[{"start":68,"end":90,"url":"http://t.co/HlOZgcBHax","expanded_url":"http://bit.ly/1ac7lRB","display_url":"bit.ly/1ac7lRB"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T11:51:39.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375949106448830464"}],"attachments":{"media_keys":{}}},{"conversation_id":"375949332283133952","author_id":"116716199","possibly_sensitive":false,"text":"RT @cancereu: Nikos Dedes: EMA could help with training patients to participate in working groups of national regulators #coiworkshop","source":"TweetDeck","id":"375949332283133952","entities":{"hashtags":[{"start":121,"end":133,"tag":"coiworkshop"}],"urls":{},"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":[{"start":14,"end":24,"probability":0.9016,"type":"Person","normalized_text":"Nikos Dedes"},{"start":27,"end":29,"probability":0.37,"type":"Organization","normalized_text":"EMA"}]},"lang":"en","created_at":"2013-09-06T11:51:20.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375949211134472192"}],"attachments":{"media_keys":{}}},{"conversation_id":"375948631704367104","author_id":"116716199","possibly_sensitive":false,"text":"RT @cancereu: expert patients need first time then money to make contributions #coiworkshop","source":"TweetDeck","id":"375948631704367104","entities":{"hashtags":[{"start":79,"end":91,"tag":"coiworkshop"}],"urls":{},"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T11:48:33.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375948570722988032"}],"attachments":{"media_keys":{}}},{"conversation_id":"375947736191078400","author_id":"116716199","possibly_sensitive":false,"text":"RT @Groote: A lot of good issues were raised during the #coiworkshop yet. Here the agenda and the livestream http://t.co/EZeD6tpXRj","source":"TweetDeck","id":"375947736191078400","entities":{"hashtags":[{"start":56,"end":68,"tag":"coiworkshop"}],"urls":[{"start":109,"end":131,"url":"http://t.co/EZeD6tpXRj","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/09/news_detail_001881.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":3,"end":10,"username":"Groote","id":"16297777"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T11:44:59.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375941063623860225"}],"attachments":{"media_keys":{}}},{"conversation_id":"375947639583678464","author_id":"116716199","possibly_sensitive":false,"text":"RT @Groote: Workshop  \"best expertise vs conflicts of interests\".  #coiworkshop (@ European Medicines Agency) http://t.co/zL6rA7mnEy","source":"TweetDeck","id":"375947639583678464","entities":{"hashtags":[{"start":67,"end":79,"tag":"coiworkshop"}],"urls":[{"start":110,"end":132,"url":"http://t.co/zL6rA7mnEy","expanded_url":"http://4sq.com/154o48B","display_url":"4sq.com/154o48B"}],"mentions":[{"start":3,"end":10,"username":"Groote","id":"16297777"}],"annotations":[{"start":83,"end":107,"probability":0.4925,"type":"Organization","normalized_text":"European Medicines Agency"}]},"lang":"en","created_at":"2013-09-06T11:44:36.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375923184237043712"}],"attachments":{"media_keys":{}}},{"conversation_id":"375946840937865216","author_id":"116716199","possibly_sensitive":false,"text":"RT @EU_ScienceChief: Still a depressing gap amongst stakeholders on conflicts on interest on expert groups at EMA workshop #coiworkshop @EM…","source":"TweetDeck","id":"375946840937865216","entities":{"hashtags":[{"start":123,"end":135,"tag":"coiworkshop"}],"urls":{},"mentions":[{"start":3,"end":19,"username":"EU_ScienceChief","id":"2743488442"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T11:41:26.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375946736042524672"}],"attachments":{"media_keys":{}}},{"conversation_id":"375946009010245632","author_id":"116716199","possibly_sensitive":false,"text":"RT @LV_MPA: Director of Business Development http://t.co/EtuZWmfAhd #newjob","source":"TweetDeck","id":"375946009010245632","entities":{"hashtags":[{"start":68,"end":75,"tag":"newjob"}],"urls":[{"start":45,"end":67,"url":"http://t.co/EtuZWmfAhd","expanded_url":"http://bit.ly/13nxB9B","display_url":"bit.ly/13nxB9B"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T11:38:07.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375945147571109888","author_id":"116716199","possibly_sensitive":false,"text":"Fernand Sauer is now addressing questions to the panel based on issues raised in their presentations: http://t.co/FlQL32MWTh  #coiworkshop","source":"Twitter Web Client","id":"375945147571109888","entities":{"hashtags":[{"start":126,"end":138,"tag":"coiworkshop"}],"urls":[{"start":102,"end":124,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":{},"annotations":[{"start":0,"end":12,"probability":0.7816,"type":"Person","normalized_text":"Fernand Sauer"}]},"lang":"en","created_at":"2013-09-06T11:34:42.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375944616584830976","author_id":"116716199","possibly_sensitive":false,"text":"Pierre Chirac from @PrescrireMieux calls for EMA to only use experts with no links to industry: http://t.co/FlQL32MWTh #coiworkshop","source":"Twitter Web Client","id":"375944616584830976","entities":{"hashtags":[{"start":119,"end":131,"tag":"coiworkshop"}],"urls":[{"start":96,"end":118,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":[{"start":19,"end":34,"username":"PrescrireMieux","id":"247239882"}],"annotations":[{"start":0,"end":12,"probability":0.9867,"type":"Person","normalized_text":"Pierre Chirac"}]},"lang":"en","created_at":"2013-09-06T11:32:35.000Z","public_metrics":{"retweet_count":1,"reply_count":3,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375942515276259328","author_id":"116716199","possibly_sensitive":false,"text":"@mpceo from @corporateeurope highlights the shortfalls of the current policy on conflicts of interests: http://t.co/FlQL32MWTh #coiworkshop","source":"Twitter Web Client","id":"375942515276259328","entities":{"hashtags":[{"start":127,"end":139,"tag":"coiworkshop"}],"urls":[{"start":104,"end":126,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":[{"start":0,"end":6,"username":"mpceo","id":"1436237509927833601"},{"start":12,"end":28,"username":"corporateeurope","id":"86301869"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T11:24:14.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"in_reply_to_user_id":"1262134932","attachments":{"media_keys":{}}},{"conversation_id":"375942315501965312","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFA_Patients: MPigeon #CEO: COIs tend to be assessed too restrictively, with inconsistency, too much room for arbitrary assessment #coi…","source":"TweetDeck","id":"375942315501965312","entities":{"hashtags":[{"start":26,"end":30,"tag":"CEO"}],"urls":{},"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T11:23:27.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375942269657812992"}],"attachments":{"media_keys":{}}},{"conversation_id":"375940055992659968","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFA_Patients: 2016 #EFPIA companies disclose all financial relations with HCPs &amp; their orgs #coiworkshop as they already do for patient…","source":"TweetDeck","id":"375940055992659968","entities":{"hashtags":[{"start":23,"end":29,"tag":"EFPIA"},{"start":100,"end":112,"tag":"coiworkshop"}],"urls":{},"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T11:14:28.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375940003446022145"}],"attachments":{"media_keys":{}}},{"conversation_id":"375939805697167360","author_id":"116716199","possibly_sensitive":false,"text":"Richard Bergström (@EFPIA) explains industry's need to work with patients &amp; HCPs and transparency plans: http://t.co/FlQL32MWTh #coiworkshop","source":"Twitter Web Client","id":"375939805697167360","entities":{"hashtags":[{"start":132,"end":144,"tag":"coiworkshop"}],"urls":[{"start":109,"end":131,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":[{"start":19,"end":25,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":0,"end":16,"probability":0.9919,"type":"Person","normalized_text":"Richard Bergström"}]},"lang":"en","created_at":"2013-09-06T11:13:28.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375938356644818944","author_id":"116716199","possibly_sensitive":false,"text":"We're publishing the highlights from next week's #veterinary committee (#CVMP) meeting next Friday: http://t.co/97o1PoIrFD","source":"Twitter Web Client","id":"375938356644818944","entities":{"hashtags":[{"start":49,"end":60,"tag":"veterinary"},{"start":72,"end":77,"tag":"CVMP"}],"urls":[{"start":100,"end":122,"url":"http://t.co/97o1PoIrFD","expanded_url":"http://bit.ly/154a4Mc","display_url":"bit.ly/154a4Mc"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-06T11:07:43.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375938182254055424","author_id":"116716199","possibly_sensitive":false,"text":"One more week to comment on our draft Community #herbal monograph on #Curcuma xanthorrhiza (#Javaneseturmeric): http://t.co/4g7RAIt9qa","source":"Twitter Web Client","id":"375938182254055424","entities":{"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":77,"tag":"Curcuma"},{"start":92,"end":109,"tag":"Javaneseturmeric"}],"urls":[{"start":112,"end":134,"url":"http://t.co/4g7RAIt9qa","expanded_url":"http://bit.ly/1a5aypw","display_url":"bit.ly/1a5aypw"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-06T11:07:01.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375938107369332736","author_id":"116716199","possibly_sensitive":false,"text":"We've just published the PRAC meeting highlights: 2013 http://t.co/8sHEWfcmhS","source":"bitly bitlink","id":"375938107369332736","entities":{"hashtags":{},"urls":[{"start":55,"end":77,"url":"http://t.co/8sHEWfcmhS","expanded_url":"http://bit.ly/18z2J5R","display_url":"bit.ly/18z2J5R"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-06T11:06:44.000Z","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375938060577288194","author_id":"116716199","possibly_sensitive":false,"text":"One week left to comment on our draft Community #herbal monograph on #Rubus idaeus (#raspberry leaf): http://t.co/QxhxYsNDUE","source":"Twitter Web Client","id":"375938060577288194","entities":{"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":75,"tag":"Rubus"},{"start":84,"end":94,"tag":"raspberry"}],"urls":[{"start":102,"end":124,"url":"http://t.co/QxhxYsNDUE","expanded_url":"http://bit.ly/1dsTkTo","display_url":"bit.ly/1dsTkTo"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-06T11:06:32.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375937601191948288","author_id":"116716199","possibly_sensitive":false,"text":"Nikos Dedes describes need for patient experts to interact w all stakeholders including industry &amp; EMA: http://t.co/FlQL32MWTh #coiworkshop","source":"Twitter Web Client","id":"375937601191948288","entities":{"hashtags":[{"start":131,"end":143,"tag":"coiworkshop"}],"urls":[{"start":108,"end":130,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":{},"annotations":[{"start":0,"end":10,"probability":0.9645,"type":"Person","normalized_text":"Nikos Dedes"}]},"lang":"en","created_at":"2013-09-06T11:04:43.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375936375402790912","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFA_Patients: Direct/Indirect interest policy is not consistent says Nikos Dedes #EATG patient rep at EMA Management Board #coiworkshop","source":"TweetDeck","id":"375936375402790912","entities":{"hashtags":[{"start":85,"end":90,"tag":"EATG"},{"start":127,"end":139,"tag":"coiworkshop"}],"urls":{},"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"}],"annotations":[{"start":73,"end":83,"probability":0.8511,"type":"Person","normalized_text":"Nikos Dedes"},{"start":106,"end":125,"probability":0.871,"type":"Organization","normalized_text":"EMA Management Board"}]},"lang":"en","created_at":"2013-09-06T10:59:51.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375936016906870784"}],"attachments":{"media_keys":{}}},{"conversation_id":"375935675683459072","author_id":"116716199","possibly_sensitive":false,"text":"Serge Bakchine, Neurology SAG chair, explains how to make work with EMA more attractive for experts: http://t.co/FlQL32MWTh #coiworkshop","source":"Twitter Web Client","id":"375935675683459072","entities":{"hashtags":[{"start":124,"end":136,"tag":"coiworkshop"}],"urls":[{"start":101,"end":123,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":{},"annotations":[{"start":0,"end":13,"probability":0.977,"type":"Person","normalized_text":"Serge Bakchine"}]},"lang":"en","created_at":"2013-09-06T10:57:04.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375935132861218816","author_id":"116716199","possibly_sensitive":false,"text":"RT @Hep_Alliance: Read the global policy report on viral hepatitis here: http://t.co/BuPLCHKQF4","source":"TweetDeck","id":"375935132861218816","entities":{"hashtags":{},"urls":[{"start":73,"end":95,"url":"http://t.co/BuPLCHKQF4","expanded_url":"http://global-report.worldhepatitisalliance.org/en/","display_url":"…bal-report.worldhepatitisalliance.org/en/"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T10:54:54.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375934440058277888"}],"attachments":{"media_keys":{}}},{"conversation_id":"375935062900228096","author_id":"116716199","possibly_sensitive":false,"text":"RT @URPLWMiPB: Message to healthcare professionals on the restriction of the use of diclofenac in relation to... http://t.co/ixf5plGvWe","source":"TweetDeck","id":"375935062900228096","entities":{"hashtags":{},"urls":[{"start":113,"end":135,"url":"http://t.co/ixf5plGvWe","expanded_url":"http://tinyurl.com/mrl8gtt","display_url":"tinyurl.com/mrl8gtt"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T10:54:38.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375933649876553728","author_id":"116716199","possibly_sensitive":false,"text":"Anja Holm, veterinary committee chair, explains difficulty in finding available experts with low \"risk\": http://t.co/FlQL32MWTh #coiworkshop","source":"Twitter Web Client","id":"375933649876553728","entities":{"hashtags":[{"start":128,"end":140,"tag":"coiworkshop"}],"urls":[{"start":105,"end":127,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":{},"annotations":[{"start":0,"end":8,"probability":0.951,"type":"Person","normalized_text":"Anja Holm"}]},"lang":"en","created_at":"2013-09-06T10:49:01.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375932357598920705","author_id":"116716199","possibly_sensitive":false,"text":"Daniel Brasseur, Paediatric Committee chair, explains how EMA could deal with conflicts of interests: http://t.co/FlQL32MWTh #coiworkshop","source":"Twitter Web Client","id":"375932357598920705","entities":{"hashtags":[{"start":125,"end":137,"tag":"coiworkshop"}],"urls":[{"start":102,"end":124,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":{},"annotations":[{"start":0,"end":14,"probability":0.9947,"type":"Person","normalized_text":"Daniel Brasseur"},{"start":17,"end":36,"probability":0.4421,"type":"Organization","normalized_text":"Paediatric Committee"}]},"lang":"en","created_at":"2013-09-06T10:43:53.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375930899860160513","author_id":"116716199","possibly_sensitive":false,"text":"Rory Breathnach from @ucddublin highlights the problems caused by \"setting the bar too high\": http://t.co/FlQL32MWTh #coiworkshop","source":"Twitter Web Client","id":"375930899860160513","entities":{"hashtags":[{"start":117,"end":129,"tag":"coiworkshop"}],"urls":[{"start":94,"end":116,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":[{"start":21,"end":31,"username":"ucddublin","id":"22132266"}],"annotations":[{"start":0,"end":14,"probability":0.9569,"type":"Person","normalized_text":"Rory Breathnach"}]},"lang":"en","created_at":"2013-09-06T10:38:05.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375929978904670208","author_id":"116716199","possibly_sensitive":false,"text":"RT @myESMO: New addition to the ESMO Guidelines collection: Gestational trophoblastic disease http://t.co/xfu7zWWmfF #oncology","source":"TweetDeck","id":"375929978904670208","entities":{"hashtags":[{"start":117,"end":126,"tag":"oncology"}],"urls":[{"start":94,"end":116,"url":"http://t.co/xfu7zWWmfF","expanded_url":"http://ow.ly/oCyOe","display_url":"ow.ly/oCyOe"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T10:34:26.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375927925851566080"}],"attachments":{"media_keys":{}}},{"conversation_id":"375929799338131457","author_id":"116716199","possibly_sensitive":false,"text":"RT @eurordis: Call for new members of the @EU_Commission expert group on #raredisease http://t.co/mytqlzTnvQ Do you have what it takes?","source":"TweetDeck","id":"375929799338131457","entities":{"hashtags":[{"start":73,"end":85,"tag":"raredisease"}],"urls":[{"start":86,"end":108,"url":"http://t.co/mytqlzTnvQ","expanded_url":"http://ow.ly/oCxcZ","display_url":"ow.ly/oCxcZ"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":42,"end":56,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T10:33:43.000Z","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375926010677846017"}],"attachments":{"media_keys":{}}},{"conversation_id":"375928721103785984","author_id":"116716199","possibly_sensitive":false,"text":"Wolf-Dieter Ludwig summarises the challenges from conflicts of interests from an academic perspective: http://t.co/FlQL32MWTh #coiworkshop","source":"Twitter Web Client","id":"375928721103785984","entities":{"hashtags":[{"start":126,"end":138,"tag":"coiworkshop"}],"urls":[{"start":103,"end":125,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":{},"annotations":[{"start":5,"end":17,"probability":0.7107,"type":"Person","normalized_text":"Dieter Ludwig"}]},"lang":"en","created_at":"2013-09-06T10:29:26.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375926614766678016","author_id":"116716199","possibly_sensitive":false,"text":"RT @cancereu: Livestream: workshop best expertise vs conflicts of \ninterests: Striking the right balance http://t.co/3g9NVjJQ7x #coiworkshop","source":"TweetDeck","id":"375926614766678016","entities":{"hashtags":[{"start":128,"end":140,"tag":"coiworkshop"}],"urls":[{"start":105,"end":127,"url":"http://t.co/3g9NVjJQ7x","expanded_url":"http://bit.ly/154oUSL","display_url":"bit.ly/154oUSL"}],"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T10:21:04.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375926253884567553","author_id":"116716199","possibly_sensitive":false,"text":"RT @innovationunion: The #antioxidants in seaweed could hold the treatment for #Parkinson’s and #Alzheimer’s diseases: http://t.co/wStHGUB7…","source":"TweetDeck","id":"375926253884567553","entities":{"hashtags":[{"start":25,"end":38,"tag":"antioxidants"},{"start":79,"end":89,"tag":"Parkinson"},{"start":96,"end":106,"tag":"Alzheimer"}],"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T10:19:37.000Z","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375922867830931457"}],"attachments":{"media_keys":{}}},{"conversation_id":"375925265236365312","author_id":"116716199","possibly_sensitive":false,"text":"Fernand Sauer summarises how the Agency uses of experts and introduces the panel &amp; plan for the day: http://t.co/FlQL32MWTh #coiworkshop","source":"Twitter Web Client","id":"375925265236365312","entities":{"hashtags":[{"start":128,"end":140,"tag":"coiworkshop"}],"urls":[{"start":105,"end":127,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":{},"annotations":[{"start":0,"end":12,"probability":0.676,"type":"Person","normalized_text":"Fernand Sauer"}]},"lang":"en","created_at":"2013-09-06T10:15:42.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375923777445826560","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFA_Patients: Transparency &amp; clear rules are key in managing conflict of interest. EFA would add: fare rules #Groote #ENVI at EMA #coiw…","source":"TweetDeck","id":"375923777445826560","entities":{"hashtags":[{"start":117,"end":124,"tag":"Groote"},{"start":125,"end":130,"tag":"ENVI"}],"urls":{},"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T10:09:47.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375919077740384256"}],"attachments":{"media_keys":{}}},{"conversation_id":"375923408284172289","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: EMA | Final agenda of the workshop on Conflicts of Interests: http://t.co/zVKmpO9wQN #coiworkshop","source":"TweetDeck","id":"375923408284172289","entities":{"hashtags":[{"start":98,"end":110,"tag":"coiworkshop"}],"urls":[{"start":75,"end":97,"url":"http://t.co/zVKmpO9wQN","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Agenda/2013/07/WC500146260.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T10:08:19.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375922769285758977","author_id":"116716199","possibly_sensitive":false,"text":"@EU_ScienceChief emphasises the need for trust &amp; challenges of industry working with the public sector: http://t.co/FlQL32MWTh #coiworkshop","source":"Twitter Web Client","id":"375922769285758977","entities":{"hashtags":[{"start":131,"end":143,"tag":"coiworkshop"}],"urls":[{"start":108,"end":130,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":[{"start":0,"end":16,"username":"EU_ScienceChief","id":"2743488442"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T10:05:47.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"in_reply_to_user_id":"569921322","attachments":{"media_keys":{}}},{"conversation_id":"375919632047030272","author_id":"116716199","possibly_sensitive":false,"text":"@Groote stresses need for transparency in dealing w balance btw expertise and conflicts of interests: http://t.co/FlQL32MWTh #coiworkshop","source":"Twitter Web Client","id":"375919632047030272","entities":{"hashtags":[{"start":125,"end":137,"tag":"coiworkshop"}],"urls":[{"start":102,"end":124,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":[{"start":0,"end":7,"username":"Groote","id":"16297777"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T09:53:19.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"in_reply_to_user_id":"16297777","attachments":{"media_keys":{}}},{"conversation_id":"375918607278292992","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: Richard Bergstrom talks CT #transparency with @bengoldacre http://t.co/uvzJprW5p2; Videos @ http://t.co/SxZA9sqK5o #ctdata","source":"TweetDeck","id":"375918607278292992","entities":{"hashtags":[{"start":38,"end":51,"tag":"transparency"},{"start":126,"end":133,"tag":"ctdata"}],"urls":[{"start":70,"end":92,"url":"http://t.co/uvzJprW5p2","expanded_url":"http://bit.ly/13n2YkM","display_url":"bit.ly/13n2YkM"},{"start":103,"end":125,"url":"http://t.co/SxZA9sqK5o","expanded_url":"http://bit.ly/164dxdE","display_url":"bit.ly/164dxdE"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":57,"end":69,"username":"bengoldacre","id":"6705042"}],"annotations":[{"start":11,"end":27,"probability":0.9968,"type":"Person","normalized_text":"Richard Bergstrom"}]},"lang":"en","created_at":"2013-09-06T09:49:14.000Z","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375918410183344129","author_id":"116716199","possibly_sensitive":false,"text":"Our ED, Guido Rasi, started the #coiworkshop, giving the history of handling conflicts of interests and today's aims: http://t.co/FlQL32MWTh","source":"Twitter Web Client","id":"375918410183344129","entities":{"hashtags":[{"start":32,"end":44,"tag":"coiworkshop"}],"urls":[{"start":118,"end":140,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":{},"annotations":[{"start":8,"end":17,"probability":0.974,"type":"Person","normalized_text":"Guido Rasi"}]},"lang":"en","created_at":"2013-09-06T09:48:27.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375914257163898880","author_id":"116716199","possibly_sensitive":false,"text":"Our workshop on conflicts of interests is starting now: Live broadcast (multimedia tab): http://t.co/FlQL32MWTh  #coiworkshop","source":"Twitter Web Client","id":"375914257163898880","entities":{"hashtags":[{"start":113,"end":125,"tag":"coiworkshop"}],"urls":[{"start":89,"end":111,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-06T09:31:57.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375912107898064896","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: Foodborne #trematodiases can result in severe liver &amp; lung disease. Safe #medicines exist to prevent, treat infection http://t.co/…","source":"TweetDeck","id":"375912107898064896","entities":{"hashtags":[{"start":19,"end":33,"tag":"trematodiases"},{"start":86,"end":96,"tag":"medicines"}],"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-09-06T09:23:25.000Z","public_metrics":{"retweet_count":36,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375912048862838785"}],"attachments":{"media_keys":{}}},{"conversation_id":"375911731740295168","author_id":"116716199","possibly_sensitive":false,"text":"RT @EUombudsman: #EUpress If you are interested in EU transparency, you can follow our #11rtkdEO event live on 27 September http://t.co/DgD…","source":"TweetDeck","id":"375911731740295168","entities":{"hashtags":[{"start":17,"end":25,"tag":"EUpress"},{"start":87,"end":96,"tag":"11rtkdEO"}],"urls":{},"mentions":[{"start":3,"end":15,"username":"EUombudsman","id":"873777758"}],"annotations":[{"start":51,"end":52,"probability":0.3631,"type":"Place","normalized_text":"EU"}]},"lang":"en","created_at":"2013-09-06T09:21:55.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375911651108986880"}],"attachments":{"media_keys":{}}},{"conversation_id":"375906436267515905","author_id":"116716199","possibly_sensitive":false,"text":"Our workshop on conflicts of interests starts in 30 minutes: Live broadcast (multimedia tab): http://t.co/FlQL32MWTh #coiworkshop","source":"Twitter Web Client","id":"375906436267515905","entities":{"hashtags":[{"start":117,"end":129,"tag":"coiworkshop"}],"urls":[{"start":94,"end":116,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-06T09:00:53.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375894554261880832","author_id":"116716199","possibly_sensitive":false,"text":"Our #veterinary committee (#CVMP) is meeting next week; highlights published on Friday: http://t.co/FOpj6RxYfy","source":"bitly bitlink","id":"375894554261880832","entities":{"hashtags":[{"start":4,"end":15,"tag":"veterinary"},{"start":27,"end":32,"tag":"CVMP"}],"urls":[{"start":88,"end":110,"url":"http://t.co/FOpj6RxYfy","expanded_url":"http://bit.ly/154a4Mc","display_url":"bit.ly/154a4Mc"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-06T08:13:40.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375894019928096768","author_id":"116716199","possibly_sensitive":false,"text":"One week left to comment on our draft Community #herbal monograph on #Curcuma xanthorrhiza (#Javaneseturmeric): http://t.co/4g7RAIt9qa","source":"Twitter Web Client","id":"375894019928096768","entities":{"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":77,"tag":"Curcuma"},{"start":92,"end":109,"tag":"Javaneseturmeric"}],"urls":[{"start":112,"end":134,"url":"http://t.co/4g7RAIt9qa","expanded_url":"http://bit.ly/1a5aypw","display_url":"bit.ly/1a5aypw"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-06T08:11:32.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375893884737318912","author_id":"116716199","possibly_sensitive":false,"text":"One more week to comment on our draft Community #herbal monograph on #Rubus idaeus (#raspberry leaf): http://t.co/QxhxYsNDUE","source":"Twitter Web Client","id":"375893884737318912","entities":{"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":75,"tag":"Rubus"},{"start":84,"end":94,"tag":"raspberry"}],"urls":[{"start":102,"end":124,"url":"http://t.co/QxhxYsNDUE","expanded_url":"http://bit.ly/1dsTkTo","display_url":"bit.ly/1dsTkTo"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-06T08:11:00.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375892865744117760","author_id":"116716199","possibly_sensitive":false,"text":"RT @AlzheimerEurope: Newsletter focus: AE delighted to join Patients' and Consumers' Working Party of @EMA_News: http://t.co/kecdnfUTkW","source":"TweetDeck","id":"375892865744117760","entities":{"hashtags":{},"urls":[{"start":113,"end":135,"url":"http://t.co/kecdnfUTkW","expanded_url":"http://www.alzheimer-europe.org/News/Alzheimer-Europe/Friday-26-July-2013-Alzheimer-Europe-joins-EMA-s-PCWP-working-group/(language)/eng-GB","display_url":"alzheimer-europe.org/News/Alzheimer…"}],"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"},{"start":102,"end":111,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":39,"end":40,"probability":0.4703,"type":"Organization","normalized_text":"AE"}]},"lang":"en","created_at":"2013-09-06T08:06:57.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375857389502615552"}],"attachments":{"media_keys":{}}},{"conversation_id":"375892269729345536","author_id":"116716199","possibly_sensitive":false,"text":"Our workshop on conflicts of interests starts at 10.30 UK time today. Live broadcast (multimedia tab): http://t.co/mwJrqMjE1D #coiworkshop","source":"bitly bitlink","id":"375892269729345536","entities":{"hashtags":[{"start":126,"end":138,"tag":"coiworkshop"}],"urls":[{"start":103,"end":125,"url":"http://t.co/mwJrqMjE1D","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"mentions":{},"annotations":[{"start":55,"end":56,"probability":0.8028,"type":"Place","normalized_text":"UK"}]},"lang":"en","created_at":"2013-09-06T08:04:35.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375646172704407552","author_id":"116716199","possibly_sensitive":false,"text":"RT @IMI_JU: IMI project EMIF publishes it's first scientific article in The Lancet Neurology online http://t.co/LoSRiwVj5G","source":"TweetDeck","id":"375646172704407552","entities":{"hashtags":{},"urls":[{"start":100,"end":122,"url":"http://t.co/LoSRiwVj5G","expanded_url":"http://bit.ly/19idXNf","display_url":"bit.ly/19idXNf"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":[{"start":72,"end":91,"probability":0.3732,"type":"Other","normalized_text":"The Lancet Neurology"}]},"lang":"en","created_at":"2013-09-05T15:46:41.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375646004604727296"}],"attachments":{"media_keys":{}}},{"conversation_id":"375641899031617536","author_id":"116716199","possibly_sensitive":false,"text":"RT @DrugInfoAssn: #Biomarker test boosts prospects for Parkinson's prediction http://t.co/8kQiGpjzI6","source":"TweetDeck","id":"375641899031617536","entities":{"hashtags":[{"start":18,"end":28,"tag":"Biomarker"}],"urls":[{"start":78,"end":100,"url":"http://t.co/8kQiGpjzI6","expanded_url":"http://www.fiercebiomarkers.com/story/biomarker-test-boosts-prospects-parkinsons-prediction/2013-08-28","display_url":"fiercebiomarkers.com/story/biomarke…"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":[{"start":55,"end":63,"probability":0.6506,"type":"Person","normalized_text":"Parkinson"}]},"lang":"en","created_at":"2013-09-05T15:29:42.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375637185833074688"}],"attachments":{"media_keys":{}}},{"conversation_id":"375641721369272320","author_id":"116716199","possibly_sensitive":false,"text":"RT @DrugInfoAssn: ICH Guideline M8 on eCTD: Questions and Answers  http://t.co/6xPJRc1iO4","source":"TweetDeck","id":"375641721369272320","entities":{"hashtags":{},"urls":[{"start":67,"end":89,"url":"http://t.co/6xPJRc1iO4","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/08/WC500148272.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":{}},"lang":"en","created_at":"2013-09-05T15:29:00.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375636681170251776"}],"attachments":{"media_keys":{}}},{"conversation_id":"375625104614780928","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: EFPIA Response to Consultation on Publication and Access to Clinical-Trial Data finalised today http://t.co/BMtlzB1xi9 #ctdata","source":"TweetDeck","id":"375625104614780928","entities":{"hashtags":[{"start":130,"end":137,"tag":"ctdata"}],"urls":[{"start":107,"end":129,"url":"http://t.co/BMtlzB1xi9","expanded_url":"http://bit.ly/18FzqgG","display_url":"bit.ly/18FzqgG"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-09-05T14:22:58.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375619082235953152","author_id":"116716199","possibly_sensitive":false,"text":"RT @HAIEurope: Register your place on our 1-day Glo.Health conference in Berlin 21/9/13: 'Big Pharma: Good Pharma – Bad Pharma?'  http://t.…","source":"TweetDeck","id":"375619082235953152","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":[{"start":73,"end":78,"probability":0.9746,"type":"Place","normalized_text":"Berlin"}]},"lang":"en","created_at":"2013-09-05T13:59:02.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375618039300898817"}],"attachments":{"media_keys":{}}},{"conversation_id":"375618317379448832","author_id":"116716199","possibly_sensitive":false,"text":"RT @IlaeWeb: New deadline to register for ILAE #VIREPA #DistanceLearning courses is 22 Sept. Course details: http://t.co/BHak5UNWeH","source":"TweetDeck","id":"375618317379448832","entities":{"hashtags":[{"start":47,"end":54,"tag":"VIREPA"},{"start":55,"end":72,"tag":"DistanceLearning"}],"urls":[{"start":109,"end":131,"url":"http://t.co/BHak5UNWeH","expanded_url":"http://www.ilae.org/Visitors/Centre/VIREPA.cfm","display_url":"ilae.org/Visitors/Centr…"}],"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"annotations":{}},"lang":"en","created_at":"2013-09-05T13:56:00.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375600084634722305"}],"attachments":{"media_keys":{}}},{"conversation_id":"375613060826005504","author_id":"116716199","possibly_sensitive":false,"text":"RT @euparkinsons: Reasons driving treatment modification in #Parkinson's: Results from the cross-sectional phase of the reason study - http…","source":"TweetDeck","id":"375613060826005504","entities":{"hashtags":[{"start":60,"end":70,"tag":"Parkinson"}],"urls":{},"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"lang":"en","created_at":"2013-09-05T13:35:06.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375612018968915968"}],"attachments":{"media_keys":{}}},{"conversation_id":"375611623635189760","author_id":"116716199","possibly_sensitive":false,"text":"RT @HealthCanada: Precautionary #recall of birth control product: Esme-28: http://t.co/7lN69bvf8u #health","source":"TweetDeck","id":"375611623635189760","entities":{"hashtags":[{"start":32,"end":39,"tag":"recall"},{"start":98,"end":105,"tag":"health"}],"urls":[{"start":75,"end":97,"url":"http://t.co/7lN69bvf8u","expanded_url":"http://bit.ly/161Ja7p","display_url":"bit.ly/161Ja7p"}],"mentions":[{"start":3,"end":16,"username":"HealthCanada","id":"928334374256472064"}],"annotations":[{"start":66,"end":69,"probability":0.6772,"type":"Person","normalized_text":"Esme"}]},"lang":"en","created_at":"2013-09-05T13:29:24.000Z","public_metrics":{"retweet_count":33,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375610080663584769"}],"attachments":{"media_keys":{}}},{"conversation_id":"375611324719722496","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: EFPIA Director General Richard Bergstrom answers questions about the 4th of the EFPIA-PhRMA Commitments in his blog http://t.co/…","source":"TweetDeck","id":"375611324719722496","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":34,"end":50,"probability":0.6104,"type":"Person","normalized_text":"Richard Bergstrom"}]},"lang":"en","created_at":"2013-09-05T13:28:13.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375607274695180288"}],"attachments":{"media_keys":{}}},{"conversation_id":"375586343830962176","author_id":"116716199","possibly_sensitive":false,"text":"RT @Aifa_ufficiale: Prohibition of the use of medicines made by the company Geymonat: http://t.co/cnAX74GPhF","source":"TweetDeck","id":"375586343830962176","entities":{"hashtags":{},"urls":[{"start":86,"end":108,"url":"http://t.co/cnAX74GPhF","expanded_url":"http://fb.me/2l9dGO8tM","display_url":"fb.me/2l9dGO8tM"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"lang":"en","created_at":"2013-09-05T11:48:57.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375578319078838272","author_id":"116716199","possibly_sensitive":false,"text":"RT @innovationunion: #JRC identifies causes for discrepancies in growth hormone measurements: Measurements of human growth hormone... http:…","source":"TweetDeck","id":"375578319078838272","entities":{"hashtags":[{"start":21,"end":25,"tag":"JRC"}],"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"lang":"en","created_at":"2013-09-05T11:17:03.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375573047551336448"}],"attachments":{"media_keys":{}}},{"conversation_id":"375575099451006976","author_id":"116716199","possibly_sensitive":false,"text":"Our workshop on conflicts of interests is tomorrow 10.30-16.00 UK time. Live broadcast (multimedia tab): http://t.co/qxCGPU3xUo #coiworkshop","source":"Twitter Web Client","id":"375575099451006976","entities":{"hashtags":[{"start":128,"end":140,"tag":"coiworkshop"}],"urls":[{"start":105,"end":127,"url":"http://t.co/qxCGPU3xUo","expanded_url":"http://bit.ly/1f6tUr9","display_url":"bit.ly/1f6tUr9"}],"mentions":{},"annotations":[{"start":63,"end":64,"probability":0.647,"type":"Place","normalized_text":"UK"}]},"lang":"en","created_at":"2013-09-05T11:04:16.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375573124143919104","author_id":"116716199","possibly_sensitive":false,"text":"RT @HepatitisEurope: After smart phones smart #syringes may help to reduce #infection of #hepatitis and #hiv http://t.co/npjhrSGeFt","source":"TweetDeck","id":"375573124143919104","entities":{"hashtags":[{"start":46,"end":55,"tag":"syringes"},{"start":75,"end":85,"tag":"infection"},{"start":89,"end":99,"tag":"hepatitis"},{"start":104,"end":108,"tag":"hiv"}],"urls":[{"start":109,"end":131,"url":"http://t.co/npjhrSGeFt","expanded_url":"http://goo.gl/TQNqFH","display_url":"goo.gl/TQNqFH"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-05T10:56:25.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375572772287549441"}],"attachments":{"media_keys":{}}},{"conversation_id":"375569399128010752","author_id":"116716199","possibly_sensitive":false,"text":"RT @euparkinsons: Therapeutic prospects 4 #Parkinson's disease: http://t.co/LR70l25ptl","source":"TweetDeck","id":"375569399128010752","entities":{"hashtags":[{"start":42,"end":52,"tag":"Parkinson"}],"urls":[{"start":64,"end":86,"url":"http://t.co/LR70l25ptl","expanded_url":"http://bit.ly/192euCN","display_url":"bit.ly/192euCN"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"lang":"en","created_at":"2013-09-05T10:41:37.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375569236266991617"}],"attachments":{"media_keys":{}}},{"conversation_id":"375567288801689601","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: Unusual increase of #paratyphoid A fever among travellers returning from Cambodia, see ECDC rapid risk assessment: http://t.co…","source":"TweetDeck","id":"375567288801689601","entities":{"hashtags":[{"start":33,"end":45,"tag":"paratyphoid"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":86,"end":93,"probability":0.8682,"type":"Place","normalized_text":"Cambodia"}]},"lang":"en","created_at":"2013-09-05T10:33:14.000Z","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375567231330971648"}],"attachments":{"media_keys":{}}},{"conversation_id":"375563230535757824","author_id":"116716199","possibly_sensitive":false,"text":"RT @EU_ScienceChief: Looking forward to speaking at the European Medicines Agency conflicts of interest workshop tomorrow #coiworkshop Need…","source":"TweetDeck","id":"375563230535757824","entities":{"hashtags":[{"start":122,"end":134,"tag":"coiworkshop"}],"urls":{},"mentions":[{"start":3,"end":19,"username":"EU_ScienceChief","id":"2743488442"}],"annotations":[{"start":56,"end":80,"probability":0.7664,"type":"Organization","normalized_text":"European Medicines Agency"}]},"lang":"en","created_at":"2013-09-05T10:17:06.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375563097706348544"}],"attachments":{"media_keys":{}}},{"conversation_id":"375551144896245760","author_id":"116716199","possibly_sensitive":false,"text":"RT @EMCDDA: Just published — the latest edition of our newsletter, Drugnet Europe: http://t.co/2Sb9hAS4eV","source":"TweetDeck","id":"375551144896245760","entities":{"hashtags":{},"urls":[{"start":83,"end":105,"url":"http://t.co/2Sb9hAS4eV","expanded_url":"http://www.emcdda.europa.eu/publications/drugnet/83","display_url":"emcdda.europa.eu/publications/d…"}],"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":67,"end":80,"probability":0.2793,"type":"Place","normalized_text":"Drugnet Europe"}]},"lang":"en","created_at":"2013-09-05T09:29:05.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375546075479695360"}],"attachments":{"media_keys":{}}},{"conversation_id":"375539676469149696","author_id":"116716199","possibly_sensitive":false,"text":"Our workshop 'best expertise vs #conflictsofinterests: striking the right balance' is tomorrow: http://t.co/qxCGPU3xUo #coiworkshop","source":"Twitter Web Client","id":"375539676469149696","entities":{"hashtags":[{"start":32,"end":53,"tag":"conflictsofinterests"},{"start":119,"end":131,"tag":"coiworkshop"}],"urls":[{"start":96,"end":118,"url":"http://t.co/qxCGPU3xUo","expanded_url":"http://bit.ly/1f6tUr9","display_url":"bit.ly/1f6tUr9"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-05T08:43:30.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375539175678025728","author_id":"116716199","possibly_sensitive":false,"text":"RT @EUombudsman: International Right to Know Day - \"EU transparency: Where are we now?\" http://t.co/fck3Nhxr56 #11rtkdEO","source":"TweetDeck","id":"375539175678025728","entities":{"hashtags":[{"start":111,"end":120,"tag":"11rtkdEO"}],"urls":[{"start":88,"end":110,"url":"http://t.co/fck3Nhxr56","expanded_url":"http://bit.ly/17mwKmT","display_url":"bit.ly/17mwKmT"}],"mentions":[{"start":3,"end":15,"username":"EUombudsman","id":"873777758"}],"annotations":[{"start":52,"end":53,"probability":0.4923,"type":"Organization","normalized_text":"EU"}]},"lang":"en","created_at":"2013-09-05T08:41:31.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375286854389874688","author_id":"116716199","possibly_sensitive":false,"text":"RT @US_FDA: Here is the latest edition of the FDA Patient Network Newsletter http://t.co/ozCO8eKVn5","source":"TweetDeck","id":"375286854389874688","entities":{"hashtags":{},"urls":[{"start":77,"end":99,"url":"http://t.co/ozCO8eKVn5","expanded_url":"http://patientnetwork.fda.gov/current-patient-network-newsletter","display_url":"patientnetwork.fda.gov/current-patien…"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":46,"end":75,"probability":0.3577,"type":"Organization","normalized_text":"FDA Patient Network Newsletter"}]},"lang":"en","created_at":"2013-09-04T15:58:53.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375285625168990209"}],"attachments":{"media_keys":{}}},{"conversation_id":"375283303789895680","author_id":"116716199","possibly_sensitive":false,"text":"RT @DrugInfoAssn: Guidance on drug-unit inspections unveiled by FDA  http://t.co/7ZkMnykcX0","source":"TweetDeck","id":"375283303789895680","entities":{"hashtags":{},"urls":[{"start":69,"end":91,"url":"http://t.co/7ZkMnykcX0","expanded_url":"http://www.business-standard.com/article/companies/us-fda-issues-draft-norms-on-drug-unit-inspections-113090200034_1.html","display_url":"business-standard.com/article/compan…"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":[{"start":64,"end":66,"probability":0.8519,"type":"Organization","normalized_text":"FDA"}]},"lang":"en","created_at":"2013-09-04T15:44:46.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375282339082797057"}],"attachments":{"media_keys":{}}},{"conversation_id":"375272002913042432","author_id":"116716199","possibly_sensitive":false,"text":"RT @AEMPSGOB: Therapeutic position report on eribulin (Halaven®) in breast cancer http://t.co/PXR3zeeaBD","source":"TweetDeck","id":"375272002913042432","entities":{"hashtags":{},"urls":[{"start":82,"end":104,"url":"http://t.co/PXR3zeeaBD","expanded_url":"http://www.aemps.gob.es/medicamentosUsoHumano/informesPublicos/docs/criterios-eribulina-04092013.pdf","display_url":"aemps.gob.es/medicamentosUs…"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"lang":"en","created_at":"2013-09-04T14:59:52.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375271809278808064","author_id":"116716199","possibly_sensitive":false,"text":"RT @AEMPSGOB: Update of the advanced-therapies section of the Spanish medicines agency's website http://t.co/Roke2OqRzL","source":"TweetDeck","id":"375271809278808064","entities":{"hashtags":{},"urls":[{"start":97,"end":119,"url":"http://t.co/Roke2OqRzL","expanded_url":"http://www.aemps.gob.es/investigacionClinica/terapiasAvanzadas/home.htm","display_url":"aemps.gob.es/investigacionC…"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"lang":"en","created_at":"2013-09-04T14:59:06.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375270414169436160","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFSA_EU: How can #EFSA enhance #transparency in risk assessment? Register to join EFSA’s stakeholder conference by 10 Sept.: http://t.c…","source":"TweetDeck","id":"375270414169436160","entities":{"hashtags":[{"start":21,"end":26,"tag":"EFSA"},{"start":35,"end":48,"tag":"transparency"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"lang":"en","created_at":"2013-09-04T14:53:33.000Z","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375257847065374720"}],"attachments":{"media_keys":{}}},{"conversation_id":"375253577478197248","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: New surveillance report shows #chlamydia most prevalent #STI in Europe, increasing rates of #gonorrhoea and #syphilis http://t…","source":"TweetDeck","id":"375253577478197248","entities":{"hashtags":[{"start":43,"end":53,"tag":"chlamydia"},{"start":69,"end":73,"tag":"STI"},{"start":105,"end":116,"tag":"gonorrhoea"},{"start":121,"end":130,"tag":"syphilis"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":77,"end":82,"probability":0.9946,"type":"Place","normalized_text":"Europe"}]},"lang":"en","created_at":"2013-09-04T13:46:39.000Z","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375247199216861184"}],"attachments":{"media_keys":{}}},{"conversation_id":"375253452005588992","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_Flu: CONSISE is intl consortium of experts working to standardise #influenza seroepidemiology for #pandemic #flu: http://t.co/BkiX…","source":"TweetDeck","id":"375253452005588992","entities":{"hashtags":[{"start":75,"end":85,"tag":"influenza"},{"start":107,"end":116,"tag":"pandemic"},{"start":117,"end":121,"tag":"flu"}],"urls":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":{}},"lang":"en","created_at":"2013-09-04T13:46:09.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375246338167812096"}],"attachments":{"media_keys":{}}},{"conversation_id":"375253379691606016","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_Flu: CONSISE experts meet in #OptionsVIII to learn from #MERS-CoV, #H7N9 and standardise #flu serology protocols&amp;methods http://t.…","source":"TweetDeck","id":"375253379691606016","entities":{"hashtags":[{"start":38,"end":50,"tag":"OptionsVIII"},{"start":65,"end":70,"tag":"MERS"},{"start":76,"end":81,"tag":"H7N9"},{"start":98,"end":102,"tag":"flu"}],"urls":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":{}},"lang":"en","created_at":"2013-09-04T13:45:52.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375246026698784770"}],"attachments":{"media_keys":{}}},{"conversation_id":"375252826471268352","author_id":"116716199","possibly_sensitive":false,"text":"RT @innovationunion: Press Centre (#EUResearchAlerts) - #EU project to find vaccine against ticks: European Union-funded researchers... htt…","source":"TweetDeck","id":"375252826471268352","entities":{"hashtags":[{"start":35,"end":52,"tag":"EUResearchAlerts"},{"start":56,"end":59,"tag":"EU"}],"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"lang":"en","created_at":"2013-09-04T13:43:40.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375233373960028161"}],"attachments":{"media_keys":{}}},{"conversation_id":"375231360908423168","author_id":"116716199","possibly_sensitive":false,"text":"RT @EUombudsman: \"EU #transparency: Where are we now?\" Register for the #EUombudsman event on 27 Sept at: http://t.co/sQ9VhBVr7Y #11rtkdEO","source":"TweetDeck","id":"375231360908423168","entities":{"hashtags":[{"start":21,"end":34,"tag":"transparency"},{"start":72,"end":84,"tag":"EUombudsman"},{"start":129,"end":138,"tag":"11rtkdEO"}],"urls":[{"start":106,"end":128,"url":"http://t.co/sQ9VhBVr7Y","expanded_url":"http://bit.ly/17mw2Gv","display_url":"bit.ly/17mw2Gv"}],"mentions":[{"start":3,"end":15,"username":"EUombudsman","id":"873777758"}],"annotations":{}},"lang":"en","created_at":"2013-09-04T12:18:22.000Z","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375231270030016512"}],"attachments":{"media_keys":{}}},{"conversation_id":"375231332575891456","author_id":"116716199","possibly_sensitive":false,"text":"RT @EURLex: .@EU_Commission authorises certain #health claims made on #foods, http://t.co/b0fXBJE5p5","source":"TweetDeck","id":"375231332575891456","entities":{"hashtags":[{"start":47,"end":54,"tag":"health"},{"start":70,"end":76,"tag":"foods"}],"urls":[{"start":78,"end":100,"url":"http://t.co/b0fXBJE5p5","expanded_url":"http://goo.gl/bp9hsi","display_url":"goo.gl/bp9hsi"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"},{"start":13,"end":27,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"fr","created_at":"2013-09-04T12:18:15.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375231008456466433"}],"attachments":{"media_keys":{}}},{"conversation_id":"375157376451489793","author_id":"116716199","possibly_sensitive":false,"text":"@HJF29088181 We've fixed it now. Apologies for the error: http://t.co/2rOJ2z4H2k","source":"TweetDeck","id":"375218390782455808","entities":{"hashtags":{},"urls":[{"start":58,"end":80,"url":"http://t.co/2rOJ2z4H2k","expanded_url":"http://bit.ly/1aiGkzn","display_url":"bit.ly/1aiGkzn"}],"mentions":[{"start":0,"end":12,"username":"HJF29088181","id":"1007144522"}],"annotations":{}},"lang":"en","created_at":"2013-09-04T11:26:50.000Z","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"375192039677509632"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"conversation_id":"375217955426295808","author_id":"116716199","possibly_sensitive":false,"text":"RT @euparkinsons: Combined #dementia-risk biomarkers in #Parkinson's disease: a prospective longitudinal study  http://t.co/pGUxGaAG85","source":"TweetDeck","id":"375217955426295808","entities":{"hashtags":[{"start":27,"end":36,"tag":"dementia"},{"start":56,"end":66,"tag":"Parkinson"}],"urls":[{"start":112,"end":134,"url":"http://t.co/pGUxGaAG85","expanded_url":"http://bit.ly/1aiCqGI","display_url":"bit.ly/1aiCqGI"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"lang":"en","created_at":"2013-09-04T11:25:06.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375211874930786305"}],"attachments":{"media_keys":{}}},{"conversation_id":"375192467140005888","author_id":"116716199","possibly_sensitive":false,"text":"RT @HepatitisEurope: Hepatitis B Vaccination Cuts Deaths From Liver Disease, Cancer: Study - US News and World Report http://t.co/L636thkr4…","source":"TweetDeck","id":"375192467140005888","entities":{"hashtags":{},"urls":{},"mentions":{},"annotations":[{"start":93,"end":99,"probability":0.5406,"type":"Organization","normalized_text":"US News"}]},"lang":"en","created_at":"2013-09-04T09:43:49.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375191084038492160"}],"attachments":{"media_keys":{}}},{"conversation_id":"375192321606041600","author_id":"116716199","possibly_sensitive":false,"text":"RT @NICEcomms: New QIPP case study now available on intravenous iron use \nhttps://t.co/1enZ998z9F[{%22srn%22:[%22 qipp %22]}]&amp;fs=qippcat.Wh…","source":"TweetDeck","id":"375192321606041600","entities":{"hashtags":{},"urls":[{"start":74,"end":97,"url":"https://t.co/1enZ998z9F","expanded_url":"https://www.evidence.nhs.uk/qipp/whats-new/search?s=date&am=","display_url":"evidence.nhs.uk/qipp/whats-new…"}],"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{}},"lang":"en","created_at":"2013-09-04T09:43:14.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375189098589212672"}],"attachments":{"media_keys":{}}},{"conversation_id":"375157376451489793","author_id":"116716199","possibly_sensitive":false,"text":"@HJF29088181 We're looking into it. Please bear with us.","source":"TweetDeck","id":"375192039677509632","entities":{"hashtags":{},"urls":{},"mentions":[{"start":0,"end":12,"username":"HJF29088181","id":"1007144522"}],"annotations":{}},"lang":"en","created_at":"2013-09-04T09:42:07.000Z","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"375190558186041344"}],"in_reply_to_user_id":"1007144522","attachments":{"media_keys":{}}},{"conversation_id":"375180309571969024","author_id":"116716199","possibly_sensitive":false,"text":"The EPAR for #Lojuxta (#lomitapide) for homozygous familial #hypercholesterolaemia is available on our website: http://t.co/4z6VutmcAQ","source":"Twitter Web Client","id":"375180309571969024","entities":{"hashtags":[{"start":13,"end":21,"tag":"Lojuxta"},{"start":23,"end":34,"tag":"lomitapide"},{"start":60,"end":82,"tag":"hypercholesterolaemia"}],"urls":[{"start":112,"end":134,"url":"http://t.co/4z6VutmcAQ","expanded_url":"http://bit.ly/15vsPup","display_url":"bit.ly/15vsPup"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-04T08:55:30.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"375180140411498496","author_id":"116716199","possibly_sensitive":false,"text":"The EPAR for #Lonquex (#lipegfilgrastim) for #neutropenia in adult #cancer patients is available on our website: http://t.co/55guqCvLOW","source":"Twitter Web Client","id":"375180140411498496","entities":{"hashtags":[{"start":13,"end":21,"tag":"Lonquex"},{"start":23,"end":39,"tag":"lipegfilgrastim"},{"start":45,"end":57,"tag":"neutropenia"},{"start":67,"end":74,"tag":"cancer"}],"urls":[{"start":113,"end":135,"url":"http://t.co/55guqCvLOW","expanded_url":"http://bit.ly/14fKBkv","display_url":"bit.ly/14fKBkv"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-04T08:54:50.000Z","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"374910685206945793","author_id":"116716199","possibly_sensitive":false,"text":"@Kanario85 @felem Por favor enviar su consulta a @AEMPSGOB, que debe ser capaz de ayudarle.","source":"TweetDeck","id":"375178566176350208","entities":{"hashtags":{},"urls":{},"mentions":[{"start":0,"end":10,"username":"Kanario85","id":"1277009732"},{"start":11,"end":17,"username":"felem","id":"3992952375"},{"start":49,"end":58,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"lang":"es","created_at":"2013-09-04T08:48:35.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"375057575257337856"}],"in_reply_to_user_id":"1277009732","attachments":{"media_keys":{}}},{"conversation_id":"375177406002495488","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: Haven't submitted abstract for #ESCAIDE 2013? Call for late breaker abstracts will be open between 9-24 September: http://t.co…","source":"TweetDeck","id":"375177406002495488","entities":{"hashtags":[{"start":44,"end":52,"tag":"ESCAIDE"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","created_at":"2013-09-04T08:43:58.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"375172871187742720"}],"attachments":{"media_keys":{}}},{"conversation_id":"375177238301646848","author_id":"116716199","possibly_sensitive":false,"text":"RT @FrancoisMaignen: Draft policy on publication and access to clinical-trial data: 1 month left for comments http://t.co/oHZcRk1PYe #ctdata","source":"TweetDeck","id":"375177238301646848","entities":{"hashtags":[{"start":133,"end":140,"tag":"ctdata"}],"urls":[{"start":110,"end":132,"url":"http://t.co/oHZcRk1PYe","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/08/news_detail_001878.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"lang":"en","created_at":"2013-09-04T08:43:18.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"374921686686388224","author_id":"116716199","possibly_sensitive":false,"text":"We've published the assessment report for #Lojuxta (#lomitapide) for homozygous familial #hypercholesterolaemia: http://t.co/uir1wQBdNn","source":"bitly bitlink","id":"374921686686388224","entities":{"hashtags":[{"start":42,"end":50,"tag":"Lojuxta"},{"start":52,"end":63,"tag":"lomitapide"},{"start":89,"end":111,"tag":"hypercholesterolaemia"}],"urls":[{"start":113,"end":135,"url":"http://t.co/uir1wQBdNn","expanded_url":"http://bit.ly/15vsPup","display_url":"bit.ly/15vsPup"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-03T15:47:50.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"374905504340135936","author_id":"116716199","possibly_sensitive":false,"text":"RT @EUEnvironment: A new EU #biocides regulation entered into force 1 Sept. More on the regulation and how it benefits our health here: htt…","source":"TweetDeck","id":"374905504340135936","entities":{"hashtags":[{"start":28,"end":37,"tag":"biocides"}],"urls":{},"mentions":[{"start":3,"end":17,"username":"EUEnvironment","id":"22362552"}],"annotations":{}},"lang":"en","created_at":"2013-09-03T14:43:32.000Z","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374904486986137600"}],"attachments":{"media_keys":{}}},{"conversation_id":"374902690964578304","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: September is World Alzheimer's Month 2013: http://t.co/mg7bRIIVqO","source":"TweetDeck","id":"374902690964578304","entities":{"hashtags":{},"urls":[{"start":56,"end":78,"url":"http://t.co/mg7bRIIVqO","expanded_url":"http://bit.ly/RQqQ5G","display_url":"bit.ly/RQqQ5G"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":26,"end":40,"probability":0.746,"type":"Other","normalized_text":"World Alzheimer"}]},"lang":"en","created_at":"2013-09-03T14:32:21.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374899298670235648"}],"attachments":{"media_keys":{}}},{"conversation_id":"374902620022145025","author_id":"116716199","possibly_sensitive":false,"text":"RT @myESMO: New Tool Enhances search for Genetic Mutations: search for probability of de novo mutations http://t.co/8cH3xJu5uf #genetics","source":"TweetDeck","id":"374902620022145025","entities":{"hashtags":[{"start":127,"end":136,"tag":"genetics"}],"urls":[{"start":104,"end":126,"url":"http://t.co/8cH3xJu5uf","expanded_url":"http://ow.ly/ovU2l","display_url":"ow.ly/ovU2l"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"lang":"en","created_at":"2013-09-03T14:32:04.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374895913040625664"}],"attachments":{"media_keys":{}}},{"conversation_id":"374888633813434368","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: Better flu vaccine on the horizon http://t.co/6R3LcoJ5AB","source":"TweetDeck","id":"374888633813434368","entities":{"hashtags":{},"urls":[{"start":47,"end":69,"url":"http://t.co/6R3LcoJ5AB","expanded_url":"http://edition.cnn.com/2013/09/03/health/better-flu-vaccine-fauci/index.html?utm_source=twitterfeed&utm_medium=twitter&utm_campaign=Feed%3A+rss%2Fcnn_health+%28RSS%3A+Health%29","display_url":"edition.cnn.com/2013/09/03/hea…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","created_at":"2013-09-03T13:36:30.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374884577279762432"}],"attachments":{"media_keys":{}}},{"conversation_id":"374888165670391808","author_id":"116716199","possibly_sensitive":false,"text":"RT @NICEcomms: NICE responds to article in @thetimes on the cost of developing new drugs \nhttp://t.co/nYf3Jxk7qh","source":"TweetDeck","id":"374888165670391808","entities":{"hashtags":{},"urls":[{"start":90,"end":112,"url":"http://t.co/nYf3Jxk7qh","expanded_url":"http://www.nice.org.uk/newsroom/news/NICERespondsToArticleInTheTimes.jsp","display_url":"nice.org.uk/newsroom/news/…"}],"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"},{"start":43,"end":52,"username":"thetimes","id":"6107422"}],"annotations":{}},"lang":"en","created_at":"2013-09-03T13:34:38.000Z","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374882202825158657"}],"attachments":{"media_keys":{}}},{"conversation_id":"374854276973359104","author_id":"116716199","possibly_sensitive":false,"text":"We've published the assessment report for #Lonquex (#lipegfilgrastim) for #neutropenia in adult #cancer patients: http://t.co/RXTMSxa3jS","source":"bitly bitlink","id":"374854276973359104","entities":{"hashtags":[{"start":42,"end":50,"tag":"Lonquex"},{"start":52,"end":68,"tag":"lipegfilgrastim"},{"start":74,"end":86,"tag":"neutropenia"},{"start":96,"end":103,"tag":"cancer"}],"urls":[{"start":114,"end":136,"url":"http://t.co/RXTMSxa3jS","expanded_url":"http://bit.ly/14fKBkv","display_url":"bit.ly/14fKBkv"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-03T11:19:58.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"374850948897968128","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: WHO guidance note on the prevention and control of #cervical #cancer http://t.co/fnkX7O6veO","source":"TweetDeck","id":"374850948897968128","entities":{"hashtags":[{"start":60,"end":69,"tag":"cervical"},{"start":70,"end":77,"tag":"cancer"}],"urls":[{"start":78,"end":100,"url":"http://t.co/fnkX7O6veO","expanded_url":"http://goo.gl/mKvhN6","display_url":"goo.gl/mKvhN6"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-09-03T11:06:45.000Z","public_metrics":{"retweet_count":72,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374850051811446784"}],"attachments":{"media_keys":{}}},{"conversation_id":"374840221033975808","author_id":"116716199","possibly_sensitive":false,"text":"@pharmatweat Please forward details of the problems to us at http://t.co/81mvfkEvbJ and we will look into it.","source":"TweetDeck","id":"374847673691803649","entities":{"hashtags":{},"urls":[{"start":61,"end":83,"url":"http://t.co/81mvfkEvbJ","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"mentions":[{"start":0,"end":12,"username":"pharmatweat","id":"1725069487"}],"annotations":{}},"lang":"en","created_at":"2013-09-03T10:53:44.000Z","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"374840221033975808"}],"in_reply_to_user_id":"1725069487","attachments":{"media_keys":{}}},{"conversation_id":"374838657544249344","author_id":"116716199","possibly_sensitive":false,"text":"@cooldoc123 Thanks for your message. Please refer to the @EU_Commission for info on the decision-making process: http://t.co/VOX6tkW6Bm","source":"TweetDeck","id":"374844641948205056","entities":{"hashtags":{},"urls":[{"start":113,"end":135,"url":"http://t.co/VOX6tkW6Bm","expanded_url":"http://bit.ly/1dWC2wD","display_url":"bit.ly/1dWC2wD"}],"mentions":[{"start":0,"end":11,"username":"cooldoc123","id":"223692135"},{"start":57,"end":71,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","created_at":"2013-09-03T10:41:41.000Z","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"374838657544249344"}],"in_reply_to_user_id":"223692135","attachments":{"media_keys":{}}},{"conversation_id":"374823759267762176","author_id":"116716199","possibly_sensitive":false,"text":"RT @AlzDisInt: World Alzheimer Month Day 3: By the end of today, 64,800 new people will have dementia. #ajourneyofcaring","source":"TweetDeck","id":"374823759267762176","entities":{"hashtags":[{"start":103,"end":120,"tag":"ajourneyofcaring"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"}],"annotations":[{"start":15,"end":41,"probability":0.2797,"type":"Other","normalized_text":"World Alzheimer Month Day 3"}]},"lang":"en","created_at":"2013-09-03T09:18:42.000Z","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374819571355508736"}],"attachments":{"media_keys":{}}},{"conversation_id":"374560385853956097","author_id":"116716199","possibly_sensitive":false,"text":"@fezziwig2008 The @EU_Commission usually grants a decision within 67 days of our opinion - see question 8 here: http://t.co/GY6RDsMIpV","source":"TweetDeck","id":"374571124820295680","entities":{"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/GY6RDsMIpV","expanded_url":"http://bit.ly/1dI5hFS","display_url":"bit.ly/1dI5hFS"}],"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"},{"start":18,"end":32,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T16:34:50.000Z","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"374562578980020224"}],"in_reply_to_user_id":"376154503","attachments":{"media_keys":{}}},{"conversation_id":"374560385853956097","author_id":"116716199","possibly_sensitive":false,"text":"@fezziwig2008 Alternatively, follow our Herceptin RSS feed: http://t.co/WibaOR4TXu","source":"TweetDeck","id":"374562060476379136","entities":{"hashtags":{},"urls":[{"start":60,"end":82,"url":"http://t.co/WibaOR4TXu","expanded_url":"http://bit.ly/17jahY5","display_url":"bit.ly/17jahY5"}],"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T15:58:48.000Z","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"374561807119425536"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"conversation_id":"374560385853956097","author_id":"116716199","possibly_sensitive":false,"text":"@fezziwig2008 We will update our information on Herceptin after the Commission decision is granted. Keep an eye on http://t.co/VPOTJIMp13.","source":"TweetDeck","id":"374561807119425536","entities":{"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/VPOTJIMp13","expanded_url":"http://bit.ly/1bofovI","display_url":"bit.ly/1bofovI"}],"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T15:57:48.000Z","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"374561391140962304"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"conversation_id":"374560385853956097","author_id":"116716199","possibly_sensitive":false,"text":"@fezziwig2008 Please refer to the @EU_Commission for information on the marketing authorisation: http://t.co/VOX6tkW6Bm","source":"TweetDeck","id":"374561391140962304","entities":{"hashtags":{},"urls":[{"start":97,"end":119,"url":"http://t.co/VOX6tkW6Bm","expanded_url":"http://bit.ly/1dWC2wD","display_url":"bit.ly/1dWC2wD"}],"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"},{"start":34,"end":48,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T15:56:09.000Z","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"374560385853956097"}],"in_reply_to_user_id":"376154503","attachments":{"media_keys":{}}},{"conversation_id":"374558310781161472","author_id":"116716199","possibly_sensitive":false,"text":"RT @EP_Environment: New medicines to display #blacktriangle http://t.co/Cm9aZ8147t lead #MEP @LindaMcAvanMEP","source":"TweetDeck","id":"374558310781161472","entities":{"hashtags":[{"start":45,"end":59,"tag":"blacktriangle"},{"start":88,"end":92,"tag":"MEP"}],"urls":[{"start":60,"end":82,"url":"http://t.co/Cm9aZ8147t","expanded_url":"http://bit.ly/15aEYPg","display_url":"bit.ly/15aEYPg"}],"mentions":[{"start":3,"end":18,"username":"EP_Environment","id":"951333319"},{"start":93,"end":108,"username":"LindaMcAvanMEP","id":"166509226"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T15:43:54.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"374558192652787714","author_id":"116716199","possibly_sensitive":false,"text":"RT @euparkinsons: Early cortical gray matter loss &amp; cognitive correlates in non-demented #Parkinson's patients: http://t.co/NfZksrB3TB","source":"TweetDeck","id":"374558192652787714","entities":{"hashtags":[{"start":93,"end":103,"tag":"Parkinson"}],"urls":[{"start":116,"end":138,"url":"http://t.co/NfZksrB3TB","expanded_url":"http://bit.ly/1dsBjo3","display_url":"bit.ly/1dsBjo3"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T15:43:26.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374547484569112576"}],"attachments":{"media_keys":{}}},{"conversation_id":"374558073219596289","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: September is World #Alzheimer's Month 2013 - find out more http://t.co/89a3juLhu3","source":"TweetDeck","id":"374558073219596289","entities":{"hashtags":[{"start":30,"end":40,"tag":"Alzheimer"}],"urls":[{"start":70,"end":92,"url":"http://t.co/89a3juLhu3","expanded_url":"http://bit.ly/RQqQ5G","display_url":"bit.ly/RQqQ5G"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T15:42:58.000Z","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374542871266725888"}],"attachments":{"media_keys":{}}},{"conversation_id":"374557921642053632","author_id":"116716199","possibly_sensitive":false,"text":"RT @UNAIDS: Thai-US partnership confirms renewed push on #HIV vaccine http://t.co/cfxT5MAiEm","source":"TweetDeck","id":"374557921642053632","entities":{"hashtags":[{"start":57,"end":61,"tag":"HIV"}],"urls":[{"start":70,"end":92,"url":"http://t.co/cfxT5MAiEm","expanded_url":"http://ow.ly/otSOM","display_url":"ow.ly/otSOM"}],"mentions":[{"start":3,"end":10,"username":"UNAIDS","id":"19177501"}],"annotations":[{"start":12,"end":18,"probability":0.5429,"type":"Organization","normalized_text":"Thai-US"}]},"lang":"en","created_at":"2013-09-02T15:42:22.000Z","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374540610541457408"}],"attachments":{"media_keys":{}}},{"conversation_id":"374557754650005504","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: New legislation Reg. (EU) No 528/2012 on biocides enters into force today. http://t.co/KBoCTCwYL0","source":"TweetDeck","id":"374557754650005504","entities":{"hashtags":{},"urls":[{"start":88,"end":110,"url":"http://t.co/KBoCTCwYL0","expanded_url":"http://bit.ly/15m40Lg","display_url":"bit.ly/15m40Lg"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T15:41:42.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374539779515633664"}],"attachments":{"media_keys":{}}},{"conversation_id":"374557663826567169","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: Today new rules from Regulation (EU) No 528/2012 concerning biocidal products came into force: http://t.co/YSjvvk6TMu","source":"TweetDeck","id":"374557663826567169","entities":{"hashtags":{},"urls":[{"start":108,"end":130,"url":"http://t.co/YSjvvk6TMu","expanded_url":"http://fb.me/6sGBKUo6p","display_url":"fb.me/6sGBKUo6p"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T15:41:20.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"374538782089179136","author_id":"116716199","possibly_sensitive":false,"text":"RT @EP_Environment: New legislation on #biocides enters into force today. Lead #MEP Krista Klass (EPP, DE) http://t.co/wspi0TFO8K","source":"Twitter for iPhone","id":"374538782089179136","entities":{"hashtags":[{"start":39,"end":48,"tag":"biocides"},{"start":79,"end":83,"tag":"MEP"}],"urls":[{"start":107,"end":129,"url":"http://t.co/wspi0TFO8K","expanded_url":"http://bit.ly/15m40Lg","display_url":"bit.ly/15m40Lg"}],"mentions":[{"start":3,"end":18,"username":"EP_Environment","id":"951333319"}],"annotations":[{"start":84,"end":95,"probability":0.951,"type":"Person","normalized_text":"Krista Klass"}]},"lang":"en","created_at":"2013-09-02T14:26:18.000Z","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374537118623604738"}],"attachments":{"media_keys":{}}},{"conversation_id":"374530764496732160","author_id":"116716199","possibly_sensitive":false,"text":"RT @beuctweet: Welcomed #blacktriangle label on drugs will be effective only if consumers know what it means and report side effects http:/…","source":"TweetDeck","id":"374530764496732160","entities":{"hashtags":[{"start":24,"end":38,"tag":"blacktriangle"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"beuctweet","id":"3061421219"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T13:54:27.000Z","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374530603850285057"}],"attachments":{"media_keys":{}}},{"conversation_id":"374526810513752064","author_id":"116716199","possibly_sensitive":false,"text":"RT @agesnews: Veterinary annual report 2012 - Details of animal health in Austria including bees on @SlideShare http://t.co/UPNpvjiQBr","source":"TweetDeck","id":"374526810513752064","entities":{"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/UPNpvjiQBr","expanded_url":"http://issuu.com/agesnews/docs/vet_jb_2012","display_url":"issuu.com/agesnews/docs/…"}],"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"},{"start":100,"end":111,"username":"SlideShare","id":"9676152"}],"annotations":[{"start":74,"end":80,"probability":0.9958,"type":"Place","normalized_text":"Austria"}]},"lang":"en","created_at":"2013-09-02T13:38:44.000Z","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"374493041375313920","author_id":"116716199","possibly_sensitive":false,"text":"RT @LV_MPA: Now it's less than three weeks left to #uppsalabio and the Swedish medicines agency meeting in Uppsala http://t.co/JlddmpiyH1","source":"TweetDeck","id":"374493041375313920","entities":{"hashtags":[{"start":51,"end":62,"tag":"uppsalabio"}],"urls":[{"start":115,"end":137,"url":"http://t.co/JlddmpiyH1","expanded_url":"http://bit.ly/19sf9ki","display_url":"bit.ly/19sf9ki"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":[{"start":107,"end":113,"probability":0.4667,"type":"Place","normalized_text":"Uppsala"}]},"lang":"en","created_at":"2013-09-02T11:24:33.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"374490621706522624","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: Information on the new regulations for monitoring the safety of medicines in force from 1 September http://t.co/dT01bpH1nL","source":"TweetDeck","id":"374490621706522624","entities":{"hashtags":{},"urls":[{"start":113,"end":135,"url":"http://t.co/dT01bpH1nL","expanded_url":"http://www.urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-z-dnia-2-wrzesnia-2013-w-zwiazku-z-wejsciem-w-zycie-od-dnia-1-wrzesnia-br-nowych-regulacji-w-zakresie-monitorowania-bezpiecz","display_url":"urpl.gov.pl/aktualnosci/in…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T11:14:56.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"374490157246078976","author_id":"116716199","possibly_sensitive":false,"text":"RT @EUombudsman: \"EU #transparency: Where are we now?\" Register for the @EUombudsman event on 27 Sept./Right to Know Day #11rtkdEO @ http:/…","source":"TweetDeck","id":"374490157246078976","entities":{"hashtags":[{"start":21,"end":34,"tag":"transparency"},{"start":121,"end":130,"tag":"11rtkdEO"}],"urls":{},"mentions":[{"start":3,"end":15,"username":"EUombudsman","id":"873777758"},{"start":72,"end":84,"username":"EUombudsman","id":"873777758"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T11:13:05.000Z","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374473670237765632"}],"attachments":{"media_keys":{}}},{"conversation_id":"374490096881655808","author_id":"116716199","possibly_sensitive":false,"text":"RT @EU_ECHA: The Biocidal Products Regulation entered into operation yesterday. Are you familiar with the changes?","source":"TweetDeck","id":"374490096881655808","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":[{"start":17,"end":44,"probability":0.3763,"type":"Organization","normalized_text":"Biocidal Products Regulation"}]},"lang":"en","created_at":"2013-09-02T11:12:51.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374473617255317504"}],"attachments":{"media_keys":{}}},{"conversation_id":"374468464582590464","author_id":"116716199","possibly_sensitive":false,"text":"RT @Aifa_ufficiale: Important information on risperidone and paliperidone from the Italian medicines agency... http://t.co/hgHJd2gBIo","source":"TweetDeck","id":"374468464582590464","entities":{"hashtags":{},"urls":[{"start":111,"end":133,"url":"http://t.co/hgHJd2gBIo","expanded_url":"http://fb.me/Z3cnUM2g","display_url":"fb.me/Z3cnUM2g"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T09:46:53.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"374467745188163584","author_id":"116716199","possibly_sensitive":false,"text":"RT @Aifa_ufficiale: Important information on medicines containing #risperidone and #paliperidone from #AIFA: http://t.co/K1qYtMATVO","source":"TweetDeck","id":"374467745188163584","entities":{"hashtags":[{"start":66,"end":78,"tag":"risperidone"},{"start":83,"end":96,"tag":"paliperidone"},{"start":102,"end":107,"tag":"AIFA"}],"urls":[{"start":109,"end":131,"url":"http://t.co/K1qYtMATVO","expanded_url":"http://www.agenziafarmaco.gov.it/sites/default/files/IT%20-DHPC%20risperidone%20paliperidone%20Clean%20AIFA.pdf","display_url":"agenziafarmaco.gov.it/sites/default/…"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T09:44:02.000Z","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"374467317188796417","author_id":"116716199","possibly_sensitive":false,"text":"RT @URPLWMiPB: The #blacktriangle symbol does not mean that the use of these medicines is subject to greater risk.","source":"TweetDeck","id":"374467317188796417","entities":{"hashtags":[{"start":19,"end":33,"tag":"blacktriangle"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T09:42:20.000Z","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"374465142161145856","author_id":"116716199","possibly_sensitive":false,"text":"RT @URPLWMiPB:Information on the new regulations for monitoring the safety of medicines in force from 1 September http://t.co/dT01bpH1nL","source":"TweetDeck","id":"374465142161145856","entities":{"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/dT01bpH1nL","expanded_url":"http://www.urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-z-dnia-2-wrzesnia-2013-w-zwiazku-z-wejsciem-w-zycie-od-dnia-1-wrzesnia-br-nowych-regulacji-w-zakresie-monitorowania-bezpiecz","display_url":"urpl.gov.pl/aktualnosci/in…"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T09:33:41.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"374464642586005504","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: Information on medicine package leaflets marked with an inverted #blacktriangle: http://t.co/dT01bpH1nL http://t.co/FFSSRuQzil","source":"TweetDeck","id":"374464642586005504","entities":{"hashtags":[{"start":78,"end":92,"tag":"blacktriangle"}],"urls":[{"start":94,"end":116,"url":"http://t.co/dT01bpH1nL","expanded_url":"http://www.urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-z-dnia-2-wrzesnia-2013-w-zwiazku-z-wejsciem-w-zycie-od-dnia-1-wrzesnia-br-nowych-regulacji-w-zakresie-monitorowania-bezpiecz","display_url":"urpl.gov.pl/aktualnosci/in…"},{"start":117,"end":139,"url":"http://t.co/FFSSRuQzil","expanded_url":"https://twitter.com/GCessak/status/374463545846398976/photo/1","display_url":"pic.twitter.com/FFSSRuQzil"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T09:31:42.000Z","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":["3_374463545854787585"]}},{"conversation_id":"374464378961403904","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: 'Self-Expiring Label Wins Design Award' - interesting news relating to medicines #packaging #safety http://t.co/QOZChWhLlu","source":"TweetDeck","id":"374464378961403904","entities":{"hashtags":[{"start":92,"end":102,"tag":"packaging"},{"start":103,"end":110,"tag":"safety"}],"urls":[{"start":111,"end":133,"url":"http://t.co/QOZChWhLlu","expanded_url":"http://bit.ly/174AeKD","display_url":"bit.ly/174AeKD"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T09:30:39.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374463187384430592"}],"attachments":{"media_keys":{}}},{"conversation_id":"374458718236450816","author_id":"116716199","possibly_sensitive":false,"text":"RT @EURLex: New ways to apply for approval of #biocidal substances - via ECHA, #EU-wide authorisation, simplifications... http://t.co/aSB9u…","source":"TweetDeck","id":"374458718236450816","entities":{"hashtags":[{"start":46,"end":55,"tag":"biocidal"},{"start":79,"end":82,"tag":"EU"}],"urls":{},"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T09:08:10.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374458526313103360"}],"attachments":{"media_keys":{}}},{"conversation_id":"374458685583802368","author_id":"116716199","possibly_sensitive":false,"text":"RT @EURLex: #EU regulation 528/2012 re making available and use of #biocidal products applies from the 1st of Sept http://t.co/BU0JiMYBMo","source":"TweetDeck","id":"374458685583802368","entities":{"hashtags":[{"start":12,"end":15,"tag":"EU"},{"start":67,"end":76,"tag":"biocidal"}],"urls":[{"start":115,"end":137,"url":"http://t.co/BU0JiMYBMo","expanded_url":"http://goo.gl/75luud","display_url":"goo.gl/75luud"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"annotations":{}},"lang":"en","created_at":"2013-09-02T09:08:02.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"374456709571293184"}],"attachments":{"media_keys":{}}},{"conversation_id":"374449907202916352","author_id":"116716199","possibly_sensitive":false,"text":"There's only one month left to comment on our draft policy on publication and access to clinical-trial data: http://t.co/sFSiCS8QRo #ctdata","source":"Twitter Web Client","id":"374449907202916352","entities":{"hashtags":[{"start":132,"end":139,"tag":"ctdata"}],"urls":[{"start":109,"end":131,"url":"http://t.co/sFSiCS8QRo","expanded_url":"http://bit.ly/1a5o0JV","display_url":"bit.ly/1a5o0JV"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-09-02T08:33:09.000Z","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373482490121711616","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: Latest on Middle East respiratory syndrome http://t.co/cuGrltAO4Q (30 August 2013) #MERS","source":"TweetDeck","id":"373482490121711616","entities":{"hashtags":[{"start":92,"end":97,"tag":"MERS"}],"urls":[{"start":52,"end":74,"url":"http://t.co/cuGrltAO4Q","expanded_url":"http://goo.gl/Ud6qwa","display_url":"goo.gl/Ud6qwa"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":19,"end":29,"probability":0.2705,"type":"Place","normalized_text":"Middle East"}]},"lang":"en","created_at":"2013-08-30T16:28:59.000Z","public_metrics":{"retweet_count":51,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373478293745729536"}],"attachments":{"media_keys":{}}},{"conversation_id":"373482448426123264","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: WHO has been informed of an additional 4 lab-confirmed cases of Middle East respiratory syndrome coronavirus infection in Saudi Ar…","source":"TweetDeck","id":"373482448426123264","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":131,"end":138,"probability":0.5303,"type":"Place","normalized_text":"Saudi Ar"}]},"lang":"en","created_at":"2013-08-30T16:28:49.000Z","public_metrics":{"retweet_count":81,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373471441762537472"}],"attachments":{"media_keys":{}}},{"conversation_id":"373482419888095232","author_id":"116716199","possibly_sensitive":false,"text":"RT @DrugInfoAssn: FDA issues guidance on #clinicaltrial rules compliance #FDA http://t.co/gefWinwnU9","source":"TweetDeck","id":"373482419888095232","entities":{"hashtags":[{"start":41,"end":55,"tag":"clinicaltrial"},{"start":73,"end":77,"tag":"FDA"}],"urls":[{"start":78,"end":100,"url":"http://t.co/gefWinwnU9","expanded_url":"http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM328855.pdf","display_url":"fda.gov/downloads/Regu…"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":[{"start":18,"end":20,"probability":0.8549,"type":"Organization","normalized_text":"FDA"}]},"lang":"en","created_at":"2013-08-30T16:28:42.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373469845817286656"}],"attachments":{"media_keys":{}}},{"conversation_id":"373460575093018624","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: Globally, from Sept 2012 to date, WHO has been informed of a total of 108 lab-confirmed cases of infection with #MERS-CoV, incl 50…","source":"TweetDeck","id":"373460575093018624","entities":{"hashtags":[{"start":121,"end":126,"tag":"MERS"}],"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T15:01:54.000Z","public_metrics":{"retweet_count":48,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373460517987184640"}],"attachments":{"media_keys":{}}},{"conversation_id":"373460558663917569","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: WHO has been informed of an additional four laboratory-confirmed cases of  #MERS-CoV infection in Saudi Arabia.","source":"TweetDeck","id":"373460558663917569","entities":{"hashtags":[{"start":84,"end":89,"tag":"MERS"}],"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":107,"end":118,"probability":0.9291,"type":"Place","normalized_text":"Saudi Arabia"}]},"lang":"en","created_at":"2013-08-30T15:01:50.000Z","public_metrics":{"retweet_count":42,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373460278211399680"}],"attachments":{"media_keys":{}}},{"conversation_id":"373457718419677184","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: How can you recognize #opioid #overdose? Small pupils, unconsciousness, a respiratory rate which is visibly slowed http://t.co/V5M…","source":"TweetDeck","id":"373457718419677184","entities":{"hashtags":[{"start":31,"end":38,"tag":"opioid"},{"start":39,"end":48,"tag":"overdose"}],"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T14:50:33.000Z","public_metrics":{"retweet_count":62,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373457620192870400"}],"attachments":{"media_keys":{}}},{"conversation_id":"373453683771441152","author_id":"116716199","possibly_sensitive":false,"text":"Our workshop 'best expertise vs #conflictsofinterests: striking the right balance' is next week: http://t.co/qxCGPU3xUo  #coiworkshop","source":"Twitter Web Client","id":"373453683771441152","entities":{"hashtags":[{"start":32,"end":53,"tag":"conflictsofinterests"},{"start":121,"end":133,"tag":"coiworkshop"}],"urls":[{"start":97,"end":119,"url":"http://t.co/qxCGPU3xUo","expanded_url":"http://bit.ly/1f6tUr9","display_url":"bit.ly/1f6tUr9"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-30T14:34:31.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373453519082110977","author_id":"116716199","possibly_sensitive":false,"text":"Next week is the September meeting of the #Pharmacovigilance Risk Assessment Committee (#PRAC); highlights on Friday: http://t.co/di0lqhsXtK","source":"Twitter Web Client","id":"373453519082110977","entities":{"hashtags":[{"start":42,"end":60,"tag":"Pharmacovigilance"},{"start":88,"end":93,"tag":"PRAC"}],"urls":[{"start":118,"end":140,"url":"http://t.co/di0lqhsXtK","expanded_url":"http://bit.ly/1fnUQCH","display_url":"bit.ly/1fnUQCH"}],"mentions":{},"annotations":[{"start":61,"end":85,"probability":0.475,"type":"Other","normalized_text":"Risk Assessment Committee"}]},"lang":"en","created_at":"2013-08-30T14:33:52.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373453266673094657","author_id":"116716199","possibly_sensitive":false,"text":"Two weeks left to comment on our draft Community #herbal monograph on #Curcuma xanthorrhiza (#Javaneseturmeric): http://t.co/4g7RAIt9qa","source":"Twitter Web Client","id":"373453266673094657","entities":{"hashtags":[{"start":49,"end":56,"tag":"herbal"},{"start":70,"end":78,"tag":"Curcuma"},{"start":93,"end":110,"tag":"Javaneseturmeric"}],"urls":[{"start":113,"end":135,"url":"http://t.co/4g7RAIt9qa","expanded_url":"http://bit.ly/1a5aypw","display_url":"bit.ly/1a5aypw"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-30T14:32:51.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373453072162643968","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: Efpia blog: A Roadmap for Sharing Clinical Trial Data - August 27 event #ctdata http://t.co/D4n24nVCRx","source":"TweetDeck","id":"373453072162643968","entities":{"hashtags":[{"start":83,"end":90,"tag":"ctdata"}],"urls":[{"start":91,"end":113,"url":"http://t.co/D4n24nVCRx","expanded_url":"http://bit.ly/17qJ5Zz","display_url":"bit.ly/17qJ5Zz"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T14:32:05.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373452979799883777"}],"attachments":{"media_keys":{}}},{"conversation_id":"373452923922952192","author_id":"116716199","possibly_sensitive":false,"text":"Just a few more days to comment on our concept paper on updating guidance on venous thromboembolic (#VTE) disease: http://t.co/6mZIJI1xz1","source":"Twitter Web Client","id":"373452923922952192","entities":{"hashtags":[{"start":100,"end":104,"tag":"VTE"}],"urls":[{"start":115,"end":137,"url":"http://t.co/6mZIJI1xz1","expanded_url":"http://bit.ly/11QCCrK","display_url":"bit.ly/11QCCrK"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-30T14:31:30.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373452730016092160","author_id":"116716199","possibly_sensitive":false,"text":"Two more weeks to comment on our draft Community #herbal monograph on #Rubus idaeus (#raspberry leaf): http://t.co/QxhxYsNDUE","source":"Twitter Web Client","id":"373452730016092160","entities":{"hashtags":[{"start":49,"end":56,"tag":"herbal"},{"start":70,"end":76,"tag":"Rubus"},{"start":85,"end":95,"tag":"raspberry"}],"urls":[{"start":103,"end":125,"url":"http://t.co/QxhxYsNDUE","expanded_url":"http://bit.ly/1dsTkTo","display_url":"bit.ly/1dsTkTo"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-30T14:30:43.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373448953712623616","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: #WestNile fever: Newly affected areas &amp; highest number of cases in EU, 2013: http://t.co/UWKpvidcrC. see infographic http://t.…","source":"TweetDeck","id":"373448953712623616","entities":{"hashtags":[{"start":13,"end":22,"tag":"WestNile"}],"urls":[{"start":94,"end":116,"url":"http://t.co/UWKpvidcrC","expanded_url":"http://bit.ly/QijONt","display_url":"bit.ly/QijONt"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":80,"end":81,"probability":0.6647,"type":"Place","normalized_text":"EU"}]},"lang":"en","created_at":"2013-08-30T14:15:43.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373448905033125890"}],"attachments":{"media_keys":{}}},{"conversation_id":"373448271370674177","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: Non-fatal opioid overdose can contribute to health conditions such as pneumonia, cerebral hypoxia, cardiac arrhythmia http://t.co/…","source":"TweetDeck","id":"373448271370674177","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T14:13:00.000Z","public_metrics":{"retweet_count":54,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373448189975621633"}],"attachments":{"media_keys":{}}},{"conversation_id":"373448238445391872","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: #WestNile fever weekly update: 26 reported cases in the #EU, with new areas affected: http://t.co/ScpAa6rPKx","source":"TweetDeck","id":"373448238445391872","entities":{"hashtags":[{"start":13,"end":22,"tag":"WestNile"},{"start":69,"end":72,"tag":"EU"}],"urls":[{"start":99,"end":121,"url":"http://t.co/ScpAa6rPKx","expanded_url":"http://bit.ly/QijONt","display_url":"bit.ly/QijONt"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T14:12:53.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373448142420967424"}],"attachments":{"media_keys":{}}},{"conversation_id":"373447618598555649","author_id":"116716199","possibly_sensitive":false,"text":"RT @FDAanimalhealth: Updated Minor Use/Minor Species Drug Designations List now available online http://t.co/V5TtYnuGFu","source":"TweetDeck","id":"373447618598555649","entities":{"hashtags":{},"urls":[{"start":97,"end":119,"url":"http://t.co/V5TtYnuGFu","expanded_url":"http://1.usa.gov/12ThmB1","display_url":"1.usa.gov/12ThmB1"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T14:10:25.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373447395993874432"}],"attachments":{"media_keys":{}}},{"conversation_id":"373438773792481280","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: If #opioids are used for non-medical purposes, or not as prescribed by doctors, or without proper medical supervision, they can ca…","source":"TweetDeck","id":"373438773792481280","entities":{"hashtags":[{"start":12,"end":20,"tag":"opioids"}],"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T13:35:16.000Z","public_metrics":{"retweet_count":75,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373438678858600449"}],"attachments":{"media_keys":{}}},{"conversation_id":"373438467130527744","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: This Week's EFPIA Newsletter (not to be missed!) http://t.co/GWJyMpySwV #ctdata #commitments #clinicaltrials","source":"TweetDeck","id":"373438467130527744","entities":{"hashtags":[{"start":83,"end":90,"tag":"ctdata"},{"start":91,"end":103,"tag":"commitments"},{"start":104,"end":119,"tag":"clinicaltrials"}],"urls":[{"start":60,"end":82,"url":"http://t.co/GWJyMpySwV","expanded_url":"http://bit.ly/12T94sW","display_url":"bit.ly/12T94sW"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T13:34:03.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373437113607258112"}],"attachments":{"media_keys":{}}},{"conversation_id":"373431164692090880","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: Some opioids are used as #medicines to treat #pain and to treat opioid dependence which is a chronic disease http://t.co/V5MeNms746","source":"TweetDeck","id":"373431164692090880","entities":{"hashtags":[{"start":34,"end":44,"tag":"medicines"},{"start":54,"end":59,"tag":"pain"}],"urls":[{"start":118,"end":140,"url":"http://t.co/V5MeNms746","expanded_url":"http://goo.gl/qjU4Ml","display_url":"goo.gl/qjU4Ml"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T13:05:02.000Z","public_metrics":{"retweet_count":35,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373431114804629505"}],"attachments":{"media_keys":{}}},{"conversation_id":"373430888165826560","author_id":"116716199","possibly_sensitive":false,"text":"One month left to comment on our draft policy on publication and access to clinical-trial data: http://t.co/00m59qdVg2 #ctdata","source":"bitly bitlink","id":"373430888165826560","entities":{"hashtags":[{"start":119,"end":126,"tag":"ctdata"}],"urls":[{"start":96,"end":118,"url":"http://t.co/00m59qdVg2","expanded_url":"http://bit.ly/1a5o0JV","display_url":"bit.ly/1a5o0JV"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-30T13:03:56.000Z","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373428947947892736","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFSA_EU: Upcoming deadline 31 August #EFSA consults on the draft Scientific Opinion on Dietary Reference Values for #vitaminC. http://t…","source":"TweetDeck","id":"373428947947892736","entities":{"hashtags":[{"start":41,"end":46,"tag":"EFSA"},{"start":120,"end":129,"tag":"vitaminC"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T12:56:13.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373428879307706370"}],"attachments":{"media_keys":{}}},{"conversation_id":"373425065783988224","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: Opioids: compounds incl #morphine, heroin, methadone that can influence people’s perceptions of pain, induce euphoria http://t.co/…","source":"TweetDeck","id":"373425065783988224","entities":{"hashtags":[{"start":33,"end":42,"tag":"morphine"}],"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T12:40:48.000Z","public_metrics":{"retweet_count":49,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373424871184666625"}],"attachments":{"media_keys":{}}},{"conversation_id":"373424950696505344","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: Each year, about 70,000-100,000 people die from #opioid #overdose which can be prevented and treated http://t.co/V5MeNms746","source":"TweetDeck","id":"373424950696505344","entities":{"hashtags":[{"start":57,"end":64,"tag":"opioid"},{"start":65,"end":74,"tag":"overdose"}],"urls":[{"start":110,"end":132,"url":"http://t.co/V5MeNms746","expanded_url":"http://goo.gl/qjU4Ml","display_url":"goo.gl/qjU4Ml"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T12:40:20.000Z","public_metrics":{"retweet_count":106,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373422553248710657"}],"attachments":{"media_keys":{}}},{"conversation_id":"373422280225095680","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: If you following EU health issues, then also follow Commissioner Tonio Borg #FF @borgton, new on Twitter.","source":"TweetDeck","id":"373422280225095680","entities":{"hashtags":[{"start":89,"end":92,"tag":"FF"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"},{"start":93,"end":101,"username":"borgton","id":"1605512862"}],"annotations":[{"start":30,"end":31,"probability":0.487,"type":"Organization","normalized_text":"EU"},{"start":65,"end":87,"probability":0.7036,"type":"Person","normalized_text":"Commissioner Tonio Borg"},{"start":110,"end":116,"probability":0.5874,"type":"Product","normalized_text":"Twitter"}]},"lang":"en","created_at":"2013-08-30T12:29:44.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373422173332844546"}],"attachments":{"media_keys":{}}},{"conversation_id":"373414548604481536","author_id":"116716199","possibly_sensitive":false,"text":"@fezziwig2008 However, it may take us 15 days to publish all of the updated information on our website after the decision is granted.","source":"TweetDeck","id":"373420933937389568","entities":{"hashtags":{},"urls":{},"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T12:24:23.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"373420505099161601"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"conversation_id":"373414548604481536","author_id":"116716199","possibly_sensitive":false,"text":"@fezziwig2008 Once the @eu_commission has granted a positive opinion, the marketing-authorisation holder can start to market.","source":"TweetDeck","id":"373420505099161601","entities":{"hashtags":{},"urls":{},"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"},{"start":23,"end":37,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T12:22:40.000Z","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"373419694512148480"}],"in_reply_to_user_id":"376154503","attachments":{"media_keys":{}}},{"conversation_id":"373414548604481536","author_id":"116716199","possibly_sensitive":false,"text":"@fezziwig2008 The @EU_Commission register of medicinal products is at http://t.co/VOX6tkW6Bm. It includes a list of recent decisions.","source":"TweetDeck","id":"373418975591690240","entities":{"hashtags":{},"urls":[{"start":70,"end":92,"url":"http://t.co/VOX6tkW6Bm","expanded_url":"http://bit.ly/1dWC2wD","display_url":"bit.ly/1dWC2wD"}],"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"},{"start":18,"end":32,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T12:16:36.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"373418626113888256"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"conversation_id":"373414548604481536","author_id":"116716199","possibly_sensitive":false,"text":"@fezziwig2008 We aim to publish updates within 15 days of the decision from the @EU_Commission: http://t.co/MaxNF3ugp7","source":"TweetDeck","id":"373418626113888256","entities":{"hashtags":{},"urls":[{"start":96,"end":118,"url":"http://t.co/MaxNF3ugp7","expanded_url":"http://bit.ly/17r9vdH","display_url":"bit.ly/17r9vdH"}],"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"},{"start":80,"end":94,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T12:15:12.000Z","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"373414548604481536"}],"in_reply_to_user_id":"376154503","attachments":{"media_keys":{}}},{"conversation_id":"373413586347253760","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: New medicines to display #blacktriangle from September 1st http://t.co/ijqgJoIfNY via @EP_Environment","source":"TweetDeck","id":"373413586347253760","entities":{"hashtags":[{"start":38,"end":52,"tag":"blacktriangle"}],"urls":[{"start":72,"end":94,"url":"http://t.co/ijqgJoIfNY","expanded_url":"http://www.europarl.europa.eu/news/en/pressroom/content/20130830IPR18304/html/New-medicines-to-display-black-triangle-from-September-1st","display_url":"europarl.europa.eu/news/en/pressr…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"},{"start":99,"end":114,"username":"EP_Environment","id":"951333319"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T11:55:11.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373411661551788032","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO_Europe: On agenda for #RC63Izmir vector-borne diseases, mental health action plan, accel. action plan for #measles &amp; #rubella http:…","source":"TweetDeck","id":"373411661551788032","entities":{"hashtags":[{"start":30,"end":40,"tag":"RC63Izmir"},{"start":114,"end":122,"tag":"measles"},{"start":129,"end":137,"tag":"rubella"}],"urls":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T11:47:32.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373411033588592640"}],"attachments":{"media_keys":{}}},{"conversation_id":"373410741144928256","author_id":"116716199","possibly_sensitive":false,"text":"One week until our workshop 'best expertise vs #conflictsofinterests: striking the right balance': http://t.co/qxCGPU3xUo #coiworkshop","source":"Twitter Web Client","id":"373410741144928256","entities":{"hashtags":[{"start":47,"end":68,"tag":"conflictsofinterests"},{"start":122,"end":134,"tag":"coiworkshop"}],"urls":[{"start":99,"end":121,"url":"http://t.co/qxCGPU3xUo","expanded_url":"http://bit.ly/1f6tUr9","display_url":"bit.ly/1f6tUr9"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-30T11:43:52.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373410538493321216","author_id":"116716199","possibly_sensitive":false,"text":"Our #Pharmacovigilance Risk Assessment Committee (#PRAC) is meeting next week; publishing the highlights on Friday: http://t.co/xuoMhEGJdA","source":"bitly bitlink","id":"373410538493321216","entities":{"hashtags":[{"start":4,"end":22,"tag":"Pharmacovigilance"},{"start":50,"end":55,"tag":"PRAC"}],"urls":[{"start":116,"end":138,"url":"http://t.co/xuoMhEGJdA","expanded_url":"http://bit.ly/1fnUQCH","display_url":"bit.ly/1fnUQCH"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-30T11:43:04.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373409782025420800","author_id":"116716199","possibly_sensitive":false,"text":"Two more weeks to comment on our draft Community #herbal monograph on #Curcuma xanthorrhiza (#Javaneseturmeric): http://t.co/gxKz3GddI3","source":"bitly bitlink","id":"373409782025420800","entities":{"hashtags":[{"start":49,"end":56,"tag":"herbal"},{"start":70,"end":78,"tag":"Curcuma"},{"start":93,"end":110,"tag":"Javaneseturmeric"}],"urls":[{"start":113,"end":135,"url":"http://t.co/gxKz3GddI3","expanded_url":"http://bit.ly/1a5aypw","display_url":"bit.ly/1a5aypw"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-30T11:40:04.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373409259637051392","author_id":"116716199","possibly_sensitive":false,"text":"Last few days to comment on our concept paper on updating our guidance on venous thromboembolic (#VTE) disease: http://t.co/6mZIJI1xz1","source":"Twitter Web Client","id":"373409259637051392","entities":{"hashtags":[{"start":97,"end":101,"tag":"VTE"}],"urls":[{"start":112,"end":134,"url":"http://t.co/6mZIJI1xz1","expanded_url":"http://bit.ly/11QCCrK","display_url":"bit.ly/11QCCrK"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-30T11:37:59.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373408863728705536","author_id":"116716199","possibly_sensitive":false,"text":"Two weeks left to comment on our draft Community #herbal monograph on #Rubus idaeus (#raspberry leaf): http://t.co/ssdnsgU6gH","source":"bitly bitlink","id":"373408863728705536","entities":{"hashtags":[{"start":49,"end":56,"tag":"herbal"},{"start":70,"end":76,"tag":"Rubus"},{"start":85,"end":95,"tag":"raspberry"}],"urls":[{"start":103,"end":125,"url":"http://t.co/ssdnsgU6gH","expanded_url":"http://bit.ly/1dsTkTo","display_url":"bit.ly/1dsTkTo"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-30T11:36:25.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373407818185199616","author_id":"116716199","possibly_sensitive":false,"text":"RT @euparkinsons: Therapeutic prospects 4 #Parkinson's disease: http://t.co/LR70l25ptl","source":"TweetDeck","id":"373407818185199616","entities":{"hashtags":[{"start":42,"end":52,"tag":"Parkinson"}],"urls":[{"start":64,"end":86,"url":"http://t.co/LR70l25ptl","expanded_url":"http://bit.ly/192euCN","display_url":"bit.ly/192euCN"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T11:32:16.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373384784698822658"}],"attachments":{"media_keys":{}}},{"conversation_id":"373407706369236992","author_id":"116716199","possibly_sensitive":false,"text":"RT @Legemiddelinfo: National electronic drug records will improve patient safety: http://t.co/P1JgPpFrsr","source":"TweetDeck","id":"373407706369236992","entities":{"hashtags":{},"urls":[{"start":82,"end":104,"url":"http://t.co/P1JgPpFrsr","expanded_url":"http://bit.ly/17qfmni","display_url":"bit.ly/17qfmni"}],"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T11:31:49.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373407343670992896","author_id":"116716199","possibly_sensitive":false,"text":"RT @EP_Environment: New medicines to display #blacktriangle from September http://t.co/Cm9aZ8147t lead MEP @LindaMcAvanMEP","source":"TweetDeck","id":"373407343670992896","entities":{"hashtags":[{"start":45,"end":59,"tag":"blacktriangle"}],"urls":[{"start":75,"end":97,"url":"http://t.co/Cm9aZ8147t","expanded_url":"http://bit.ly/15aEYPg","display_url":"bit.ly/15aEYPg"}],"mentions":[{"start":3,"end":18,"username":"EP_Environment","id":"951333319"},{"start":107,"end":122,"username":"LindaMcAvanMEP","id":"166509226"}],"annotations":{}},"lang":"en","created_at":"2013-08-30T11:30:22.000Z","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373377159798480896","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: What is #WestNile fever, how is it transmitted, how ECDC maps help to manage #WestNile risk in Europe. Watch video: http://t.c…","source":"TweetDeck","id":"373377159798480896","entities":{"hashtags":[{"start":21,"end":30,"tag":"WestNile"},{"start":90,"end":99,"tag":"WestNile"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":108,"end":113,"probability":0.9731,"type":"Place","normalized_text":"Europe"}]},"lang":"en","created_at":"2013-08-30T09:30:26.000Z","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373375532953399296"}],"attachments":{"media_keys":{}}},{"conversation_id":"373112556149547008","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: Fresh out from Efpia's blog: EFPIA-PhRMA Commitments: Breaking Down the Basics of Commitment 3 http://t.co/QMhdwKfmL8  #ctdata","source":"TweetDeck","id":"373112556149547008","entities":{"hashtags":[{"start":130,"end":137,"tag":"ctdata"}],"urls":[{"start":106,"end":128,"url":"http://t.co/QMhdwKfmL8","expanded_url":"http://bit.ly/157IOZl","display_url":"bit.ly/157IOZl"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":26,"end":30,"probability":0.3536,"type":"Organization","normalized_text":"Efpia"}]},"lang":"en","created_at":"2013-08-29T15:59:00.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373104645331099648"}],"attachments":{"media_keys":{}}},{"conversation_id":"373100048860868608","author_id":"116716199","possibly_sensitive":false,"text":"RT @MHRApress: Medicines regulator issues warning against dangerous tanning products http://t.co/BXF3cwMnRv","source":"TweetDeck","id":"373100048860868608","entities":{"hashtags":{},"urls":[{"start":85,"end":107,"url":"http://t.co/BXF3cwMnRv","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON309624","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"annotations":{}},"lang":"en","created_at":"2013-08-29T15:09:18.000Z","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373099447619575808"}],"attachments":{"media_keys":{}}},{"conversation_id":"373099741640683520","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: European Commission : CORDIS : Newsroom : Work on cell memory mechanism could help identify disease-causing mutations http:/…","source":"TweetDeck","id":"373099741640683520","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"annotations":{}},"lang":"en","created_at":"2013-08-29T15:08:04.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373088750202396672"}],"attachments":{"media_keys":{}}},{"conversation_id":"373099669020499968","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: European Commission : CORDIS : Newsroom : Ground-breaking work to improve gene therapy http://t.co/WXnNVi0qXf","source":"TweetDeck","id":"373099669020499968","entities":{"hashtags":{},"urls":[{"start":102,"end":124,"url":"http://t.co/WXnNVi0qXf","expanded_url":"http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&SESSION=&RCN=36000","display_url":"cordis.europa.eu/fetch?CALLER=E…"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"annotations":{}},"lang":"en","created_at":"2013-08-29T15:07:47.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373088395989225472"}],"attachments":{"media_keys":{}}},{"conversation_id":"373099581837672448","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: Massive study closes in on cancers risk markers - Information Centre - Research &amp; Innovation - European Commission http://t.…","source":"TweetDeck","id":"373099581837672448","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"annotations":{}},"lang":"en","created_at":"2013-08-29T15:07:26.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373087714381295616"}],"attachments":{"media_keys":{}}},{"conversation_id":"373099496764608512","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: Latest update on Middle East respiratory syndrome http://t.co/zqTM7DuN0i (29 August 2013) #MERS","source":"TweetDeck","id":"373099496764608512","entities":{"hashtags":[{"start":99,"end":104,"tag":"MERS"}],"urls":[{"start":59,"end":81,"url":"http://t.co/zqTM7DuN0i","expanded_url":"http://goo.gl/nIhVhN","display_url":"goo.gl/nIhVhN"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":26,"end":36,"probability":0.3038,"type":"Place","normalized_text":"Middle East"}]},"lang":"en","created_at":"2013-08-29T15:07:06.000Z","public_metrics":{"retweet_count":66,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373085711273979905"}],"attachments":{"media_keys":{}}},{"conversation_id":"373082054269091842","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: EFPIA Director General Richard Bergström on the Commitments for Clinical Trial Data Sharing http://t.co/4pWYxFpk8e #ctdata","source":"TweetDeck","id":"373082054269091842","entities":{"hashtags":[{"start":126,"end":133,"tag":"ctdata"}],"urls":[{"start":103,"end":125,"url":"http://t.co/4pWYxFpk8e","expanded_url":"http://bit.ly/1dpV3c3","display_url":"bit.ly/1dpV3c3"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"ca","created_at":"2013-08-29T13:57:47.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373081761452163072","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: FDA-Led Study Describes Mechanism Potentially Responsible for Respiratory Side Effect Assoc w/a Pig Influenza Vaccine http://t…","source":"TweetDeck","id":"373081761452163072","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","created_at":"2013-08-29T13:56:38.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373079921465524224"}],"attachments":{"media_keys":{}}},{"conversation_id":"373065380568530944","author_id":"116716199","possibly_sensitive":false,"text":"RT @MHRApress: Read about our latest enforcement raid and watch a video of the events that day http://t.co/04j0flADBW","source":"TweetDeck","id":"373065380568530944","entities":{"hashtags":{},"urls":[{"start":95,"end":117,"url":"http://t.co/04j0flADBW","expanded_url":"http://www.chemistanddruggist.co.uk/feature-content/-/article_display_list/16170597/the-war-on-unlicensed-drugs","display_url":"chemistanddruggist.co.uk/feature-conten…"}],"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"annotations":{}},"lang":"en","created_at":"2013-08-29T12:51:32.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373065034315751425"}],"attachments":{"media_keys":{}}},{"conversation_id":"373065264377913344","author_id":"116716199","possibly_sensitive":false,"text":"RT @FDACBER: FDA-Led Study Describes Mechanism Potentially Responsible for Respiratory Side Effect Assoc w/a Pig Influenza Vaccine http://t…","source":"TweetDeck","id":"373065264377913344","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":{}},"lang":"en","created_at":"2013-08-29T12:51:04.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373062827986010112"}],"attachments":{"media_keys":{}}},{"conversation_id":"373065159469977600","author_id":"116716199","possibly_sensitive":false,"text":"RT @IlaeWeb: Follow discussion of creating definition of Epilepsy: http://t.co/oTBJ6J6EWf","source":"TweetDeck","id":"373065159469977600","entities":{"hashtags":{},"urls":[{"start":67,"end":89,"url":"http://t.co/oTBJ6J6EWf","expanded_url":"http://www.ilae.org/Visitors/Centre/Definition.cfm","display_url":"ilae.org/Visitors/Centr…"}],"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"annotations":{}},"lang":"en","created_at":"2013-08-29T12:50:40.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373060405729316864"}],"attachments":{"media_keys":{}}},{"conversation_id":"373049363951804416","author_id":"116716199","possibly_sensitive":false,"text":"RT @IFAHEurope: Thanks to #veterinarymedicine &amp; control systems #bluetongue outbreaks in Europe have fallen dramatically since 2008 - http:…","source":"TweetDeck","id":"373049363951804416","entities":{"hashtags":[{"start":26,"end":45,"tag":"veterinarymedicine"},{"start":68,"end":79,"tag":"bluetongue"}],"urls":{},"mentions":{},"annotations":[{"start":89,"end":94,"probability":0.9956,"type":"Place","normalized_text":"Europe"}]},"lang":"en","created_at":"2013-08-29T11:47:53.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373049234460659713"}],"attachments":{"media_keys":{}}},{"conversation_id":"373049351452786688","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: New EFPIA webpage on Compulsory licensing &amp; access to medicines http://t.co/MLDM9TVvF6","source":"TweetDeck","id":"373049351452786688","entities":{"hashtags":{},"urls":[{"start":79,"end":101,"url":"http://t.co/MLDM9TVvF6","expanded_url":"http://bit.ly/15ml5Ur","display_url":"bit.ly/15ml5Ur"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-08-29T11:47:50.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373047757071601664"}],"attachments":{"media_keys":{}}},{"conversation_id":"373037638535491586","author_id":"116716199","possibly_sensitive":false,"text":"One day left to comment on our draft guideline on the acceptability of #names for human #medicines: http://t.co/B6HAiNP9K6","source":"Twitter Web Client","id":"373037638535491586","entities":{"hashtags":[{"start":71,"end":77,"tag":"names"},{"start":88,"end":98,"tag":"medicines"}],"urls":[{"start":100,"end":122,"url":"http://t.co/B6HAiNP9K6","expanded_url":"http://bit.ly/13EDaO8","display_url":"bit.ly/13EDaO8"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-29T11:01:18.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373024159179485184","author_id":"116716199","possibly_sensitive":false,"text":"RT @EASDnews: #diabetes - Pancreatic safety of GLP-1-based therapeutic agents: further insights from rodent studies? http://t.co/Z1Cdxor5wt","source":"TweetDeck","id":"373024159179485184","entities":{"hashtags":[{"start":14,"end":23,"tag":"diabetes"}],"urls":[{"start":117,"end":139,"url":"http://t.co/Z1Cdxor5wt","expanded_url":"http://goo.gl/kmZ0Jt","display_url":"goo.gl/kmZ0Jt"}],"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"annotations":{}},"lang":"en","created_at":"2013-08-29T10:07:44.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"373024013104058370"}],"attachments":{"media_keys":{}}},{"conversation_id":"373001294090215426","author_id":"116716199","possibly_sensitive":false,"text":"One more day to comment on our draft guideline on the acceptability of #names for human #medicines: http://t.co/B6HAiNP9K6","source":"Twitter Web Client","id":"373001294090215426","entities":{"hashtags":[{"start":71,"end":77,"tag":"names"},{"start":88,"end":98,"tag":"medicines"}],"urls":[{"start":100,"end":122,"url":"http://t.co/B6HAiNP9K6","expanded_url":"http://bit.ly/13EDaO8","display_url":"bit.ly/13EDaO8"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-29T08:36:53.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"373000688361820160","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: Take part in #ESCAIDE 2013, conference on #infectious #disease #epidemiology: discounted registration until 31 August http://t…","source":"TweetDeck","id":"373000688361820160","entities":{"hashtags":[{"start":26,"end":34,"tag":"ESCAIDE"},{"start":55,"end":66,"tag":"infectious"},{"start":67,"end":75,"tag":"disease"},{"start":76,"end":89,"tag":"epidemiology"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","created_at":"2013-08-29T08:34:28.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372997159123025921"}],"attachments":{"media_keys":{}}},{"conversation_id":"372761976235384832","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: WHO has been informed of an additional 8 lab-confirmed cases of Middle East respiratory syndrome coronavirus http://t.co/W8TzW6e1z…","source":"Twitter for iPhone","id":"372761976235384832","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-08-28T16:45:55.000Z","public_metrics":{"retweet_count":63,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372758010612809728"}],"attachments":{"media_keys":{}}},{"conversation_id":"372761848267173888","author_id":"116716199","possibly_sensitive":false,"text":"RT @euparkinsons: New spinal fluid test may be first to detect Parkinson's disease early http://t.co/nnccnuYWCc via @TIMEHealthland","source":"Twitter for iPhone","id":"372761848267173888","entities":{"hashtags":{},"urls":[{"start":89,"end":111,"url":"http://t.co/nnccnuYWCc","expanded_url":"http://ti.me/145TGa8","display_url":"ti.me/145TGa8"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"},{"start":116,"end":131,"username":"TIMEHealthland","id":"2484760141"}],"annotations":[{"start":63,"end":71,"probability":0.6464,"type":"Person","normalized_text":"Parkinson"}]},"lang":"en","created_at":"2013-08-28T16:45:24.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372754643018711040"}],"attachments":{"media_keys":{}}},{"conversation_id":"372754358418800640","author_id":"116716199","possibly_sensitive":false,"text":"RT @euparkinsons: \"It typically takes 12 to 15 years 2 develop a new medicine\". Read about clinical trials &amp; treatment development @ http:/…","source":"Twitter for iPhone","id":"372754358418800640","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"lang":"en","created_at":"2013-08-28T16:15:39.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372750591102947328"}],"attachments":{"media_keys":{}}},{"conversation_id":"372722468798332928","author_id":"116716199","possibly_sensitive":false,"text":"The European Commission is inviting submissions of published articles to the EU Health Prize for Journalists: http://t.co/TIyjyrDE2g","source":"bitly bitlink","id":"372722468798332928","entities":{"hashtags":{},"urls":[{"start":110,"end":132,"url":"http://t.co/TIyjyrDE2g","expanded_url":"http://bit.ly/1dqdsX9","display_url":"bit.ly/1dqdsX9"}],"mentions":{},"annotations":[{"start":4,"end":22,"probability":0.4303,"type":"Organization","normalized_text":"European Commission"},{"start":77,"end":91,"probability":0.3883,"type":"Organization","normalized_text":"EU Health Prize"}]},"lang":"en","created_at":"2013-08-28T14:08:56.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"372716640238329856","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: Three subtypes of gastric #Cancer suggest different treatment approaches http://t.co/9sebYyDGBK","source":"TweetDeck","id":"372716640238329856","entities":{"hashtags":[{"start":37,"end":44,"tag":"Cancer"}],"urls":[{"start":84,"end":106,"url":"http://t.co/9sebYyDGBK","expanded_url":"http://bit.ly/1aNmADe","display_url":"bit.ly/1aNmADe"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-08-28T13:45:46.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372711018763280384"}],"attachments":{"media_keys":{}}},{"conversation_id":"372688649168900096","author_id":"116716199","possibly_sensitive":false,"text":"RT @myESMO: First ever ESMO Guidlines on #PenileCancer now available for download here http://t.co/zwdHsc8bla #urogenital","source":"TweetDeck","id":"372688649168900096","entities":{"hashtags":[{"start":41,"end":54,"tag":"PenileCancer"},{"start":110,"end":121,"tag":"urogenital"}],"urls":[{"start":87,"end":109,"url":"http://t.co/zwdHsc8bla","expanded_url":"http://ow.ly/ol4xW","display_url":"ow.ly/ol4xW"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":[{"start":23,"end":36,"probability":0.5826,"type":"Person","normalized_text":"ESMO Guidlines"}]},"lang":"en","created_at":"2013-08-28T11:54:32.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372688250835857408"}],"attachments":{"media_keys":{}}},{"conversation_id":"372685992987492352","author_id":"116716199","possibly_sensitive":false,"text":"RT @Aifa_ufficiale: Important information on the risk of capillary leak associated with #filgrastim &amp; #pegfilgrastim: http://t.co/nGXhdFSJ2a","source":"TweetDeck","id":"372685992987492352","entities":{"hashtags":[{"start":88,"end":99,"tag":"filgrastim"},{"start":106,"end":120,"tag":"pegfilgrastim"}],"urls":[{"start":122,"end":144,"url":"http://t.co/nGXhdFSJ2a","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/nota-informativa-importante-sul-rischio-di-aumentata-permeabilit%C3%A0-capillare-associata-filgra","display_url":"agenziafarmaco.gov.it/it/content/not…"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"lang":"en","created_at":"2013-08-28T11:43:59.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"372660042186899456","author_id":"116716199","possibly_sensitive":false,"text":"RT @euparkinsons: Stay up-2-date with the latest #Parkinson's #Disease research articles: http://t.co/Q352Vog3Z9","source":"TweetDeck","id":"372660042186899456","entities":{"hashtags":[{"start":49,"end":59,"tag":"Parkinson"},{"start":62,"end":70,"tag":"Disease"}],"urls":[{"start":90,"end":112,"url":"http://t.co/Q352Vog3Z9","expanded_url":"http://bit.ly/O15CaG","display_url":"bit.ly/O15CaG"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"lang":"en","created_at":"2013-08-28T10:00:52.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372659989636059136"}],"attachments":{"media_keys":{}}},{"conversation_id":"372648490134163456","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: Three days to closing #ESCAIDE 'early bird' discounted registration. Register before Saturday, 31 August! http://t.co/oe3J6w3y…","source":"TweetDeck","id":"372648490134163456","entities":{"hashtags":[{"start":35,"end":43,"tag":"ESCAIDE"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","created_at":"2013-08-28T09:14:58.000Z","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372644052220379136"}],"attachments":{"media_keys":{}}},{"conversation_id":"372647655190827008","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: #clinicaltrials &amp; #datatransparency Richard Bergström: IP not the problem- lack of IP is the problem.","source":"TweetDeck","id":"372647655190827008","entities":{"hashtags":[{"start":11,"end":26,"tag":"clinicaltrials"},{"start":33,"end":50,"tag":"datatransparency"}],"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":47,"end":63,"probability":0.9819,"type":"Person","normalized_text":"Richard Bergström"}]},"lang":"en","created_at":"2013-08-28T09:11:39.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372375653439373312"}],"attachments":{"media_keys":{}}},{"conversation_id":"372647595107438592","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: #clinicaltrialtransparency event in Brussels: J Busato of @Epposi #trialtransparency is less about intellectual property &amp; m…","source":"TweetDeck","id":"372647595107438592","entities":{"hashtags":[{"start":15,"end":41,"tag":"clinicaltrialtransparency"},{"start":81,"end":99,"tag":"trialtransparency"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":73,"end":80,"username":"EPPOSI","id":"403437053"}],"annotations":[{"start":51,"end":58,"probability":0.9824,"type":"Place","normalized_text":"Brussels"}]},"lang":"en","created_at":"2013-08-28T09:11:24.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372374011612647424"}],"attachments":{"media_keys":{}}},{"conversation_id":"372647366194888704","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_Flu: ECDC comments on #MERS-CoV found in bat in Saudi Arabia http://t.co/Fvm4US5hrn","source":"TweetDeck","id":"372647366194888704","entities":{"hashtags":[{"start":31,"end":36,"tag":"MERS"}],"urls":[{"start":70,"end":92,"url":"http://t.co/Fvm4US5hrn","expanded_url":"http://bit.ly/1dLOejN","display_url":"bit.ly/1dLOejN"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":[{"start":57,"end":68,"probability":0.9509,"type":"Place","normalized_text":"Saudi Arabia"}]},"lang":"en","created_at":"2013-08-28T09:10:30.000Z","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372373039348199425"}],"attachments":{"media_keys":{}}},{"conversation_id":"372647136657412096","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: #clinicaltrialtransparency event in Brussels: Nicola Perrin of @wellcometrust We need a data access model that covers the gl…","source":"TweetDeck","id":"372647136657412096","entities":{"hashtags":[{"start":15,"end":41,"tag":"clinicaltrialtransparency"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":78,"end":92,"username":"wellcometrust","id":"19837528"}],"annotations":[{"start":51,"end":58,"probability":0.9891,"type":"Place","normalized_text":"Brussels"},{"start":61,"end":73,"probability":0.8592,"type":"Person","normalized_text":"Nicola Perrin"}]},"lang":"en","created_at":"2013-08-28T09:09:35.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372354792019865600"}],"attachments":{"media_keys":{}}},{"conversation_id":"372646994139176960","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: #clinicaltrialtransparency event in Brussels: Nicola Perrin of @wellcometrust Its not just access to commercial trials. Acad…","source":"TweetDeck","id":"372646994139176960","entities":{"hashtags":[{"start":15,"end":41,"tag":"clinicaltrialtransparency"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":78,"end":92,"username":"wellcometrust","id":"19837528"}],"annotations":[{"start":51,"end":58,"probability":0.9912,"type":"Place","normalized_text":"Brussels"},{"start":61,"end":73,"probability":0.8369,"type":"Person","normalized_text":"Nicola Perrin"}]},"lang":"en","created_at":"2013-08-28T09:09:01.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372354368017674240"}],"attachments":{"media_keys":{}}},{"conversation_id":"372646659093983232","author_id":"116716199","possibly_sensitive":false,"text":"RT @eurogender: #WHO released its #2013 Update on #PriorityMedicines for #Europe and the #World: http://t.co/JXBZQVgEw4","source":"TweetDeck","id":"372646659093983232","entities":{"hashtags":[{"start":16,"end":20,"tag":"WHO"},{"start":50,"end":68,"tag":"PriorityMedicines"},{"start":73,"end":80,"tag":"Europe"},{"start":89,"end":95,"tag":"World"}],"urls":[{"start":97,"end":119,"url":"http://t.co/JXBZQVgEw4","expanded_url":"http://www.who.int/medicines/areas/priority_medicines/MasterDocJune28_FINAL_Web.pdf","display_url":"who.int/medicines/area…"}],"mentions":[{"start":3,"end":14,"username":"eurogender","id":"146793059"}],"annotations":{}},"lang":"en","created_at":"2013-08-28T09:07:41.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372349108096233472"}],"attachments":{"media_keys":{}}},{"conversation_id":"372646496367558656","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: #clinicaltrialtransparency event in #Brussels @bengoldacre calls for retrospective clinical trial result #transparency, goin…","source":"TweetDeck","id":"372646496367558656","entities":{"hashtags":[{"start":15,"end":41,"tag":"clinicaltrialtransparency"},{"start":51,"end":60,"tag":"Brussels"},{"start":120,"end":133,"tag":"transparency"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":61,"end":73,"username":"bengoldacre","id":"6705042"}],"annotations":{}},"lang":"en","created_at":"2013-08-28T09:07:02.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372346501856370688"}],"attachments":{"media_keys":{}}},{"conversation_id":"372646477468012544","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: #clinicaltrials &amp; #datatransparency Richard Bergström: we are ready to be held to account and are ready to work with our stakeho…","source":"TweetDeck","id":"372646477468012544","entities":{"hashtags":[{"start":11,"end":26,"tag":"clinicaltrials"},{"start":33,"end":50,"tag":"datatransparency"}],"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":47,"end":63,"probability":0.9769,"type":"Person","normalized_text":"Richard Bergström"}]},"lang":"en","created_at":"2013-08-28T09:06:58.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372345611304960001"}],"attachments":{"media_keys":{}}},{"conversation_id":"372646457620594688","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: #clinicaltrialtransparency event in Brussels @bengoldacre Many journals have failed to police their publication Peer reviews…","source":"TweetDeck","id":"372646457620594688","entities":{"hashtags":[{"start":15,"end":41,"tag":"clinicaltrialtransparency"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":60,"end":72,"username":"bengoldacre","id":"6705042"}],"annotations":[{"start":51,"end":58,"probability":0.9921,"type":"Place","normalized_text":"Brussels"}]},"lang":"en","created_at":"2013-08-28T09:06:53.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372345206080684032"}],"attachments":{"media_keys":{}}},{"conversation_id":"372646394970271744","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: #clinicaltrialtransparency event in Brussels: Richard Bergstrom of @EFPIA concerns about patents &amp; commercial confidentialit…","source":"TweetDeck","id":"372646394970271744","entities":{"hashtags":[{"start":15,"end":41,"tag":"clinicaltrialtransparency"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":82,"end":88,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":51,"end":58,"probability":0.9914,"type":"Place","normalized_text":"Brussels"},{"start":61,"end":77,"probability":0.9308,"type":"Person","normalized_text":"Richard Bergstrom"}]},"lang":"en","created_at":"2013-08-28T09:06:38.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372339051891671040"}],"attachments":{"media_keys":{}}},{"conversation_id":"372646375898771456","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: #clinicaltrialtransparency event in Brussels: Richard Bergstrom of @EFPIA industry's recent #trialtransparency principles ar…","source":"TweetDeck","id":"372646375898771456","entities":{"hashtags":[{"start":15,"end":41,"tag":"clinicaltrialtransparency"},{"start":107,"end":125,"tag":"trialtransparency"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":82,"end":88,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":51,"end":58,"probability":0.9918,"type":"Place","normalized_text":"Brussels"},{"start":61,"end":77,"probability":0.9428,"type":"Person","normalized_text":"Richard Bergstrom"}]},"lang":"en","created_at":"2013-08-28T09:06:34.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372338735691493376"}],"attachments":{"media_keys":{}}},{"conversation_id":"372646334580662272","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: #clinicaltrialtransparency event in Brussels: @bengoldacre just because something is approved doesn't mean you should use it…","source":"TweetDeck","id":"372646334580662272","entities":{"hashtags":[{"start":15,"end":41,"tag":"clinicaltrialtransparency"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":61,"end":73,"username":"bengoldacre","id":"6705042"}],"annotations":[{"start":51,"end":58,"probability":0.9902,"type":"Place","normalized_text":"Brussels"}]},"lang":"en","created_at":"2013-08-28T09:06:24.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372338263001821185"}],"attachments":{"media_keys":{}}},{"conversation_id":"372646287432511488","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: #clinicaltrialtransparency event in Brussels: Susanna Palkonen @eupatientsforum informed consent and data protection need Eu…","source":"TweetDeck","id":"372646287432511488","entities":{"hashtags":[{"start":15,"end":41,"tag":"clinicaltrialtransparency"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":78,"end":94,"username":"eupatientsforum","id":"545343465"}],"annotations":[{"start":51,"end":58,"probability":0.9904,"type":"Place","normalized_text":"Brussels"},{"start":61,"end":76,"probability":0.9553,"type":"Person","normalized_text":"Susanna Palkonen"}]},"lang":"en","created_at":"2013-08-28T09:06:13.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372337057885982720"}],"attachments":{"media_keys":{}}},{"conversation_id":"372646244839346176","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: #clinicaltrialtransparency event in Brussels: Susanna Palkonen of @eupatientsforum vital for both clinicians &amp; patients 2hav…","source":"TweetDeck","id":"372646244839346176","entities":{"hashtags":[{"start":15,"end":41,"tag":"clinicaltrialtransparency"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":81,"end":97,"username":"eupatientsforum","id":"545343465"}],"annotations":[{"start":51,"end":58,"probability":0.9925,"type":"Place","normalized_text":"Brussels"},{"start":61,"end":76,"probability":0.961,"type":"Person","normalized_text":"Susanna Palkonen"}]},"lang":"en","created_at":"2013-08-28T09:06:02.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372335456890785792"}],"attachments":{"media_keys":{}}},{"conversation_id":"372646205438033920","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: #clinicaltrialtranspareny event in Brussels: @bengoldacre concerned @EFPIA trial transparency plans do not go as far as @EMA…","source":"TweetDeck","id":"372646205438033920","entities":{"hashtags":[{"start":15,"end":40,"tag":"clinicaltrialtranspareny"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":60,"end":72,"username":"bengoldacre","id":"6705042"},{"start":83,"end":89,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":50,"end":57,"probability":0.9927,"type":"Place","normalized_text":"Brussels"}]},"lang":"en","created_at":"2013-08-28T09:05:53.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372334717829255168"}],"attachments":{"media_keys":{}}},{"conversation_id":"372646187331235840","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: #clinicaltrialtranspareny event in Brussels: @bengoldacre current clinical #trials registers lack audit of compliance of res…","source":"TweetDeck","id":"372646187331235840","entities":{"hashtags":[{"start":15,"end":40,"tag":"clinicaltrialtranspareny"},{"start":90,"end":97,"tag":"trials"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":60,"end":72,"username":"bengoldacre","id":"6705042"}],"annotations":[{"start":50,"end":57,"probability":0.9908,"type":"Place","normalized_text":"Brussels"}]},"lang":"en","created_at":"2013-08-28T09:05:49.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372334430058070016"}],"attachments":{"media_keys":{}}},{"conversation_id":"372646168293310464","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: Wellcome Research Foundation Fellow @bengoldacre all #trials should be registered and summary reports made available, includ…","source":"TweetDeck","id":"372646168293310464","entities":{"hashtags":[{"start":68,"end":75,"tag":"trials"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":51,"end":63,"username":"bengoldacre","id":"6705042"}],"annotations":[{"start":15,"end":42,"probability":0.7327,"type":"Organization","normalized_text":"Wellcome Research Foundation"}]},"lang":"en","created_at":"2013-08-28T09:05:44.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372333725238845440"}],"attachments":{"media_keys":{}}},{"conversation_id":"372645420008501248","author_id":"116716199","possibly_sensitive":false,"text":"RT @Aifa_ufficiale: Prevention and control of influenza. Recommendations from the Ministry of Health for 2013-2014: http://t.co/8gG4mMZ8Lj","source":"TweetDeck","id":"372645420008501248","entities":{"hashtags":{},"urls":[{"start":116,"end":138,"url":"http://t.co/8gG4mMZ8Lj","expanded_url":"http://fb.me/2hTytgK3L","display_url":"fb.me/2hTytgK3L"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"lang":"en","created_at":"2013-08-28T09:02:46.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"372641818774888448","author_id":"116716199","possibly_sensitive":false,"text":"RT @innovationunion: #ResearchHeadlines - Massive study closes in on #Cancers risk markers: Cancer research has taken a huge leap... http:/…","source":"TweetDeck","id":"372641818774888448","entities":{"hashtags":[{"start":21,"end":39,"tag":"ResearchHeadlines"},{"start":69,"end":77,"tag":"Cancers"}],"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"lang":"en","created_at":"2013-08-28T08:48:27.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372287872503513088"}],"attachments":{"media_keys":{}}},{"conversation_id":"372641519465144320","author_id":"116716199","possibly_sensitive":false,"text":"RT @URPLWMiPB: Information on infusion solutions containing hydroxyethyl starch http://t.co/9HLnSLXD79","source":"TweetDeck","id":"372641519465144320","entities":{"hashtags":{},"urls":[{"start":80,"end":102,"url":"http://t.co/9HLnSLXD79","expanded_url":"http://www.urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-z-dnia-27-sierpnia-2013-roku-dotyczaca-roztworow-infuzyjnych-zawierajacych-hydroksyetyloskrobie","display_url":"urpl.gov.pl/aktualnosci/in…"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"lang":"en","created_at":"2013-08-28T08:47:16.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"372641023610355712","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: Information from the Polish medicines agency on infusion solutions containing hydroxyethyl starch: http://t.co/pML2qsr6i8","source":"TweetDeck","id":"372641023610355712","entities":{"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/pML2qsr6i8","expanded_url":"http://fb.me/36mCJjPxZ","display_url":"fb.me/36mCJjPxZ"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","created_at":"2013-08-28T08:45:18.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"372339657738309632","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: #clinicaltrialtransparency event in Brussels: Hans Georg Eichler of @EMA_News Risk benefit equation on #trialtransparency fa…","source":"Twitter for iPad","id":"372339657738309632","entities":{"hashtags":[{"start":15,"end":41,"tag":"clinicaltrialtransparency"},{"start":118,"end":136,"tag":"trialtransparency"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":83,"end":92,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":51,"end":58,"probability":0.9824,"type":"Place","normalized_text":"Brussels"},{"start":61,"end":78,"probability":0.7031,"type":"Person","normalized_text":"Hans Georg Eichler"}]},"lang":"en","created_at":"2013-08-27T12:47:46.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"372337830397108224"}],"attachments":{"media_keys":{}}},{"conversation_id":"370949325922525184","author_id":"116716199","possibly_sensitive":false,"text":"RT @myESMO: Hot off the press: download yr copy of updated ESMO Guidelines on primary #breastcancer http://t.co/khTjCEXFTs","source":"Twitter for iPhone","id":"370949325922525184","entities":{"hashtags":[{"start":86,"end":99,"tag":"breastcancer"}],"urls":[{"start":100,"end":122,"url":"http://t.co/khTjCEXFTs","expanded_url":"http://ow.ly/ocYmu","display_url":"ow.ly/ocYmu"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"lang":"en","created_at":"2013-08-23T16:43:05.000Z","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370941114188324864"}],"attachments":{"media_keys":{}}},{"conversation_id":"370906669322350592","author_id":"116716199","possibly_sensitive":false,"text":"RT @innovationunion: Research in #eHealth: analysis and data: Over the years of the 7th Framework Program (FP7), the eHealth Unit of... htt…","source":"TweetDeck","id":"370906669322350592","entities":{"hashtags":[{"start":33,"end":41,"tag":"eHealth"}],"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"lang":"en","created_at":"2013-08-23T13:53:35.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370906526849855490"}],"attachments":{"media_keys":{}}},{"conversation_id":"370895796428079104","author_id":"116716199","possibly_sensitive":false,"text":"RT @LV_MPA: Group Head: Unit for Medical Information: http://t.co/WSAOh3Pqxd #newjob","source":"TweetDeck","id":"370895796428079104","entities":{"hashtags":[{"start":77,"end":84,"tag":"newjob"}],"urls":[{"start":54,"end":76,"url":"http://t.co/WSAOh3Pqxd","expanded_url":"http://bit.ly/1d8KBqe","display_url":"bit.ly/1d8KBqe"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"lang":"en","created_at":"2013-08-23T13:10:23.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370887924973572096","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: #WestNile fever weekly update: two new affected provinces in Italy, place of infection identified for Austrian case http://t.c…","source":"TweetDeck","id":"370887924973572096","entities":{"hashtags":[{"start":13,"end":22,"tag":"WestNile"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":74,"end":78,"probability":0.9979,"type":"Place","normalized_text":"Italy"}]},"lang":"en","created_at":"2013-08-23T12:39:06.000Z","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370887807763775488"}],"attachments":{"media_keys":{}}},{"conversation_id":"370863417239666688","author_id":"116716199","possibly_sensitive":false,"text":"Our workshop 'best expertise vs #conflictsofinterests: striking the right balance' is in two weeks: http://t.co/qxCGPU3xUo  #coiworkshop","source":"Twitter Web Client","id":"370863417239666688","entities":{"hashtags":[{"start":32,"end":53,"tag":"conflictsofinterests"},{"start":124,"end":136,"tag":"coiworkshop"}],"urls":[{"start":100,"end":122,"url":"http://t.co/qxCGPU3xUo","expanded_url":"http://bit.ly/1f6tUr9","display_url":"bit.ly/1f6tUr9"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-23T11:01:43.000Z","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370863307130818560","author_id":"116716199","possibly_sensitive":false,"text":"Last few days to comment on a new model of disease progression and trial evaluation in #Alzheimer's disease: http://t.co/Izrc2TPeTV","source":"Twitter Web Client","id":"370863307130818560","entities":{"hashtags":[{"start":87,"end":97,"tag":"Alzheimer"}],"urls":[{"start":109,"end":131,"url":"http://t.co/Izrc2TPeTV","expanded_url":"http://bit.ly/16I4Ljl","display_url":"bit.ly/16I4Ljl"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-23T11:01:17.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370863233524981760","author_id":"116716199","possibly_sensitive":false,"text":"One more week to comment on our draft guideline on the acceptability of #names for human #medicines: http://t.co/B6HAiNP9K6","source":"Twitter Web Client","id":"370863233524981760","entities":{"hashtags":[{"start":72,"end":78,"tag":"names"},{"start":89,"end":99,"tag":"medicines"}],"urls":[{"start":101,"end":123,"url":"http://t.co/B6HAiNP9K6","expanded_url":"http://bit.ly/13EDaO8","display_url":"bit.ly/13EDaO8"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-23T11:00:59.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370863165694689280","author_id":"116716199","possibly_sensitive":false,"text":"One more week to comment on our concept paper on updating our guidance on venous thromboembolic (#VTE) disease: http://t.co/6mZIJI1xz1","source":"Twitter Web Client","id":"370863165694689280","entities":{"hashtags":[{"start":97,"end":101,"tag":"VTE"}],"urls":[{"start":112,"end":134,"url":"http://t.co/6mZIJI1xz1","expanded_url":"http://bit.ly/11QCCrK","display_url":"bit.ly/11QCCrK"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-23T11:00:43.000Z","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370850382844817408","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: Work on cell memory mechanism could help identify disease-causing mutations http://t.co/o7HTmaZFga","source":"TweetDeck","id":"370850382844817408","entities":{"hashtags":{},"urls":[{"start":89,"end":111,"url":"http://t.co/o7HTmaZFga","expanded_url":"http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&SESSION=&RCN=35997","display_url":"cordis.europa.eu/fetch?CALLER=E…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","created_at":"2013-08-23T10:09:56.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370839944098758656"}],"attachments":{"media_keys":{}}},{"conversation_id":"370850123771027456","author_id":"116716199","possibly_sensitive":false,"text":"RT @myCORDIS: Work on cell memory mechanism could help identify disease-causing mutations http://t.co/7XyAAXs1XR #FP7","source":"TweetDeck","id":"370850123771027456","entities":{"hashtags":[{"start":113,"end":117,"tag":"FP7"}],"urls":[{"start":90,"end":112,"url":"http://t.co/7XyAAXs1XR","expanded_url":"http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&SESSION=&RCN=35997","display_url":"cordis.europa.eu/fetch?CALLER=E…"}],"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"annotations":{}},"lang":"en","created_at":"2013-08-23T10:08:54.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370830693766811648"}],"attachments":{"media_keys":{}}},{"conversation_id":"370820110929649664","author_id":"116716199","possibly_sensitive":false,"text":"Two weeks until our workshop 'best expertise vs #conflictsofinterests: striking the right balance' http://t.co/IO7nFwBCvs #coiworkshop","source":"bitly bitlink","id":"370820110929649664","entities":{"hashtags":[{"start":48,"end":69,"tag":"conflictsofinterests"},{"start":122,"end":134,"tag":"coiworkshop"}],"urls":[{"start":99,"end":121,"url":"http://t.co/IO7nFwBCvs","expanded_url":"http://bit.ly/1f6tUr9","display_url":"bit.ly/1f6tUr9"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-23T08:09:38.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370819555045564416","author_id":"116716199","possibly_sensitive":false,"text":"We're closed on Monday. We have an emergency phone number for problems with medicines: http://t.co/YbMjsXHhiL","source":"Twitter Web Client","id":"370819555045564416","entities":{"hashtags":{},"urls":[{"start":87,"end":109,"url":"http://t.co/YbMjsXHhiL","expanded_url":"http://bit.ly/1dvNTS4","display_url":"bit.ly/1dvNTS4"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-23T08:07:26.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370819260735442944","author_id":"116716199","possibly_sensitive":false,"text":"Only a few days left to comment on a new model of disease progression and trial evaluation in #Alzheimer's disease: http://t.co/Izrc2TPeTV","source":"Twitter Web Client","id":"370819260735442944","entities":{"hashtags":[{"start":94,"end":104,"tag":"Alzheimer"}],"urls":[{"start":116,"end":138,"url":"http://t.co/Izrc2TPeTV","expanded_url":"http://bit.ly/16I4Ljl","display_url":"bit.ly/16I4Ljl"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-23T08:06:15.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370818937644015616","author_id":"116716199","possibly_sensitive":false,"text":"One week left to comment on our draft guideline on the acceptability of #names for human #medicines: http://t.co/B6HAiNP9K6","source":"Twitter Web Client","id":"370818937644015616","entities":{"hashtags":[{"start":72,"end":78,"tag":"names"},{"start":89,"end":99,"tag":"medicines"}],"urls":[{"start":101,"end":123,"url":"http://t.co/B6HAiNP9K6","expanded_url":"http://bit.ly/13EDaO8","display_url":"bit.ly/13EDaO8"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-23T08:04:58.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370818783603998720","author_id":"116716199","possibly_sensitive":false,"text":"One week left to comment on our concept paper on updating our guidance on venous thromboembolic (#VTE) disease: http://t.co/6mZIJI1xz1","source":"Twitter Web Client","id":"370818783603998720","entities":{"hashtags":[{"start":97,"end":101,"tag":"VTE"}],"urls":[{"start":112,"end":134,"url":"http://t.co/6mZIJI1xz1","expanded_url":"http://bit.ly/11QCCrK","display_url":"bit.ly/11QCCrK"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-23T08:04:22.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370558387442188288","author_id":"116716199","possibly_sensitive":false,"text":"RT @TOPRANEWS: The September 2013 edition of Regulatory Rapporteur is now available online. Download here: http://t.co/28zHVFFiZQ","source":"TweetDeck","id":"370558387442188288","entities":{"hashtags":{},"urls":[{"start":107,"end":129,"url":"http://t.co/28zHVFFiZQ","expanded_url":"http://www.topra.org/publications/regulatory-rapporteur","display_url":"topra.org/publications/r…"}],"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":[{"start":45,"end":65,"probability":0.586,"type":"Organization","normalized_text":"Regulatory Rapporteur"}]},"lang":"en","created_at":"2013-08-22T14:49:38.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370555654642991104"}],"attachments":{"media_keys":{}}},{"conversation_id":"370539534377046016","author_id":"116716199","possibly_sensitive":false,"text":"RT @EU_eHealth: #Integrate symposium at European #Cancer Conference Amsterdam. Main topic: sharing data in #oncology http://t.co/b7V9KQAsu0…","source":"TweetDeck","id":"370539534377046016","entities":{"hashtags":[{"start":16,"end":26,"tag":"Integrate"},{"start":49,"end":56,"tag":"Cancer"},{"start":107,"end":116,"tag":"oncology"}],"urls":[{"start":117,"end":139,"url":"http://t.co/b7V9KQAsu0","expanded_url":"http://dlvr.it/3lHwRm","display_url":"dlvr.it/3lHwRm"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"annotations":[{"start":68,"end":76,"probability":0.7856,"type":"Place","normalized_text":"Amsterdam"}]},"lang":"en","created_at":"2013-08-22T13:34:43.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370539128607092738"}],"attachments":{"media_keys":{}}},{"conversation_id":"370530879766282240","author_id":"116716199","possibly_sensitive":false,"text":"RT @FDADeviceInfo: New test system identifies 193 different yeasts &amp; bacteria known to cause illness http://t.co/ryZwtrD6kd #fda #medicalde…","source":"TweetDeck","id":"370530879766282240","entities":{"hashtags":[{"start":128,"end":132,"tag":"fda"}],"urls":[{"start":105,"end":127,"url":"http://t.co/ryZwtrD6kd","expanded_url":"http://1.usa.gov/18M2mFV","display_url":"1.usa.gov/18M2mFV"}],"mentions":[{"start":3,"end":17,"username":"FDADeviceInfo","id":"140427956"}],"annotations":{}},"lang":"en","created_at":"2013-08-22T13:00:20.000Z","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370530736819810306"}],"attachments":{"media_keys":{}}},{"conversation_id":"370530865404968960","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: EC | The EU funded p-medicine project is online http://t.co/huFzzMiHkZ","source":"TweetDeck","id":"370530865404968960","entities":{"hashtags":{},"urls":[{"start":61,"end":83,"url":"http://t.co/huFzzMiHkZ","expanded_url":"http://ec.europa.eu/information_society/newsroom/cf/dae/itemdetail.cfm?item_id=11819&utm_source=dlvr.it&utm_medium=twitter","display_url":"ec.europa.eu/information_so…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":18,"end":23,"probability":0.4435,"type":"Organization","normalized_text":"The EU"}]},"lang":"en","created_at":"2013-08-22T13:00:17.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370530674224017408"}],"attachments":{"media_keys":{}}},{"conversation_id":"370530781518893056","author_id":"116716199","possibly_sensitive":false,"text":"RT @innovationunion: #ResearchHeadlines - Sponge enzymes: nature's little bio-builders: Sponges seem an unlikely source for... http://t.co/…","source":"TweetDeck","id":"370530781518893056","entities":{"hashtags":[{"start":21,"end":39,"tag":"ResearchHeadlines"}],"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"lang":"en","created_at":"2013-08-22T12:59:57.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370528035922923520"}],"attachments":{"media_keys":{}}},{"conversation_id":"370525459811168256","author_id":"116716199","possibly_sensitive":false,"text":"Our office is closed on Monday. We have an emergency phone number for problems with medicines: http://t.co/zGjMe4pJBG","source":"bitly bitlink","id":"370525459811168256","entities":{"hashtags":{},"urls":[{"start":95,"end":117,"url":"http://t.co/zGjMe4pJBG","expanded_url":"http://bit.ly/1dvNTS4","display_url":"bit.ly/1dvNTS4"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-22T12:38:48.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370509587247427584","author_id":"116716199","possibly_sensitive":false,"text":"Send us your comments on our draft Community #herbal monograph on #Arnica montana (Arnica flower): http://t.co/dbbuXKklAT","source":"Twitter Web Client","id":"370509587247427584","entities":{"hashtags":[{"start":45,"end":52,"tag":"herbal"},{"start":66,"end":73,"tag":"Arnica"}],"urls":[{"start":99,"end":121,"url":"http://t.co/dbbuXKklAT","expanded_url":"http://bit.ly/16gs5T8","display_url":"bit.ly/16gs5T8"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-22T11:35:43.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370509469173960705","author_id":"116716199","possibly_sensitive":false,"text":"RT @innovationunion: Personalized medicine: Watch videos of experts online: The EU funded p-medicine project is online. The new... http://t…","source":"TweetDeck","id":"370509469173960705","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"lang":"en","created_at":"2013-08-22T11:35:15.000Z","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370508659387686912"}],"attachments":{"media_keys":{}}},{"conversation_id":"370509205620654080","author_id":"116716199","possibly_sensitive":false,"text":"RT @LV_MPA: Monthly report from the Committee for Medicinal Products for Human Use (July 2013): http://t.co/QIYj0YEKjH","source":"TweetDeck","id":"370509205620654080","entities":{"hashtags":{},"urls":[{"start":96,"end":118,"url":"http://t.co/QIYj0YEKjH","expanded_url":"http://bit.ly/1bW1T5J","display_url":"bit.ly/1bW1T5J"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"lang":"en","created_at":"2013-08-22T11:34:13.000Z","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370508714375397376","author_id":"116716199","possibly_sensitive":false,"text":"RT @EU_eHealth: Personalized medicine: Watch videos of experts online http://t.co/q4ScE8XX74 @VPHportal #pmedicine #ehealth","source":"TweetDeck","id":"370508714375397376","entities":{"hashtags":[{"start":104,"end":114,"tag":"pmedicine"},{"start":115,"end":123,"tag":"ehealth"}],"urls":[{"start":70,"end":92,"url":"http://t.co/q4ScE8XX74","expanded_url":"http://p-medicine.eu/news/news-details/article/summer-school-in-computational-oncology-2013/","display_url":"p-medicine.eu/news/news-deta…"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":93,"end":103,"username":"VPHportal","id":"519631200"}],"annotations":{}},"lang":"en","created_at":"2013-08-22T11:32:15.000Z","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370501678673313792"}],"attachments":{"media_keys":{}}},{"conversation_id":"370483995076984832","author_id":"116716199","possibly_sensitive":false,"text":"A public consultation is open on our draft Community #herbal monograph on #Arnica montana (Arnica flower): http://t.co/FfVL2gvB4r","source":"bitly bitlink","id":"370483995076984832","entities":{"hashtags":[{"start":53,"end":60,"tag":"herbal"},{"start":74,"end":81,"tag":"Arnica"}],"urls":[{"start":107,"end":129,"url":"http://t.co/FfVL2gvB4r","expanded_url":"http://bit.ly/16gs5T8","display_url":"bit.ly/16gs5T8"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-22T09:54:02.000Z","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370483607733030912","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO_Europe_TB: #Tuberculosis costs the #EU is at least €5.9 billion per year | #TBChat http://t.co/iNmjHaGtRF","source":"TweetDeck","id":"370483607733030912","entities":{"hashtags":[{"start":19,"end":32,"tag":"Tuberculosis"},{"start":43,"end":46,"tag":"EU"},{"start":83,"end":90,"tag":"TBChat"}],"urls":[{"start":91,"end":113,"url":"http://t.co/iNmjHaGtRF","expanded_url":"http://erj.ersjournals.com/content/early/2013/08/15/09031936.00079413.abstract","display_url":"erj.ersjournals.com/content/early/…"}],"mentions":[{"start":3,"end":17,"username":"WHO_Europe_TB","id":"920721606"}],"annotations":{}},"lang":"en","created_at":"2013-08-22T09:52:30.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370478069175164929"}],"attachments":{"media_keys":{}}},{"conversation_id":"370469165028880385","author_id":"116716199","possibly_sensitive":false,"text":"RT @HAIEurope: A beautifully clear article by #TheConversation on the importance of #consumergroup #independence from industry http://t.co/…","source":"TweetDeck","id":"370469165028880385","entities":{"hashtags":[{"start":46,"end":62,"tag":"TheConversation"},{"start":84,"end":98,"tag":"consumergroup"},{"start":99,"end":112,"tag":"independence"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":{}},"lang":"en","created_at":"2013-08-22T08:55:06.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370468865244807168"}],"attachments":{"media_keys":{}}},{"conversation_id":"370466861504528384","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: EFPIA Director General Richard Bergstrom blogs on the second of the @PhRMA EFPIA data-sharing commitments - http://t.co/9BfOo9ex…","source":"TweetDeck","id":"370466861504528384","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":79,"end":85,"username":"PhRMA","id":"116748080"}],"annotations":[{"start":34,"end":50,"probability":0.6135,"type":"Person","normalized_text":"Richard Bergstrom"}]},"lang":"en","created_at":"2013-08-22T08:45:57.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370466809700306944"}],"attachments":{"media_keys":{}}},{"conversation_id":"370466771377352704","author_id":"116716199","possibly_sensitive":false,"text":"RT @EASDnews: Do current incretin mimetics exploit the full therapeutic potential inherent in GLP-1 receptor stimulation? - http://t.co/Bht…","source":"TweetDeck","id":"370466771377352704","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"annotations":{}},"lang":"en","created_at":"2013-08-22T08:45:35.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370466573233831936"}],"attachments":{"media_keys":{}}},{"conversation_id":"370461494623748096","author_id":"116716199","possibly_sensitive":false,"text":"Send us your comments on our draft Community #herbal monograph on #Melaleuca (#teatree oil): http://t.co/MjYUhWL20a","source":"Twitter Web Client","id":"370461494623748096","entities":{"hashtags":[{"start":45,"end":52,"tag":"herbal"},{"start":66,"end":76,"tag":"Melaleuca"},{"start":78,"end":86,"tag":"teatree"}],"urls":[{"start":93,"end":115,"url":"http://t.co/MjYUhWL20a","expanded_url":"http://bit.ly/1d1Ut4T","display_url":"bit.ly/1d1Ut4T"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-22T08:24:37.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370461400180604928","author_id":"116716199","possibly_sensitive":false,"text":"Send us your comments on our draft #herbal Community list entry on #Melaleuca (#teatree oil): http://t.co/4X4rEHQmzW","source":"Twitter Web Client","id":"370461400180604928","entities":{"hashtags":[{"start":35,"end":42,"tag":"herbal"},{"start":67,"end":77,"tag":"Melaleuca"},{"start":79,"end":87,"tag":"teatree"}],"urls":[{"start":94,"end":116,"url":"http://t.co/4X4rEHQmzW","expanded_url":"http://bit.ly/16cbm39","display_url":"bit.ly/16cbm39"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-22T08:24:15.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370203307631181824","author_id":"116716199","possibly_sensitive":false,"text":"A public consultation is open on our draft Community #herbal monograph on #Melaleuca (#teatree oil): http://t.co/wuz9cw3eDS","source":"bitly bitlink","id":"370203307631181824","entities":{"hashtags":[{"start":53,"end":60,"tag":"herbal"},{"start":74,"end":84,"tag":"Melaleuca"},{"start":86,"end":94,"tag":"teatree"}],"urls":[{"start":101,"end":123,"url":"http://t.co/wuz9cw3eDS","expanded_url":"http://bit.ly/1d1Ut4T","display_url":"bit.ly/1d1Ut4T"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-21T15:18:41.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370202930034798592","author_id":"116716199","possibly_sensitive":false,"text":"A public consultation is open on our draft #herbal Community list entry on #Melaleuca (#teatree oil):  http://t.co/DK3vYXxo2Q","source":"bitly bitlink","id":"370202930034798592","entities":{"hashtags":[{"start":43,"end":50,"tag":"herbal"},{"start":75,"end":85,"tag":"Melaleuca"},{"start":87,"end":95,"tag":"teatree"}],"urls":[{"start":103,"end":125,"url":"http://t.co/DK3vYXxo2Q","expanded_url":"http://bit.ly/16cbm39","display_url":"bit.ly/16cbm39"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-21T15:17:11.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370174694181601280","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: A Dry Pipeline for Psychiatric Drugs http://t.co/478dNES67O","source":"TweetDeck","id":"370174694181601280","entities":{"hashtags":{},"urls":[{"start":50,"end":72,"url":"http://t.co/478dNES67O","expanded_url":"http://nyti.ms/152JClk","display_url":"nyti.ms/152JClk"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","created_at":"2013-08-21T13:24:59.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370170930556715009"}],"attachments":{"media_keys":{}}},{"conversation_id":"370174517341351936","author_id":"116716199","possibly_sensitive":false,"text":"RT @WDD: Promote the #WDD #campaign on your blog/website using our new banners: http://t.co/Wsf6odw0MG #diabetes","source":"TweetDeck","id":"370174517341351936","entities":{"hashtags":[{"start":21,"end":25,"tag":"WDD"},{"start":26,"end":35,"tag":"campaign"},{"start":103,"end":112,"tag":"diabetes"}],"urls":[{"start":80,"end":102,"url":"http://t.co/Wsf6odw0MG","expanded_url":"http://bit.ly/rQA2mp","display_url":"bit.ly/rQA2mp"}],"mentions":[{"start":3,"end":7,"username":"WDD","id":"15179874"}],"annotations":{}},"lang":"en","created_at":"2013-08-21T13:24:17.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370162884082282496"}],"attachments":{"media_keys":{}}},{"conversation_id":"370147832625655808","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_TB: Europe is facing a rise in tuberculosis http://t.co/HtBObHmjvt   via @el_pais","source":"TweetDeck","id":"370147832625655808","entities":{"hashtags":{},"urls":[{"start":53,"end":75,"url":"http://t.co/HtBObHmjvt","expanded_url":"http://bit.ly/172fzZY","display_url":"bit.ly/172fzZY"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"},{"start":82,"end":90,"username":"el_pais","id":"7996082"}],"annotations":[{"start":13,"end":18,"probability":0.9895,"type":"Place","normalized_text":"Europe"}]},"lang":"en","created_at":"2013-08-21T11:38:14.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370143022681702401","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: 'A Dry Pipeline for Psychiatric Drugs' http://t.co/EWk31qN5xz","source":"TweetDeck","id":"370143022681702401","entities":{"hashtags":{},"urls":[{"start":50,"end":72,"url":"http://t.co/EWk31qN5xz","expanded_url":"http://nyti.ms/12lrvpN","display_url":"nyti.ms/12lrvpN"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-08-21T11:19:08.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370139751010938880"}],"attachments":{"media_keys":{}}},{"conversation_id":"370138537544261632","author_id":"116716199","possibly_sensitive":false,"text":"Register now for our information day on using #MedDRA, including #medicationerrors, on 22 October: http://t.co/aVsafoAHRx","source":"Twitter Web Client","id":"370138537544261632","entities":{"hashtags":[{"start":46,"end":53,"tag":"MedDRA"},{"start":65,"end":82,"tag":"medicationerrors"}],"urls":[{"start":99,"end":121,"url":"http://t.co/aVsafoAHRx","expanded_url":"http://bit.ly/14iub92","display_url":"bit.ly/14iub92"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-21T11:01:18.000Z","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370124327783772160","author_id":"116716199","possibly_sensitive":false,"text":"RT @myESMO: Expert Highlights from the Inaugural NCCN Guideline for #PenileCancer http://t.co/xjkel9J4pO via @NCCNMeetings","source":"TweetDeck","id":"370124327783772160","entities":{"hashtags":[{"start":68,"end":81,"tag":"PenileCancer"}],"urls":[{"start":82,"end":104,"url":"http://t.co/xjkel9J4pO","expanded_url":"http://ow.ly/o7y0g","display_url":"ow.ly/o7y0g"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"lang":"en","created_at":"2013-08-21T10:04:50.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370123592811679744"}],"attachments":{"media_keys":{}}},{"conversation_id":"370124012237910016","author_id":"116716199","possibly_sensitive":false,"text":"We're hosting an information day on using #MedDRA and #medicationerrors on 22 October: http://t.co/vvQkInYWei","source":"bitly bitlink","id":"370124012237910016","entities":{"hashtags":[{"start":42,"end":49,"tag":"MedDRA"},{"start":54,"end":71,"tag":"medicationerrors"}],"urls":[{"start":87,"end":109,"url":"http://t.co/vvQkInYWei","expanded_url":"http://bit.ly/14iub92","display_url":"bit.ly/14iub92"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-21T10:03:35.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"370117286801473536","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: WHO medicine prequalification verifies that a medicine meets international pharmaceutical quality standards http://t.co/F0lPXT7uId","source":"TweetDeck","id":"370117286801473536","entities":{"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/F0lPXT7uId","expanded_url":"http://goo.gl/F379cn","display_url":"goo.gl/F379cn"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-08-21T09:36:52.000Z","public_metrics":{"retweet_count":44,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370110419991404545"}],"attachments":{"media_keys":{}}},{"conversation_id":"370117228630663168","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: For the first time ever, WHO prequalifies medicine for neglected tropical disease - 100 mg tablet diethylcabamazine to treat eleph…","source":"TweetDeck","id":"370117228630663168","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"lang":"en","created_at":"2013-08-21T09:36:38.000Z","public_metrics":{"retweet_count":124,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"370109046474285056"}],"attachments":{"media_keys":{}}},{"conversation_id":"370093339246215168","author_id":"116716199","possibly_sensitive":false,"text":"Yesterday we published the first conclusions of parallel assessment of quality-by-design applications with @US_FDA: http://t.co/uQhabq0WR3","source":"Twitter Web Client","id":"370093339246215168","entities":{"hashtags":{},"urls":[{"start":116,"end":138,"url":"http://t.co/uQhabq0WR3","expanded_url":"http://bit.ly/13CzwJR","display_url":"bit.ly/13CzwJR"}],"mentions":[{"start":107,"end":114,"username":"US_FDA","id":"208120290"}],"annotations":{}},"lang":"en","created_at":"2013-08-21T08:01:42.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"369827591290908672","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: Pomalidomide approved for use across Europe http://t.co/N6ZZhF9NZq","source":"TweetDeck","id":"369827591290908672","entities":{"hashtags":{},"urls":[{"start":59,"end":81,"url":"http://t.co/N6ZZhF9NZq","expanded_url":"http://www.myeloma.org.uk/about-muk/news/myeloma-news/pomalidomide-approved-for-use-across-europe/#.UhN5aAANbRs.twitter","display_url":"myeloma.org.uk/about-muk/news…"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"annotations":[{"start":52,"end":57,"probability":0.9879,"type":"Place","normalized_text":"Europe"}]},"lang":"en","created_at":"2013-08-20T14:25:43.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"369824391091060738"}],"attachments":{"media_keys":{}}},{"conversation_id":"369823852404436994","author_id":"116716199","possibly_sensitive":false,"text":"We've published the first conclusions of parallel assessment of quality-by-design applications with @US_FDA: http://t.co/H21J68dRfK","source":"bitly bitlink","id":"369823852404436994","entities":{"hashtags":{},"urls":[{"start":109,"end":131,"url":"http://t.co/H21J68dRfK","expanded_url":"http://bit.ly/13CzwJR","display_url":"bit.ly/13CzwJR"}],"mentions":[{"start":100,"end":107,"username":"US_FDA","id":"208120290"}],"annotations":{}},"lang":"en","created_at":"2013-08-20T14:10:52.000Z","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"369822799579578368","author_id":"116716199","possibly_sensitive":false,"text":"RT @EAHPtweet: #EAHP are holding a special meeting on reducing #hospital #medication #error and interested stakeholders are invited  http:/…","source":"TweetDeck","id":"369822799579578368","entities":{"hashtags":[{"start":15,"end":20,"tag":"EAHP"},{"start":63,"end":72,"tag":"hospital"},{"start":73,"end":84,"tag":"medication"},{"start":85,"end":91,"tag":"error"}],"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"annotations":{}},"lang":"en","created_at":"2013-08-20T14:06:41.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"369822750380003329"}],"attachments":{"media_keys":{}}},{"conversation_id":"369804907601068032","author_id":"116716199","possibly_sensitive":false,"text":"Send us your comments on the #herbal monograph on #Ononis spinosa (#restharrow root): http://t.co/OmQbThkwmI","source":"Twitter Web Client","id":"369804907601068032","entities":{"hashtags":[{"start":29,"end":36,"tag":"herbal"},{"start":50,"end":57,"tag":"Ononis"},{"start":67,"end":78,"tag":"restharrow"}],"urls":[{"start":86,"end":108,"url":"http://t.co/OmQbThkwmI","expanded_url":"http://bit.ly/164YuMb","display_url":"bit.ly/164YuMb"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-20T12:55:35.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"369804817645834240","author_id":"116716199","possibly_sensitive":false,"text":"One more week to comment on a new model of disease progression and trial evaluation in #Alzheimer's disease: http://t.co/Izrc2TPeTV","source":"Twitter Web Client","id":"369804817645834240","entities":{"hashtags":[{"start":87,"end":97,"tag":"Alzheimer"}],"urls":[{"start":109,"end":131,"url":"http://t.co/Izrc2TPeTV","expanded_url":"http://bit.ly/16I4Ljl","display_url":"bit.ly/16I4Ljl"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-20T12:55:13.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"369804609910747136","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: Aedes Albopictus is an invasive mosquito in Europe, vector of diseases as #chikungunya &amp; #dengue. #WorldMosquitoDay http://t.c…","source":"TweetDeck","id":"369804609910747136","entities":{"hashtags":[{"start":87,"end":99,"tag":"chikungunya"},{"start":106,"end":113,"tag":"dengue"},{"start":115,"end":132,"tag":"WorldMosquitoDay"}],"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":13,"end":28,"probability":0.5211,"type":"Person","normalized_text":"Aedes Albopictus"},{"start":57,"end":62,"probability":0.9942,"type":"Place","normalized_text":"Europe"}]},"lang":"en","created_at":"2013-08-20T12:54:24.000Z","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"369798234006642688"}],"attachments":{"media_keys":{}}},{"conversation_id":"369775438396411904","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: Today is #WorldMosquitoDay. Have you seen ECDC maps on invasive mosquitoes in Europe? http://t.co/E5r2eP8iMk","source":"TweetDeck","id":"369775438396411904","entities":{"hashtags":[{"start":22,"end":39,"tag":"WorldMosquitoDay"}],"urls":[{"start":99,"end":121,"url":"http://t.co/E5r2eP8iMk","expanded_url":"http://bit.ly/SIlfjp","display_url":"bit.ly/SIlfjp"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":91,"end":96,"probability":0.9985,"type":"Place","normalized_text":"Europe"}]},"lang":"en","created_at":"2013-08-20T10:58:29.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"369769480747880448"}],"attachments":{"media_keys":{}}},{"conversation_id":"369775239011790848","author_id":"116716199","possibly_sensitive":false,"text":"RT @euparkinsons: The# Parkinson's disease–linked proteins #Fbxo7 and #Parkin interact to mediate mitophagy http://t.co/YfF0XApUWA","source":"TweetDeck","id":"369775239011790848","entities":{"hashtags":[{"start":59,"end":65,"tag":"Fbxo7"},{"start":70,"end":77,"tag":"Parkin"}],"urls":[{"start":108,"end":130,"url":"http://t.co/YfF0XApUWA","expanded_url":"http://bit.ly/14wTEaZ","display_url":"bit.ly/14wTEaZ"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"lang":"en","created_at":"2013-08-20T10:57:41.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"369755133887778816"}],"attachments":{"media_keys":{}}},{"conversation_id":"369754353156251648","author_id":"116716199","possibly_sensitive":false,"text":"RT @URPLWMiPB: Information on the implementation of the recommendations of the CMDh for medicines containing codeine. http://t.co/4fiqJBfAvq","source":"TweetDeck","id":"369754353156251648","entities":{"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/4fiqJBfAvq","expanded_url":"http://urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-rejestracji-dnia-20-sierpnia-2013-r-w-sprawie-implementacji-rekomendacji-grupy-koordynacyjnej-cmdh","display_url":"urpl.gov.pl/aktualnosci/in…"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"lang":"en","created_at":"2013-08-20T09:34:42.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"369751661373575168","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak:Information on the implementation of the recommendations of the CMDh for medicines containing codeine:: http://t.co/PlwP5pGbdQ","source":"TweetDeck","id":"369751661373575168","entities":{"hashtags":{},"urls":[{"start":116,"end":138,"url":"http://t.co/PlwP5pGbdQ","expanded_url":"http://www.urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-rejestracji-dnia-20-sierpnia-2013-r-w-sprawie-implementacji-rekomendacji-grupy-koordynacyjnej-cmdh","display_url":"urpl.gov.pl/aktualnosci/in…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","created_at":"2013-08-20T09:24:00.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"369747310701731840","author_id":"116716199","possibly_sensitive":false,"text":"A public consultation is open on the #herbal monograph on #Ononis spinosa (#restharrow root): http://t.co/8b0v4Q1Caw","source":"bitly bitlink","id":"369747310701731840","entities":{"hashtags":[{"start":37,"end":44,"tag":"herbal"},{"start":58,"end":65,"tag":"Ononis"},{"start":75,"end":86,"tag":"restharrow"}],"urls":[{"start":94,"end":116,"url":"http://t.co/8b0v4Q1Caw","expanded_url":"http://bit.ly/164YuMb","display_url":"bit.ly/164YuMb"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-20T09:06:43.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"369744011579637761","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: Today is #WorldMosquitoDay. Have you seen ECDC maps on invasive #mosquitoes in #Europe? http://t.co/mxCpRoQzXM","source":"TweetDeck","id":"369744011579637761","entities":{"hashtags":[{"start":22,"end":39,"tag":"WorldMosquitoDay"},{"start":77,"end":88,"tag":"mosquitoes"},{"start":92,"end":99,"tag":"Europe"}],"urls":[{"start":101,"end":123,"url":"http://t.co/mxCpRoQzXM","expanded_url":"http://bit.ly/SIlfjp","display_url":"bit.ly/SIlfjp"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","created_at":"2013-08-20T08:53:36.000Z","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"369743790019731456"}],"attachments":{"media_keys":{}}},{"conversation_id":"369736023615344640","author_id":"116716199","possibly_sensitive":false,"text":"One week left to comment on a new model of disease progression and trial evaluation in #Alzheimer's disease: http://t.co/Izrc2TPeTV","source":"Twitter Web Client","id":"369736023615344640","entities":{"hashtags":[{"start":87,"end":97,"tag":"Alzheimer"}],"urls":[{"start":109,"end":131,"url":"http://t.co/Izrc2TPeTV","expanded_url":"http://bit.ly/16I4Ljl","display_url":"bit.ly/16I4Ljl"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-20T08:21:52.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"369497687118606336","author_id":"116716199","possibly_sensitive":false,"text":"RT @FDAanimalhealth: Do you know what happens when a problem with an FDA regulated product is reported? http://t.co/yZRjupSm14","source":"Twitter for iPhone","id":"369497687118606336","entities":{"hashtags":{},"urls":[{"start":104,"end":126,"url":"http://t.co/yZRjupSm14","expanded_url":"http://1.usa.gov/pOpSme","display_url":"1.usa.gov/pOpSme"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":[{"start":69,"end":71,"probability":0.7922,"type":"Organization","normalized_text":"FDA"}]},"lang":"en","created_at":"2013-08-19T16:34:48.000Z","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"369496191525855233"}],"attachments":{"media_keys":{}}},{"conversation_id":"369492914059366400","author_id":"116716199","possibly_sensitive":false,"text":"RT @DrugInfoAssn: Expert Discusses Placebo Effect On Clinical Outcomes.http://t.co/nPQG0h3Oly","source":"Twitter for iPhone","id":"369492914059366400","entities":{"hashtags":{},"urls":[{"start":71,"end":93,"url":"http://t.co/nPQG0h3Oly","expanded_url":"http://well.blogs.nytimes.com/2013/08/15/a-powerful-tool-in-the-doctors-toolkit/?ref=health&_r=0","display_url":"well.blogs.nytimes.com/2013/08/15/a-p…"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":{}},"lang":"en","created_at":"2013-08-19T16:15:50.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"369489880587321344"}],"attachments":{"media_keys":{}}},{"conversation_id":"369492639345016832","author_id":"116716199","possibly_sensitive":false,"text":"RT @EU_eHealth: The #FP7 p-medicine project is online! More about data sharing &amp; integration via VPH models to personalised medicine: http:…","source":"Twitter for iPhone","id":"369492639345016832","entities":{"hashtags":[{"start":20,"end":24,"tag":"FP7"}],"urls":{},"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"annotations":{}},"lang":"en","created_at":"2013-08-19T16:14:44.000Z","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"369489793421307904"}],"attachments":{"media_keys":{}}},{"conversation_id":"369486756397461504","author_id":"116716199","possibly_sensitive":false,"text":"RT @myESMO: Signatures of Mutational Processes in Cancer: analysis of 4,938,362 mutations from 7,042 cancers http://t.co/q9VaXXPAJQ","source":"Twitter for iPhone","id":"369486756397461504","entities":{"hashtags":{},"urls":[{"start":109,"end":131,"url":"http://t.co/q9VaXXPAJQ","expanded_url":"http://bit.ly/1dmjF3R","display_url":"bit.ly/1dmjF3R"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{}},"lang":"en","created_at":"2013-08-19T15:51:22.000Z","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"369485350869020672"}],"attachments":{"media_keys":{}}},{"conversation_id":"369480177082183680","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: 'Tuberculosis \"time bomb\" costs Europe billions of euros a year' - http://t.co/AGfpp09i0F","source":"TweetDeck","id":"369480177082183680","entities":{"hashtags":{},"urls":[{"start":78,"end":100,"url":"http://t.co/AGfpp09i0F","expanded_url":"http://reut.rs/14NSYV1","display_url":"reut.rs/14NSYV1"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":43,"end":48,"probability":0.9601,"type":"Place","normalized_text":"Europe"}]},"lang":"en","created_at":"2013-08-19T15:25:13.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"369480061453225984"}],"attachments":{"media_keys":{}}},{"conversation_id":"369452966144909312","author_id":"116716199","possibly_sensitive":false,"text":"RT @EU_ECHA: ECHA publishes Guidance on applications for technical equivalence concerning biocides http://t.co/3K4JKE4ers","source":"TweetDeck","id":"369452966144909312","entities":{"hashtags":{},"urls":[{"start":99,"end":121,"url":"http://t.co/3K4JKE4ers","expanded_url":"http://bit.ly/12izXWI","display_url":"bit.ly/12izXWI"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":[{"start":13,"end":16,"probability":0.5751,"type":"Organization","normalized_text":"ECHA"}]},"lang":"en","created_at":"2013-08-19T13:37:05.000Z","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"369452901271216128"}],"attachments":{"media_keys":{}}},{"conversation_id":"369447997580775424","author_id":"116716199","possibly_sensitive":false,"text":"RT @innovationunion: 'Heart's own stem cells offer hope for new treatment of heart failure' #fp7 http://t.co/GPV7IpWUpf","source":"TweetDeck","id":"369447997580775424","entities":{"hashtags":[{"start":92,"end":96,"tag":"fp7"}],"urls":[{"start":97,"end":119,"url":"http://t.co/GPV7IpWUpf","expanded_url":"http://www.pharmanews.eu/research-and-development/1319-hearts-own-stem-cells-offer-hope-for-new-treatment-of-heart-failure","display_url":"pharmanews.eu/research-and-d…"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"lang":"en","created_at":"2013-08-19T13:17:21.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"369447952747491328"}],"attachments":{"media_keys":{}}},{"conversation_id":"369447872854761472","author_id":"116716199","possibly_sensitive":false,"text":"RT @GCessak: 'Heart's own stem cells offer hope for new treatment of heart failure' - http://t.co/a1xsS0mnOZ","source":"TweetDeck","id":"369447872854761472","entities":{"hashtags":{},"urls":[{"start":86,"end":108,"url":"http://t.co/a1xsS0mnOZ","expanded_url":"http://bit.ly/14cXCcD","display_url":"bit.ly/14cXCcD"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"lang":"en","created_at":"2013-08-19T13:16:51.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"369446716774182914"}],"attachments":{"media_keys":{}}},{"conversation_id":"369447828802007040","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: 'Heart's own stem cells offer hope for new treatment of heart failure' - http://t.co/zNyXmYSnu1","source":"TweetDeck","id":"369447828802007040","entities":{"hashtags":{},"urls":[{"start":84,"end":106,"url":"http://t.co/zNyXmYSnu1","expanded_url":"http://bit.ly/14cXCcD","display_url":"bit.ly/14cXCcD"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-08-19T13:16:41.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"369446066912894977"}],"attachments":{"media_keys":{}}},{"conversation_id":"369416031392903169","author_id":"116716199","possibly_sensitive":false,"text":"Send us your comments on our draft #herbal monograph on #Fucus vesiculosus (#bladderwrack): http://t.co/aFrkCHxfSr","source":"Twitter Web Client","id":"369416031392903169","entities":{"hashtags":[{"start":35,"end":42,"tag":"herbal"},{"start":56,"end":62,"tag":"Fucus"},{"start":76,"end":89,"tag":"bladderwrack"}],"urls":[{"start":92,"end":114,"url":"http://t.co/aFrkCHxfSr","expanded_url":"http://bit.ly/13LHnj8","display_url":"bit.ly/13LHnj8"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-19T11:10:19.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"333531395681054720","author_id":"116716199","possibly_sensitive":false,"text":"@wombarrapete @fiouw More details on orphan designations are here: http://t.co/nBhWNZiRJS http://t.co/jNm5SORCXx","source":"TweetDeck","id":"369415488037605376","entities":{"hashtags":{},"urls":[{"start":67,"end":89,"url":"http://t.co/nBhWNZiRJS","expanded_url":"http://bit.ly/16Zy2IA","display_url":"bit.ly/16Zy2IA"},{"start":90,"end":112,"url":"http://t.co/jNm5SORCXx","expanded_url":"http://bit.ly/150UJve","display_url":"bit.ly/150UJve"}],"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"},{"start":14,"end":20,"username":"Fiouw","id":"1367162942"}],"annotations":{}},"lang":"en","created_at":"2013-08-19T11:08:10.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"369415289110155264"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"conversation_id":"333531395681054720","author_id":"116716199","possibly_sensitive":false,"text":"@wombarrapete @fiouw Yes, orphan designations are only for medicines for diseases that are life-threatening or chronically debilitating.","source":"TweetDeck","id":"369415289110155264","entities":{"hashtags":{},"urls":{},"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"},{"start":14,"end":20,"username":"Fiouw","id":"1367162942"}],"annotations":{}},"lang":"en","created_at":"2013-08-19T11:07:22.000Z","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"369414395077488640"}],"in_reply_to_user_id":"17509073","attachments":{"media_keys":{}}},{"conversation_id":"333531395681054720","author_id":"116716199","possibly_sensitive":false,"text":"@wombarrapete @fiouw Orphan designations are based on the seriousness &amp; rarity of the condition, &amp; the existence of alternative treatments.","source":"TweetDeck","id":"369413271834476544","entities":{"hashtags":{},"urls":{},"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"},{"start":14,"end":20,"username":"Fiouw","id":"1367162942"}],"annotations":{}},"lang":"en","created_at":"2013-08-19T10:59:22.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"369412501634416640"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"conversation_id":"333531395681054720","author_id":"116716199","possibly_sensitive":false,"text":"@wombarrapete @fiouw Apologies, the correct link for the orphan designation is http://t.co/ybv9RSBgHs","source":"TweetDeck","id":"369412501634416640","entities":{"hashtags":{},"urls":[{"start":79,"end":101,"url":"http://t.co/ybv9RSBgHs","expanded_url":"http://bit.ly/1ajS6bP","display_url":"bit.ly/1ajS6bP"}],"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"},{"start":14,"end":20,"username":"Fiouw","id":"1367162942"}],"annotations":{}},"lang":"en","created_at":"2013-08-19T10:56:18.000Z","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"369411157016076288"}],"in_reply_to_user_id":"17509073","attachments":{"media_keys":{}}},{"conversation_id":"369410407435231232","author_id":"116716199","possibly_sensitive":false,"text":"A public consultation is open on our draft #herbal monograph on #Fucus vesiculosus (#bladderwrack): http://t.co/aFrkCHxfSr","source":"bitly bitlink","id":"369410407435231232","entities":{"hashtags":[{"start":43,"end":50,"tag":"herbal"},{"start":64,"end":70,"tag":"Fucus"},{"start":84,"end":97,"tag":"bladderwrack"}],"urls":[{"start":100,"end":122,"url":"http://t.co/aFrkCHxfSr","expanded_url":"http://bit.ly/13LHnj8","display_url":"bit.ly/13LHnj8"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-19T10:47:59.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"369408019710615552","author_id":"116716199","possibly_sensitive":false,"text":"RT @innovationunion: #Brain changes detected 20 Years before Alzheimer’s symptoms http://t.co/B3LyGG46TG","source":"TweetDeck","id":"369408019710615552","entities":{"hashtags":[{"start":21,"end":27,"tag":"Brain"}],"urls":[{"start":82,"end":104,"url":"http://t.co/B3LyGG46TG","expanded_url":"http://www.alzinfo.org/07/articles/diagnosis-and-causes/brain-detected-20-years-alzheimers-symptoms","display_url":"alzinfo.org/07/articles/di…"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":[{"start":61,"end":69,"probability":0.589,"type":"Other","normalized_text":"Alzheimer"}]},"lang":"en","created_at":"2013-08-19T10:38:29.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"369396950514143232"}],"attachments":{"media_keys":{}}},{"conversation_id":"369407409586204672","author_id":"116716199","possibly_sensitive":false,"text":"RT @EPHA_EU: Costs of #tuberculosis disease in the #EU – a systematic analysis and cost calculation:  http://t.co/2UuSo2nJc3  @ERSTalk @ERS…","source":"TweetDeck","id":"369407409586204672","entities":{"hashtags":[{"start":22,"end":35,"tag":"tuberculosis"},{"start":51,"end":54,"tag":"EU"}],"urls":[{"start":102,"end":124,"url":"http://t.co/2UuSo2nJc3","expanded_url":"http://bit.ly/1a8WqdI","display_url":"bit.ly/1a8WqdI"}],"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"},{"start":126,"end":134,"username":"ErStalk","id":"1195975053575258112"}],"annotations":{}},"lang":"en","created_at":"2013-08-19T10:36:04.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"369396485089021952"}],"attachments":{"media_keys":{}}},{"conversation_id":"369407144065388544","author_id":"116716199","possibly_sensitive":false,"text":"RT @URPLWMiPB: List of medicinal products that were granted a marketing authorisation in July 2013. http://t.co/vjntsZdqi9","source":"TweetDeck","id":"369407144065388544","entities":{"hashtags":{},"urls":[{"start":100,"end":122,"url":"http://t.co/vjntsZdqi9","expanded_url":"http://tnij.org/y4y3","display_url":"tnij.org/y4y3"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"lang":"en","created_at":"2013-08-19T10:35:01.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"368421127447539713","author_id":"116716199","possibly_sensitive":false,"text":"@StripSafely @webDM1 We do not deal with medical devices such as test strips: these are regulated at national level.http://t.co/v1ddkkIgB6","source":"TweetDeck","id":"369374395505995776","entities":{"hashtags":{},"urls":[{"start":116,"end":138,"url":"http://t.co/v1ddkkIgB6","expanded_url":"http://bit.ly/17XsIT4","display_url":"bit.ly/17XsIT4"}],"mentions":[{"start":0,"end":12,"username":"StripSafely","id":"1496947920"},{"start":13,"end":20,"username":"webDM1","id":"758619698"}],"annotations":{}},"lang":"en","created_at":"2013-08-19T08:24:53.000Z","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"368436912203497472"}],"in_reply_to_user_id":"1496947920","attachments":{"media_keys":{}}},{"conversation_id":"369373332283486209","author_id":"116716199","possibly_sensitive":false,"text":"The EPAR for #Imvanex, a vaccine to protect against #smallpox in adults, is available on our website: http://t.co/grAx6M9sAB","source":"Twitter Web Client","id":"369373332283486209","entities":{"hashtags":[{"start":13,"end":21,"tag":"Imvanex"},{"start":52,"end":61,"tag":"smallpox"}],"urls":[{"start":102,"end":124,"url":"http://t.co/grAx6M9sAB","expanded_url":"http://bit.ly/1dcYfpJ","display_url":"bit.ly/1dcYfpJ","status":429,"unwound_url":"https://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002596/human_med_001666.jsp&mid=WC0b01ac058001d124"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-19T08:20:39.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"368378853376675840","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_EU: All the latest on this week's #westnile fever cases is here: http://t.co/q6kIyfNOeB. There's an infographic too: http://t.co/S…","source":"TweetDeck","id":"368378853376675840","entities":{"hashtags":[{"start":43,"end":52,"tag":"westnile"}],"urls":[{"start":74,"end":96,"url":"http://t.co/q6kIyfNOeB","expanded_url":"http://bit.ly/LIn3v2","display_url":"bit.ly/LIn3v2"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"lang":"en","created_at":"2013-08-16T14:28:57.000Z","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"368377241442336769"}],"attachments":{"media_keys":{}}},{"conversation_id":"368374870041976832","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO_Europe: Final version of the European Health Report 2012 is now available in print – covers 53 countries http://t.co/E4wmlan3VA","source":"TweetDeck","id":"368374870041976832","entities":{"hashtags":{},"urls":[{"start":113,"end":135,"url":"http://t.co/E4wmlan3VA","expanded_url":"http://bit.ly/1cIVsHh","display_url":"bit.ly/1cIVsHh"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":37,"end":63,"probability":0.5693,"type":"Other","normalized_text":"European Health Report 2012"}]},"lang":"en","created_at":"2013-08-16T14:13:07.000Z","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"368374817625358336"}],"attachments":{"media_keys":{}}},{"conversation_id":"368349468036694016","author_id":"116716199","possibly_sensitive":false,"text":"@GBRChris_A Yes but concerns remain that stored smallpox virus could be deliberately released as bioterrorism: http://t.co/zQ07GZwN36 (p. 9)","source":"TweetDeck","id":"368367672817623040","entities":{"hashtags":{},"urls":[{"start":111,"end":133,"url":"http://t.co/zQ07GZwN36","expanded_url":"http://bit.ly/1abxylR","display_url":"bit.ly/1abxylR"}],"mentions":[{"start":0,"end":11,"username":"GBRChris_A","id":"362672893"}],"annotations":{}},"lang":"en","created_at":"2013-08-16T13:44:31.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"368355640340905984"}],"in_reply_to_user_id":"362672893","attachments":{"media_keys":{}}},{"conversation_id":"368365736521396224","author_id":"116716199","possibly_sensitive":false,"text":"RT @US_FDA: What is American foulbrood? Learn here and read about the New Drug Approved to Help Agriculture's Honey #Bees http://t.co/pxXPm…","source":"TweetDeck","id":"368365736521396224","entities":{"hashtags":[{"start":116,"end":121,"tag":"Bees"}],"urls":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":{}},"lang":"en","created_at":"2013-08-16T13:36:50.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"368362399805370368"}],"attachments":{"media_keys":{}}},{"conversation_id":"368349468036694016","author_id":"116716199","possibly_sensitive":false,"text":"We've published the assessment report for #Imvanex, a vaccine to protect against #smallpox in adults: http://t.co/foVwlCYYSA","source":"bitly bitlink","id":"368349468036694016","entities":{"hashtags":[{"start":42,"end":50,"tag":"Imvanex"},{"start":81,"end":90,"tag":"smallpox"}],"urls":[{"start":102,"end":124,"url":"http://t.co/foVwlCYYSA","expanded_url":"http://bit.ly/1dcYfpJ","display_url":"bit.ly/1dcYfpJ"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-16T12:32:11.000Z","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"368347882484940800","author_id":"116716199","possibly_sensitive":false,"text":"RT @AEMPSGOB: Publication of the monthly report from the Spanish medicines agency for the month of July 2013 http://t.co/8CtHlg3ntd","source":"TweetDeck","id":"368347882484940800","entities":{"hashtags":{},"urls":[{"start":109,"end":131,"url":"http://t.co/8CtHlg3ntd","expanded_url":"http://www.aemps.gob.es/informa/informeMensual/2013/julio/home.htm","display_url":"aemps.gob.es/informa/inform…"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"lang":"en","created_at":"2013-08-16T12:25:53.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"368347565747879936","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO_Europe: Top 5 key facts you need to know from European Health Report 2012 #EHR2012 http://t.co/acgfuZQAzd","source":"TweetDeck","id":"368347565747879936","entities":{"hashtags":[{"start":82,"end":90,"tag":"EHR2012"}],"urls":[{"start":91,"end":113,"url":"http://t.co/acgfuZQAzd","expanded_url":"http://bit.ly/19xkvf1","display_url":"bit.ly/19xkvf1"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":54,"end":80,"probability":0.2387,"type":"Other","normalized_text":"European Health Report 2012"}]},"lang":"en","created_at":"2013-08-16T12:24:37.000Z","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"368347507908026369"}],"attachments":{"media_keys":{}}},{"conversation_id":"368342439293353984","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: \"It’s time for rapprochement between academic campaigners &amp; pharma companies over clinical trials data transparency\" http://t.co…","source":"TweetDeck","id":"368342439293353984","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"lang":"en","created_at":"2013-08-16T12:04:15.000Z","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"368342147202048000"}],"attachments":{"media_keys":{}}},{"conversation_id":"368340796963311616","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO_Europe: 40% of communicable disease deaths due to #TB –browse the new online version of the European Health Report 2012 http://t.co…","source":"TweetDeck","id":"368340796963311616","entities":{"hashtags":[{"start":58,"end":61,"tag":"TB"}],"urls":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":100,"end":121,"probability":0.6284,"type":"Other","normalized_text":"European Health Report"}]},"lang":"en","created_at":"2013-08-16T11:57:44.000Z","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"368340736070012928"}],"attachments":{"media_keys":{}}},{"conversation_id":"368335361887711232","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO_Europe: Clickable version of the European Health Report 2012 is now online with added graphics. Report covers &gt;900 mil people http:…","source":"TweetDeck","id":"368335361887711232","entities":{"hashtags":{},"urls":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":41,"end":67,"probability":0.4876,"type":"Other","normalized_text":"European Health Report 2012"}]},"lang":"en","created_at":"2013-08-16T11:36:08.000Z","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"368335112615636992"}],"attachments":{"media_keys":{}}},{"conversation_id":"368331460039565314","author_id":"116716199","possibly_sensitive":false,"text":"Two more weeks to comment on our draft guideline on the acceptability of #names for human #medicines:  http://t.co/B6HAiNP9K6","source":"Twitter Web Client","id":"368331460039565314","entities":{"hashtags":[{"start":73,"end":79,"tag":"names"},{"start":90,"end":100,"tag":"medicines"}],"urls":[{"start":103,"end":125,"url":"http://t.co/B6HAiNP9K6","expanded_url":"http://bit.ly/13EDaO8","display_url":"bit.ly/13EDaO8"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-16T11:20:38.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"368331393702428674","author_id":"116716199","possibly_sensitive":false,"text":"Two more weeks to comment on our concept paper on updating our guidance on venous thromboembolic (#VTE) disease: http://t.co/6mZIJI1xz1","source":"Twitter Web Client","id":"368331393702428674","entities":{"hashtags":[{"start":98,"end":102,"tag":"VTE"}],"urls":[{"start":113,"end":135,"url":"http://t.co/6mZIJI1xz1","expanded_url":"http://bit.ly/11QCCrK","display_url":"bit.ly/11QCCrK"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-16T11:20:22.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"368295296125915136","author_id":"116716199","possibly_sensitive":false,"text":"RT @IntDiabetesFed: Today we're reading: Study to investigate causes of Type 1 #diabetes http://t.co/KbJYPsy8WB via @abcnews","source":"TweetDeck","id":"368295296125915136","entities":{"hashtags":[{"start":79,"end":88,"tag":"diabetes"}],"urls":[{"start":89,"end":111,"url":"http://t.co/KbJYPsy8WB","expanded_url":"http://bit.ly/19h3u55","display_url":"bit.ly/19h3u55"}],"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"},{"start":116,"end":124,"username":"abcnews","id":"2768501"}],"annotations":{}},"lang":"en","created_at":"2013-08-16T08:56:55.000Z","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"368295160607555586"}],"attachments":{"media_keys":{}}},{"conversation_id":"368293947632013312","author_id":"116716199","possibly_sensitive":false,"text":"RT @EU_ECHA: The August issue of the ECHA Newsletter focuses on #biocides http://t.co/jKLBeOMD1L","source":"TweetDeck","id":"368293947632013312","entities":{"hashtags":[{"start":64,"end":73,"tag":"biocides"}],"urls":[{"start":74,"end":96,"url":"http://t.co/jKLBeOMD1L","expanded_url":"http://newsletter.echa.europa.eu","display_url":"newsletter.echa.europa.eu"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":[{"start":37,"end":51,"probability":0.707,"type":"Organization","normalized_text":"ECHA Newsletter"}]},"lang":"en","created_at":"2013-08-16T08:51:34.000Z","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"368293736326766592"}],"attachments":{"media_keys":{}}},{"conversation_id":"368285772690259968","author_id":"116716199","possibly_sensitive":false,"text":"Two weeks left to comment on our draft guideline on the acceptability of #names for human #medicines:  http://t.co/S8zeHc5Mun","source":"bitly bitlink","id":"368285772690259968","entities":{"hashtags":[{"start":73,"end":79,"tag":"names"},{"start":90,"end":100,"tag":"medicines"}],"urls":[{"start":103,"end":125,"url":"http://t.co/S8zeHc5Mun","expanded_url":"http://bit.ly/13EDaO8","display_url":"bit.ly/13EDaO8"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-16T08:19:05.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"368285376852815872","author_id":"116716199","possibly_sensitive":false,"text":"Two weeks left to comment on our concept paper on updating our guidance on venous thromboembolic (#VTE) disease: http://t.co/f3x2wY1iZ3","source":"bitly bitlink","id":"368285376852815872","entities":{"hashtags":[{"start":98,"end":102,"tag":"VTE"}],"urls":[{"start":113,"end":135,"url":"http://t.co/f3x2wY1iZ3","expanded_url":"http://bit.ly/11QCCrK","display_url":"bit.ly/11QCCrK"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-16T08:17:30.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"368284480886165505","author_id":"116716199","possibly_sensitive":false,"text":"Yesterday we published a reflection paper on general issues for consideration regarding coated #nanomedicines: http://t.co/bxxO26zhnc","source":"Twitter Web Client","id":"368284480886165505","entities":{"hashtags":[{"start":95,"end":109,"tag":"nanomedicines"}],"urls":[{"start":111,"end":133,"url":"http://t.co/bxxO26zhnc","expanded_url":"http://bit.ly/19vluw5","display_url":"bit.ly/19vluw5"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-16T08:13:57.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"368284013196500992","author_id":"116716199","possibly_sensitive":false,"text":"RT @EFPIA: Check out our video \"The Journey of Clinical Trials\". We think it's fun! http://t.co/YUsZhDZIRS","source":"TweetDeck","id":"368284013196500992","entities":{"hashtags":{},"urls":[{"start":84,"end":106,"url":"http://t.co/YUsZhDZIRS","expanded_url":"http://ow.ly/nQbCE","display_url":"ow.ly/nQbCE"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":32,"end":61,"probability":0.9147,"type":"Other","normalized_text":"The Journey of Clinical Trials"}]},"lang":"en","created_at":"2013-08-16T08:12:05.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"368281729666408448"}],"attachments":{"media_keys":{}}},{"conversation_id":"368283038503161856","author_id":"116716199","possibly_sensitive":false,"text":"RT @WDD: The #WDD newsletter is out! All you need to know is in there! http://t.co/nHN87a3QKq #diabetes","source":"TweetDeck","id":"368283038503161856","entities":{"hashtags":[{"start":13,"end":17,"tag":"WDD"},{"start":94,"end":103,"tag":"diabetes"}],"urls":[{"start":71,"end":93,"url":"http://t.co/nHN87a3QKq","expanded_url":"http://bit.ly/14R1BLz","display_url":"bit.ly/14R1BLz"}],"mentions":[{"start":3,"end":7,"username":"WDD","id":"15179874"}],"annotations":{}},"lang":"en","created_at":"2013-08-16T08:08:13.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"368281127531720704"}],"attachments":{"media_keys":{}}},{"conversation_id":"368037733715165185","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: Disease Outbreak News on wild poliovirus type 1 (WPV1) in Israel: http://t.co/y9T5Z3xlXz. No case of paralytic #polio reported.","source":"TweetDeck","id":"368037733715165185","entities":{"hashtags":[{"start":120,"end":126,"tag":"polio"}],"urls":[{"start":75,"end":97,"url":"http://t.co/y9T5Z3xlXz","expanded_url":"http://goo.gl/rRPeH4","display_url":"goo.gl/rRPeH4"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":67,"end":72,"probability":0.9884,"type":"Place","normalized_text":"Israel"}]},"lang":"en","created_at":"2013-08-15T15:53:28.000Z","public_metrics":{"retweet_count":66,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"368023809527263232"}],"attachments":{"media_keys":{}}},{"conversation_id":"368037636948389888","author_id":"116716199","possibly_sensitive":false,"text":"RT @WHO: Update: WHO estimates risk of further int'l spread of wild #poliovirus type 1 (WPV1) from Israel to remain moderate to high","source":"TweetDeck","id":"368037636948389888","entities":{"hashtags":[{"start":68,"end":79,"tag":"poliovirus"}],"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":99,"end":104,"probability":0.9869,"type":"Place","normalized_text":"Israel"}]},"lang":"en","created_at":"2013-08-15T15:53:05.000Z","public_metrics":{"retweet_count":38,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"368019631534927872"}],"attachments":{"media_keys":{}}},{"conversation_id":"368008958386401280","author_id":"116716199","possibly_sensitive":false,"text":"We've published a reflection paper on general issues for consideration regarding coated #nanomedicines: http://t.co/1y3H8BDSit","source":"bitly bitlink","id":"368008958386401280","entities":{"hashtags":[{"start":88,"end":102,"tag":"nanomedicines"}],"urls":[{"start":104,"end":126,"url":"http://t.co/1y3H8BDSit","expanded_url":"http://bit.ly/19vluw5","display_url":"bit.ly/19vluw5"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-15T13:59:07.000Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"367992377568661504","author_id":"116716199","possibly_sensitive":false,"text":"RT @IlaeWeb: New definition of #Epilepsy created by ILAE - contribute your comments at http://t.co/oTBJ6J6EWf","source":"TweetDeck","id":"367992377568661504","entities":{"hashtags":[{"start":31,"end":40,"tag":"Epilepsy"}],"urls":[{"start":87,"end":109,"url":"http://t.co/oTBJ6J6EWf","expanded_url":"http://www.ilae.org/Visitors/Centre/Definition.cfm","display_url":"ilae.org/Visitors/Centr…"}],"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"annotations":{}},"lang":"en","created_at":"2013-08-15T12:53:14.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"367992204943302656"}],"attachments":{"media_keys":{}}},{"conversation_id":"367992306114514944","author_id":"116716199","possibly_sensitive":false,"text":"RT @ECDC_Flu: Study finds no evidence of #H1N1pdm09 infection a contributor to childhood narcolepsy after Pandemrix vacc in Finland http://…","source":"TweetDeck","id":"367992306114514944","entities":{"hashtags":[{"start":41,"end":51,"tag":"H1N1pdm09"}],"urls":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":[{"start":106,"end":119,"probability":0.3053,"type":"Person","normalized_text":"Pandemrix vacc"},{"start":124,"end":130,"probability":0.9857,"type":"Place","normalized_text":"Finland"}]},"lang":"en","created_at":"2013-08-15T12:52:57.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"367991844245741568"}],"attachments":{"media_keys":{}}},{"conversation_id":"367971186871123968","author_id":"116716199","possibly_sensitive":false,"text":"RT @LV_MPA: The Swedish medicines agency presents its interim report January-June 2013 http://t.co/C89eOvEnlA","source":"TweetDeck","id":"367971186871123968","entities":{"hashtags":{},"urls":[{"start":87,"end":109,"url":"http://t.co/C89eOvEnlA","expanded_url":"http://bit.ly/1byJ74m","display_url":"bit.ly/1byJ74m"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"lang":"en","created_at":"2013-08-15T11:29:02.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"367956056053665792","author_id":"116716199","possibly_sensitive":false,"text":"RT @innovationunion: #Mosquito meets human. Amazing videos show what happens inside you when a mosquito looks for blood: http://t.co/0mpkfB…","source":"TweetDeck","id":"367956056053665792","entities":{"hashtags":[{"start":21,"end":30,"tag":"Mosquito"}],"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"lang":"en","created_at":"2013-08-15T10:28:54.000Z","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"367955109222694912"}],"attachments":{"media_keys":{}}},{"conversation_id":"367944411155791872","author_id":"116716199","possibly_sensitive":false,"text":"RT @NICEcomms: Read what NICE says on treatments for #ADHD following reports of a rise in prescriptions http://t.co/Dxa39LiTs7","source":"TweetDeck","id":"367944411155791872","entities":{"hashtags":[{"start":53,"end":58,"tag":"ADHD"}],"urls":[{"start":104,"end":126,"url":"http://t.co/Dxa39LiTs7","expanded_url":"http://www.nice.org.uk/newsroom/news/AvoidDrugTreatmentChildrenYoungPeopleModerateADHD.jsp","display_url":"nice.org.uk/newsroom/news/…"}],"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{}},"lang":"en","created_at":"2013-08-15T09:42:38.000Z","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"367944312484405248"}],"attachments":{"media_keys":{}}},{"conversation_id":"367941381710675968","author_id":"116716199","possibly_sensitive":false,"text":"RT @EU_Consumer: Are #sunscreens using #zinc oxide #nanoparticles safe? A summary from #EU Scientific Committee on #Consumer #Safety http:/…","source":"TweetDeck","id":"367941381710675968","entities":{"hashtags":[{"start":21,"end":32,"tag":"sunscreens"},{"start":39,"end":44,"tag":"zinc"},{"start":51,"end":65,"tag":"nanoparticles"},{"start":87,"end":90,"tag":"EU"},{"start":115,"end":124,"tag":"Consumer"},{"start":125,"end":132,"tag":"Safety"}],"urls":{},"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"}],"annotations":{}},"lang":"en","created_at":"2013-08-15T09:30:36.000Z","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"367941276768817152"}],"attachments":{"media_keys":{}}},{"conversation_id":"367941009952763904","author_id":"116716199","possibly_sensitive":false,"text":"RT @innovationunion: Milestone study probes #cancer origin http://t.co/RF2DAH69mN #health","source":"TweetDeck","id":"367941009952763904","entities":{"hashtags":[{"start":44,"end":51,"tag":"cancer"},{"start":82,"end":89,"tag":"health"}],"urls":[{"start":59,"end":81,"url":"http://t.co/RF2DAH69mN","expanded_url":"http://www.bbc.co.uk/news/health-23665996","display_url":"bbc.co.uk/news/health-23…"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"lang":"en","created_at":"2013-08-15T09:29:07.000Z","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"367940647669739522"}],"attachments":{"media_keys":{}}},{"conversation_id":"367934504490373120","author_id":"116716199","possibly_sensitive":false,"text":"You can now register for our workshop on conflicts of interests (6 September) up until 28 August: http://t.co/e3cGwXAd9p #coiworkshop","source":"Twitter Web Client","id":"367934504490373120","entities":{"hashtags":[{"start":121,"end":133,"tag":"coiworkshop"}],"urls":[{"start":98,"end":120,"url":"http://t.co/e3cGwXAd9p","expanded_url":"http://bit.ly/14bOWQ3","display_url":"bit.ly/14bOWQ3"}],"mentions":{},"annotations":{}},"lang":"en","created_at":"2013-08-15T09:03:16.000Z","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"conversation_id":"367679817128222721","author_id":"116716199","possibly_sensitive":false,"text":"RT @FDAanimalhealth: New #Drug Approved to Help Agriculture's Helpful Honey #Bees http://t.co/XvfFVWifAs","source":"TweetDeck","id":"367679817128222721","entities":{"hashtags":[{"start":25,"end":30,"tag":"Drug"},{"start":76,"end":81,"tag":"Bees"}],"urls":[{"start":82,"end":104,"url":"http://t.co/XvfFVWifAs","expanded_url":"http://1.usa.gov/14DLssQ","display_url":"1.usa.gov/14DLssQ"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{}},"lang":"en","created_at":"2013-08-14T16:11:14.000Z","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"367679658591920128"}],"attachments":{"media_keys":{}}}]
